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This thesis examines the consequences of partial vision loss, namely macular 
disease (MD), on both the structure and function of the posterior visual pathway. 
Using both cross-sectional and longitudinal analyses we explored how the anatomy 
of MD patients may change differently than in those aging naturally. The patient 
group showed reduced cortical thickness, which appears to largely impact the 
anatomical representation of central vision. However, they also showed reduced 
fractional anisotropy of the underlying white matter; but both the fiber bundles 
projecting to central and peripheral representations in early visual cortex were 
affected, suggesting broader deficits emerge in visual white matter. Our longitudinal 
assessments identified continued decline in cortical thickness and myelin density, 
even in long-standing vision loss, but individual case studies indicate the greatest 
changes in cortex likely emerge early in the disease following functional vision loss. 
We next assessed how partial vision loss may impact functional connectivity 
between striate and extrastriate cortex and found a selective reduction in functional 
connectivity between striate and the fusiform face area patients with central field 
loss. Finally, we used transient retinal lesions to test for responses in a ‘simulated 
lesion projection zone’ (sLPZ) in sighted participants, providing some evidence that 
peripheral visual stimulation can produce ‘patient-like’ responses in central 
representations in some individual controls while performing a task. This suggests 
LPZ responses - often deemed the ‘signature of reorganization of visual processing’ 
- may be driven by unmasked top-down feedback. Collectively, our findings add to 
growing evidence for atrophy in the posterior visual pathway in MD. Given that the 
viability of the visual brain may limit the success of visual restoration, development of 
neuroprotective strategies will benefit from a better understanding of the time scale 
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Chapter 1: A review of the neural and behavioural 
consequences of eye disease 
1.1 Overview 
The central aim of this thesis is to enhance our understanding of how the brain is 
impacted by eye disease, specifically in the visual cortex. The primary question in 
this field asks whether visual cortex remains dormant due to lack of visual input, 
deteriorates over time, or whether it undergoes some form of cortical reorganisation 
which may help patients process remaining vision more effectively. Whilst it is the 
eye that receives visual input, it is often forgotten that the brain processes and 
makes sense of incoming information. A great deal of clinical research on eye 
disease has focused on the physiological changes and degeneration of the eye with 
the aim of preventing, treating, and restoring functionally useful vision. 
Comparatively fewer studies are actively monitoring other aspects of vision, notably 
the consequences on basic visual perception such as face or object recognition, as 
well as the neural consequences of eye disease. Magnetic Resonance Imaging 
(MRI) has provided neuroscientists with a safe and non-invasive means of evaluating 
both the structure and function of the human brain. Approximately 20% of cortex 
within the human brain is recruited to process visual information, primarily occupying 
the occipital lobe, and extending to temporal and parietal regions (Wandell, 
Dumoulin, & Brewer, 2007). Given that sight ultimately takes place in the brain, 
structural and functional consequences of sight loss on both the anterior (eye) and 
posterior (brain) parts of the visual pathway should be explored together. 
This review will explore different methods employed by researchers to assess the 
extent to which eye disease impacts on visual cortex, considering both neural and 
behavioural consequences. First, research concerning structural changes in the 
brain will be considered for different types of eye disease, primarily the leading 
causes of blindness - macular degeneration and glaucoma. Additionally, it will also 
provide an overview of an on-going debate within the literature concerning whether 
cortical reorganisation occurs following vision loss, a question that will be addressed 
further in Chapter 6. Finally, the review will discuss the importance of refining 
methods used with visually impaired individuals, and the impact this has on clinical 





The focus of the review will be on studies investigating visual loss; however it must 
be acknowledged that fMRI is widely used to examine how the brain represents the 
visual world in normally-sighted individuals, which provides the necessary context for 
understanding how mechanisms underlying ‘normal’ visual function can be affected 
by eye disease. The opening section of this review will also discuss the structural 
changes associated with natural aging, to provide context particularly when 
discussing research investigating structural changes associated with vision loss in an 
aging population. Given that most studies investigate age-related visual diseases, it 
is important to know how the brain changes due to natural aging, enabling us to 
disentangle whether it is aging or eye disease that is driving any changes observed 
in visual cortex in visually impaired participants. Additionally, for the most part, 
degeneration of the eye is the cause of visual dysfunction, however there are cases 
where the eyes remain intact but damage to the visual brain (from trauma or 
disease) results in visual deficits (Brown, Woodall, Kitching, Baseler, & Morland, 
2016). This review will focus on visual loss caused by eye disease, given that 
partially sighted individuals recruited for the empirical chapters have forms of eye 
disease only.  
1.2 Overview of eye diseases 
Throughout this review, literature relating to different forms of central and peripheral 
vision loss will be discussed in the context of what we already know about visual 
processing in normally sighted individuals. Primarily, macular degeneration (both 
age-related and inherited forms), glaucoma, and retinitis pigmentosa will be 
discussed. Whilst it is known that visual loss may have other underlying causes, they 
will not be covered in detail in this review.  
1.2.1 Macular degeneration 
Macular degeneration (MD) refers to a collection of disorders which cause a 
progressive loss of the central vision following damage to the macula, the central 
part of the retina. There are a sub-group of disorders which have an early onset and 
are commonly known as juvenile macular dystrophies (JMD), and those with a later 
onset are collectively referred to as age-related macular degeneration (AMD). 
Stargardt’s disease and cone rod dystrophy (CRD) are among the most common 
inherited juvenile forms of MD. Like AMD, forms of JMD are progressive, with an 





known mutation of the ABCA4 gene (Lois, Halfyard, Bird, Holder, & Fitzke, 2004). 
Fatty substances accumulate within the RPE which in turn causes the 
photoreceptors in the macular to degenerate. CRD refers to a collection of disorders 
causing progressive vision loss first affecting the cones and later in the disease, the 
rods. CRD is caused by mutations in multiple genes, some of which are linked to 
other diseases such as Stargardt’s disease and retinitis pigmentosa (Gill, Georgiou, 
Kalitzeos, Moore, & Michaelides, 2019).  
Currently, AMD is the leading cause of central visual loss in the western world 
(Rostron & McKibbin, 2012). In the UK, approximately 2.4% of individuals aged 50+ 
year, 4.8% aged over 65 years and 12.2% aged over 80 years are affected by late 
stage AMD (NICE, 2018). Whilst most forms of JMD are inherited, AMD as the name 
suggests, occurs later in life with a variety of different risk factors, most notably 
smoking (Lim, Mitchell, Seddon, Holz, & Wong, 2012). There are two forms of AMD 
as shown in Figure 1.1: neovascular or ‘wet’ AMD, and geographic atrophy or ‘dry’ 
AMD. Dry AMD is the most common form, characterised by the progressive build-up 
of drusen (waste products) in the retinal pigment epithelium (RPE), in turn damaging 
the photoreceptors and causing the loss of central vision. Wet AMD damages the 
macular in a different way; blood, lipids and fluid leak and cause swelling under the 
macula. Additionally, the breakthrough of new blood vessel growth to the neural 
retinal (choroidal neovascularisation) results in scarring. Dry AMD is currently the 
most common form of age-related vision loss, yet currently there is no cure. The wet 
form is more treatable, and patients are recommended to have anti-vascular 
endothelial growth factor drugs (anti-VEGF) which aim to prevent further leaks and 
prevent the growth of new blood vessels. This does not necessarily result in 
improved vision in all cases, but it does prevent the progression of the disease and 
stabilise vision, and so interventions should be administered at the earliest time in 





1.3. Structural changes associated with natural aging 
It is known that as we age, our brains show signs of gradual structural decline. 
Structural changes refer to reductions in cortical thickness, volume and/or surface 
area, the extent to which increases with age. This happens gradually over the 
lifespan as a result of the natural aging process, notably after 50 years of age (Salat 
et al., 2004). However, in cases of neurological disease, eye disease or trauma to 
the eye or brain, changes can become more significant and can occur more rapidly, 
depending on the nature of the disease. Collectively, research has tried to establish 
three key points: (1) what the expected rate of change is in the human brain with 
normal aging, (2) determine whether any observed changes are uniform and 
constant across the whole brain, or (3) whether there are specific brain regions with 
more rapid changes.  
Figure 1.1. Illustrations of the retina and schematics of the outer layers of the retina in 
normally sighted individuals, dry AMD, and wet AMD. Both forms damage the retinal pigment 
epithelium (RPE) but through different mechanisms. In dry AMD, a fatty waste product – 
drusen - builds up and can be detected in retinal imaging (yellow substance appearing in the 
macula). The cross-sectional schematic of part of the retina shows the build-up of drusen 
which in turn damages the RPE and photoreceptors, largely the cones. In wet AMD, the 
damage is caused by the growth of leaky blood vessels, which if not treated with anti-VEGF 
drugs, will continue to haemorrhage (reddening of the macula in the retinal image) and 





For visual areas, evidence concerning structural changes is quite mixed; earlier 
studies found small changes in the occipital cortex, including the occipital pole (Fjell 
et al., 2009; Salat et al., 2004), while others have seen no significant change in 
primary visual cortex (Naftali Raz et al., 2005; Thambisetty et al., 2010). One study 
of interest examined visual cortex in more detail, parcellating visual cortex into 9 
different regions of interest (ROIs), each representing a different mean eccentricity, 
ranging from < 1˚, up to 63.3˚ (Griffis, Burge, & Visscher, 2016). Different portions of 
the calcarine sulcus were examined, including the sulcal wall, gyral crown, as well as 
the sulcus depth. Results showed a significant interaction between age group and 
ROI whereby older participants exhibit a reduction in cortical thickness in the 4 ROIs 
representing the most eccentric parts of vision – the more anterior portions of the 
calcarine sulcus. No significant differences between age groups were observed for 
the more central representations (up to 7˚ eccentricity). Findings suggest that 
peripheral vision may be more affected by age-related decline in contrast to central 
vision (Griffis et al., 2016). Whilst this study did not acquire any measures of visual 
acuity or assess visual perception at different eccentricities, previous studies using 
tasks engaging peripheral vision have supported this conclusion. Distractor and 
attention-based tasks highlight a steep decline in performance, associated with aging 
(Ball, Edwards, & Ross, 2007; Owsley, 2011). Arguably, any attention-driven tasks 
will rely on central vision and sighted individuals will always opt to use their central 
vision to complete tasks successfully. Perhaps this biases us to use central vision, 
and by not utilising peripheral vision to the same extent, any deterioration in 
peripheral vision may go undetected. This may also explain how glaucoma can go 
unnoticed for many years. This work is of particular interest when determining how 
visual cortex changes as a result of disease versus natural aging; this will be 
explored further in this thesis. 
Evidence has been largely mixed, primarily because of the varying methods used to 
parcellate the brain into different ROIs, but also because most studies use a cross-
sectional design, incorporating data from a range of ages as opposed to conducting 
within-subject comparisons over time. Furthermore, it is known that in contrast to 
non-visual brain regions, visual cortex, particularly primary visual cortex is thin, and 
as such, some protocols or analysis techniques may not be sensitive enough to 





Essen, 2014). Studies which interrogated the calcarine sulcus further by parcellating 
it into regions representing different parts of the visual field are more likely to detect 
subtle changes compared to those who opted for examining the calcarine sulcus as 
a whole. Due to cortical magnification, it is likely any subtle changes in more anterior 
calcarine sulcus are averaged out by the stability of central representations. To 
address this gap in the literature, a longitudinal study following patients with macular 
disease, as well as sighted controls, will be described Chapter 2.  
Cortical myelin can also be assessed using in vivo MRI; areas of cortex known to be 
thinner such as the primary sensory regions are often highly myelinated, apart from 
motor cortex (Glasser & Van Essen, 2011). It has been suggested that regions with 
more myelin are often considered to be less ‘plastic’; primary visual cortex is a good 
example as it is present in those who are congenitally blind and it develops without 
the need for visual experience (Glasser et al., 2014). Cortical regions deemed as 
being capable of greater plasticity are thought to be thicker and consist of more 
complex intracortical circuits (Glasser et al., 2014). With natural aging, degeneration 
is not limited to just cortical neurons, but also extends to myelin. Oligodendrocytes – 
cells within the central nervous system that produce myelin – are considered to be 
the most vulnerable cells within the brain (Peters, 2002).  
Whilst cortical myelin is thought to be better preserved with age compared to myelin 
in the white matter, it is important to recognise that degeneration is not uniform 
across the whole brain (Fjell & Walhovd, 2010; Lu et al., 2011; Peters, 2002). 
Myelination in prefrontal and association areas continues well into our 40’s whereas 
primary sensory regions such as the visual cortex are heavily myelinated in early life, 
commencing in utero, and appear to be least affected by natural aging (Fjell & 
Walhovd, 2010). Areas undergoing myelination later in life are the most vulnerable to 
aging and indeed are shown to degenerate first (Lu et al., 2011). A consequence of 
natural aging is cognitive decline; increased forgetfulness, poor short-term memory 
and taking longer to learn new things (Bartzokis, 2004; Peters, 2002). These are all 
exacerbated in age-related neurodegenerative diseases such as Alzheimer’s 
Disease (Peters, 2002). The decline in myelin could explain this as the main role for 
myelin is to improve conduction speed and timing of neuronal circuits, which in turn 
boosts cognitive processing speeds (Bartzokis, 2004; Lu et al., 2011; Williamson & 





reduction in the fast-conducting central nervous system axons as a result of natural 
aging. Visual cortex, the area of interest for this thesis, seems to be resistant to 
aging and some have proposed a ‘first in, last out’ theory behind the regional 
variability of myelin degeneration (Davis et al., 2009; Fjell & Walhovd, 2010). 
Currently, little is known about the consequences of eye disease on cortical myelin. 
As mentioned previously, primary visual cortex develops and is heavily myelinated 
even in congenital blindness, but how this may change as a result of acquired vision 
loss is currently unknown. We will discuss cortical myelin density in macular disease 
and sighted controls in Chapter 2. 
1.4. Structural changes associated with central vision loss 
When present in both eyes, macular degeneration results in overlapping visual 
defects, and the cortical representation of this part of the visual field – referred to as 
the lesion projection zone (LPZ) – lacks normal visual input (Figure 1.2). Changes in 
cortical architecture have been observed in macular disease (MD) across multiple 
studies, particularly with hereditary forms such as Stargardt’s disease (Beer, Plank, 
& Greenlee, 2020). Using whole brain and ROI based analyses, MD patients show 
reduced grey and white matter within visual cortex, mainly at the occipital pole (the 
anatomical location of the LPZ).  There was also atrophy of the LGN, and within the 
optic radiations which connect the LGN and primary visual cortex. This suggests 
deficits extend far beyond the retina and impact on the posterior visual pathway 
(Hernowo et al., 2014). Results for age-related MD are quite similar, with patients 
exhibiting significantly reduced grey matter within the occipital lobe, largely at the 
occipital pole (Boucard et al., 2009). A larger scale anatomical study demonstrated 
very little difference between JMD and AMD populations, suggesting the overall 
consequences on cortical structure are consistent across forms of central vision loss, 
irrespective of aetiology and age of disease onset (Hernowo et al., 2014). However, 
notable differences emerged between the groups when assessing the state of white 
matter in frontal regions in AMD, which could be attributed to the age difference, or 
the comorbidity between AMD and mild cognitive impairment (Beer et al., 2020; 
Hernowo et al., 2014). Olivo and colleagues (Olivo et al., 2015) argued that previous 
methods were not sensitive enough to detect possible subtle changes in the white 
matter in cases of JMD. By using diffusion MRI as well as voxel-based morphometry 





indeed detected in JMD participants. Results showed widespread reductions in grey 
matter volume and fractional anisotropy (suggesting a reduction in white matter 
integrity) in Stargardt’s disease (a form of JMD), largely in more posterior areas, but 
these changes were not exclusively in the optic pathway.  It is possible that the 
observed differences in JMD, despite being subtle, may be showing some form of 
protection against degeneration (Olivo et al., 2015).  
In addition to the white matter changes in the frontal regions of AMD patients, using 
diffusion-weighted MRI (dMRI), others have shown that as well as reduced grey 
matter in visual cortex, patients with AMD also exhibit localised deficits within the 
optic radiations, specifically in the portion directly projecting to foveal representations 
- the LPZ (Yoshimine et al., 2018). This study examined individuals receiving 
treatment for neovascular AMD, for an undefined period of time. The optic radiation 
Figure 1.2: Schematic of the representation of the visual field in normally sighted individuals, 
central vision loss and peripheral vision loss. In normally sighted individuals you can see a 
larger representation of the entire visual field from the central representations (warmer 
colours), expanding to the more peripheral visual field representations (cooler colours). In 
individuals with visual field loss, there is an absence of activation in the part of visual cortex 
representing the retinal lesion – referred to as the lesion projection zone (LPZ). The remaining 
part of the visual field will elicit responses in the corresponding part of visual cortex - the intact 
projection zone – IPZ. In cases of central vision loss, the LPZ spans a larger region of cortex 
due to cortical magnification – given we use foveal vision for finer visual tasks, there is a larger 
representation within cortex, hence a larger region remains unstimulated. In cases of 
peripheral vision loss, the LPZ appear smaller given that a smaller amount of cortex is 





was segmented into sections depending on where in primary visual cortex it 
projected to; fovea (0°- 3°), mid-periphery (15° - 30°) and far periphery (30° - 90°). 
Results showed tracts that projected to the foveal representation were the only ones 
significantly affected by the disease; other portions projecting to more peripheral 
representations in primary visual cortex did not differ significantly from the age-
matched controls. At what stage in the disease progression these changes occur is 
still unknown as participants in this particular study appear to be in the later stages of 
the disease. To help address this question, we compare changes in a group of AMD 
patients with established bilateral AMD against sighted controls, as well as two 
cases of AMD before and after diagnosis in Chapter 3. 
Assessments of the representations of the intact parts of the peripheral visual fields 
that remain unaffected by the disease – referred to as the intact projection zone 
(IPZ) - yield mixed results. The cortex in the calcarine sulcus is known to be thinner, 
meaning subtle changes are harder to detect. As described previously, any 
inconsistency may also be attributed to the differences in protocols, analysis 
methods and the way the cortex is parcellated into different ROIs. Some groups 
have suggested that there is evidence of thinning in this region in addition to the LPZ 
(Doety Prins et al., 2016), however others have reported the opposite pattern of 
results, and conclude central vision loss can even cause cortical thickening in the 
representation of the intact visual field (Burge et al., 2016). Burge and colleagues 
attribute this thickening to the increased reliance on remaining peripheral vision, 
arguing it may be indicative of cortex compensating for the lost vision. What is not 
clear, is why patients differ. It seems plausible that factors influencing the change in 
cortex in either direction could include the time since disease onset, extent of the 
vision loss and the diagnosis (JMD vs AMD for example). In Chapter 2 we will 
discuss cases for which we have measures of cortical thickness before and after 
AMD diagnosis alongside a group of MD patients with longstanding central vision 
loss. This offers some insights into how results may differ in individuals at different 
stages of the disease progression.  
It is currently unknown whether treatment of the eye (anti-VEGF injections for wet 
AMD for example) would result in preserved cortical structure and prevent 
degeneration. Evidence from Hanson et al (2019) suggests that while visual acuity 





wet AMD, visual cortex still reduces in volume – likely driven by reductions in cortical 
thickness in the LPZ. Whilst significant changes in visual cortex were not observed 3 
months after the second eye was diagnosed with AMD, cortical atrophy was evident 
5 years post diagnosis. This highlights why research into neuroprotective strategies 
needs to be considered. What also remains unclear is the relationship between 
structure and function of the retina and how changes in the retinal drive the cortical 
atrophy observed; this may prove important for the success of restorative treatments 
as if visual cortex continues to decline in spite of successful stabilisation of visual 
function in the eye, new incoming information may not be processed appropriately, 
therefore limiting the chances of patients gaining some form of functionally useful 
vision. This is a particularly pressing issue for the dry form of AMD, given there are 
no treatments currently available to slow the progression of the disease. 
1.5. Assessing the function of visual cortex  
A great deal of clinical research concerning eye disease focuses on monitoring 
physiological changes in the eye, with the overall aim of treating the eye, preventing 
further sight loss, and restoring functionally useful vision. However there is also 
evidence to suggest that further up the visual pathway, parts of visual cortex 
representing regions of the visual field which are no longer receiving input, are 
subject to change (Baker, Dilks, Peli, & Kanwisher, 2008; Baker, Peli, Knouf, & 
Kanwisher, 2005; Dilks, Julian, Peli, & Kanwisher, 2014; Hoffmann & Dumoulin, 
2015). Results from visual assessments such as visual acuity and contrast sensitivity 
do not inform us about the consequences on higher-level visual processing, hence 
incorporating fMRI alongside other psychophysical based measures is important for 
determining the consequences of vision loss on the posterior visual pathway.  
Reorganisation of function was first described in other modalities. Phantom limb 
syndrome is characterised by sensations, typically pain, coming from a limb that has 
been removed. Studies have found a correlation between the amount of cortical 
reorganisation observed from fMRI and the extent to which individuals experience 
phantom limb pain, as patients who do not experience pain show differential 
reorganisation in motor and somatosensory areas (Flor et al., 1994; Karl, Birbaumer, 
Lutzenberger, Cohen, & Flor, 2001). Similarly, in cases of tinnitus – where sounds 
are heard in the absence of any external auditory stimuli - the extent to which 





organisation (Elbert & Flor, 1999). Collectively, this suggests cortical reorganisation 
may not always have an adaptive function, and in the case of sight loss, 
reorganisation is not always ideal if attempts to restore vision are to be successful.  
1.5.1 Reorganisation of function in visual cortex following central vision 
loss 
There is a debate in the literature concerning functional changes in visual cortex 
following central vision loss. Cortical reorganisation can refer to anatomical changes, 
but generally it concerns how neural activity, in response to a visual stimulus, 
changes as a result of eye damage or disease. FMRI in conjunction with clinical 
measures (visual acuity, contrast sensitivity and perimetry for example) allows 
researchers to determine the extent of the damage at various points along the visual 
pathway. Retinotopic mapping has been widely used in sighted populations and to 
an extent in those with visual deficits. Given that fixation instability is a common 
problem particularly in cases with central vision loss, researchers cannot rely on 
participants fixating steadily on a small central fixation point to map out visual cortex. 
Instead, a full field flickering checkerboard stimulus can be used to identify parts of 
visual cortex that are no longer receiving input – this is referred to as the lesion 
projection zone (LPZ). In addition to conflicting results concerning the status of the 
LPZ, definitions of what constitutes cortical reorganisation differ across research 
groups. Cortical reorganisation can be referred to as a change from what we know 
about the organisation of the visual system in normally sighted individuals but 
observing abnormal signals does not necessarily mean that any cortical 
reorganisation has occurred (Morland, 2015). Some research groups adopt a 
broader definition; if an individual with sight loss demonstrates a response that 
cannot be replicated in sighted individuals, it suggests reorganisation has occurred. 
Three overarching theories regarding the function within the LPZ will be discussed, 






Firstly, it must be acknowledged that multiple research groups have not observed 
any evidence of reorganisation in patients with macular lesions, nor did they observe 
any notable activity in the LPZ – often taken as a signature of functional 
reorganisation of visual processing (Baseler et al., 2011; Smirnakis et al., 2005; 
Sunness, Liu, & Yantis, 2004). Furthermore, when contrasted with sighted control 
participants who had a simulated central lesion (presented a stimulus with a grey 
disc obscuring the central part of the image), no discernible differences were 
observed (Baseler et al., 2011). Collectively, the aforementioned studies suggest the 
LPZ lies dormant, showing no evidence of functional reorganisation. 
Figure 1.3: The reorganisation debate. An illustration of central vision loss; MD participant 
viewing an image of a face that falls within the intact part of the visual field and can be 
seen by the observer, abutting the central scotoma (black filled circle). The dotted line at 
the occipital pole denotes the lesion projection zone (LPZ), the representation of the 
scotoma. The unfilled arrow leaving the scotoma represents a lack of input coming from 
this part of the visual field. The orange filled arrows/shapes represent visual input that can 
be processed by the visual system. A: No reorganisation occurs – the LPZ remains silent 
and stimuli falling on intact parts of the visual field are processed as normal.  B: 
Reorganisation occurs – the LPZ takes on the processing of information presented to the 
intact parts of the visual field. C: No reorganisation occurs but activity may be observed 
within the LPZ, perhaps evidence of unmasking of feedback from extrastriate areas, 





There is evidence to suggest that cortical reorganisation might occur following 
central vision loss, however the mechanisms underlying it are largely speculative 
(Baker et al., 2008, 2005; Dilks, Baker, Peli, & Kanwisher, 2009). Some researchers 
have suggested following bilateral central vision loss, the function of the LPZ 
changes, and it begins processing information presented to intact parts of the visual 
field (Baker et al., 2005; Dilks et al., 2014). Sighted controls did not exhibit the same 
patterns of response, suggesting a change in cortical function associated with vision 
loss. It is difficult to establish what drives this observed LPZ activity, given that 
patients do not engage in the same viewing conditions for each experiment. One 
argument for why reorganisation is not observed in all patients, is because it relies 
on absolute bilateral loss with no evidence of foveal sparing (Dilks et al., 2014). This 
highlights the importance of acquiring careful measures of the scotoma using 
microperimetry for example, to establish the coordinates of visual space affected by 
the visual impairment and in turn, accurately map the representation in visual cortex 
(Morland, 2015).  
A consequence of central vision loss is the natural development of a new fixation 
point; a preferred retinal locus (PRL). The PRL develops in a part of the intact 
peripheral retina, typically abutting the scotoma, usually within 6 months of diagnosis 
(Cheung & Legge, 2005; Schumacher et al., 2008). Researchers suggested that the 
establishment of a PRL might trigger reorganisation as the PRL is in theory taking on 
the role of the fovea, hence being used for fixation (Plank et al., 2017; Schumacher 
et al., 2008). However, others have demonstrated no significant difference in the 
extent of LPZ activation when presenting stimuli at the PRL compared to another 
peripheral location in the retina, equidistant from the boundary of the scotoma. 
Authors suggest conflicting results could simply be driven by attentional 
mechanisms, task and/or stimulus type (Dilks et al., 2009; Plank et al., 2017).   
A third explanation suggests whilst the LPZ may not have been reorganised, signals 
can be observed under specific viewing conditions, when engaging in a stimulus 
related task. This may be due to the unmasking of feedback from extrastriate areas – 
a mechanism found in the normal visual system, which may be ‘unlocked’ by the 
absence of geniculo-cortical signals coming from the retina (see Figure 1.4).  
Masuda and colleagues observed LPZ responses in individuals with MD, as well as 





2008; Masuda et al., 2010). Interestingly, this activity was observed when 
participants engaged in a stimulus-related task, but not when passively viewing the 
same stimulus (Masuda et al., 2008). This was observed in 3 out of 4 patients 
irrespective of stimulus type, and highlights that perhaps the reason different 
research groups have conflicting results may be due to the different paradigms used. 
Moreover, age-matched sighted control participants showed no evidence of task-
related activity in their simulated LPZ, generated by obscuring the central vision with 
a uniform grey disc and presenting stimuli peripherally. Supporting this, Plank et al 
(2017) demonstrate that task and/or stimulus type can elicit responses in the LPZ, 
particularly when viewing naturalistic images at the PRL. Collectively, results suggest 
activity observed in the visually impaired might be due to the unmasking of a normal 
feedback mechanism from extrastriate cortex, brought on by task demands. The 
studies from Masuda and colleagues are of particular importance to the work 
presented in Chapter 6 of this thesis and therefore warranted a more detailed 
appraisal. 
The reorganisation debate largely stems from the fact different research groups 
employ different stimulus types and experimental paradigms to investigate activity 
within the LPZ, but also can be attributed to the different ways in which 
reorganisation of visual function is defined (Morland, 2015). To determine under 
what viewing conditions LPZ responses can reliably be observed, experimental 
design should be systematically varied using the same participant cohort. 
Additionally, most patient studies examine LPZ responses at the individual level 
without explicitly testing the reliability of the responses and establishing if they are 
legitimate or due to noise. Studies with sighted participants have shown that when 
viewing a naturalistic scene that has been partially occluded, meaningful stimulus-
related information can be decoded from the representation of the unstimulated 
region, suggesting it has been fed back from higher cortical areas (Muckli et al., 
2015; Smith & Muckli, 2010; Williams et al., 2008). In cases of visual impairment, by 
correlating the pattern of responses of voxels within the LPZ across different scans 
using the same paradigm, researchers could assess the reliability of the responses 
in the LPZ. This technique will be implemented in Chapter 6 allowing us to determine 
whether responses observed in sighted individuals with simulated retinal lesions are 





in terms of the reliability and magnitude of the responses. Thus far, studies have not 
detected such responses in the simulated LPZ of sighted participants, but also 
collectively, fewer than 50% of patients exhibit LPZ responses when examining the 
literature (Morland, 2015).  
While it is beyond the scope of this review, it is worth noting there is evidence of 
cortical reorganisation in individuals with congenital vision loss. Individuals with rod 
achromacy (whose vision is dominated by rod function as they have no functioning 
cones and therefore a deficit in central vision) demonstrate LPZ responses when 
viewing stimuli under scotopic conditions. This is a surprising finding given they have 
no functioning cones, and only rods function under such viewing conditions (Baseler 
Figure 1.4. Illustration of the unmasking of feedback theory (Masuda et al., 2008). LPZ activity 
under different viewing conditions (passive viewing and engaging in a one-back task) for a 
sighted individual (upper panel) and an MD patient (lower panel). Sighted controls, when 
passively viewing a peripheral stimulus (A) do not exhibit a response in the simulated LPZ but 
there is a feedforward signal coming from the eye (green filled arrow), and a V1 response in area 
representing the stimulus (green oval). When completing a one-back task (B), there is a cortico-
cortical feedback signal (green filled arrow) as well as the feedforward signal coming from the eye 
(green filled arrow); the combined signals do not result in sLPZ responses. MD patients do not 
exhibit feedforward signal from the macula but do have a V1 response to the peripheral stimulus 
(green oval). When passively viewing stimuli, no LPZ signals are evident (C), however when 
engaging in a task, as the cortico-cortical signals are not cancelled out by an incoming 





et al., 2002). Sighted controls did not exhibit activity in the same zone under the 
same viewing conditions. This study clearly highlights that reorganisation of V1 in 
terms of the remapping of eccentricity is possible in certain visual disorders and is 
perhaps dependent on congenital loss.  This is not necessarily a desirable result 
however, given that there is evidence gene therapy has been successful in restoring 
cone function in animal models (Lipinski, Thake, & MacLaren, 2013); cortical 
reorganisation will negatively impact on the success or restoration of visual function, 
unless visual cortex is capable of reorganising again to compensate for the change.  
1.5.2 The impact of vision loss on higher-level visual processing 
Until recently, the focus of vision loss research has been on cortical reorganisation 
and whether any discernible responses can be detected in the LPZ. There are 
comparatively fewer studies exploring the neural response to more complex visual 
stimuli, such as faces and scenes. Psychophysical work however is becoming more 
prevalent, building on standard visual assessments. Psychophysical studies will 
primarily be discussed since there is a notable absence of fMRI studies investigating 
higher-level visual processing following vision loss.  
1.5.2.1 Face and object perception 
Faces are highly complex stimuli with which we, as human observers, are very 
familiar. We are incredibly skilled when it comes to detecting changes in identity and 
expression in faces. Given the vast social cues a face can exhibit, it is 
understandable the inability to process faces is highly debilitating. Neuroimaging 
research has demonstrated that face processing recruits multiple interconnected 
neural regions, including the fusiform face area (FFA), occipital face area (OFA) and 
superior temporal sulcus (STS) (Haxby, Hoffman, & Gobbini, 2000). Most of the 
literature concerning face processing focuses on individuals with normal or 
corrected-to-normal vision, and individuals who demonstrate selective impairments 
with face processing, either through congenital or acquired disease or injury affecting 
the aforementioned cortical regions. The impact of visual impairment (resulting from 
eye disease of injury) on face-selective regions is not as well documented.  
A common complaint among individuals with macular degeneration (MD) concerns 
face recognition. Individuals report they frequently struggle to identify familiar faces 





contain a lot of complex visual information, we utilise our central vision, where acuity 
is highest, hence MD will impact highly on face recognition. Despite developing a 
PRL, the diminished acuity means deficits cannot be overcome by simply stabilising 
eye movements. Various psychophysical studies have demonstrated a decline in 
performance in age-related MD (AMD) patients when categorising facial expressions 
and identity (Boucart et al., 2008; Tejeria, Harper, Artes, & Dickinson, 2002). 
Interestingly, it appears that patients generally perform better on tasks involving 
categorisation of emotions when compared to tasks requiring participants to state if 
the face is showing and expression or not (Boucart et al., 2008). To categorise the 
expression, patients could only rely on low spatial frequency information. Given that 
AMD patients struggle with higher spatial frequencies and rely on intact peripheral 
vision to see, this might explain why distinguishing the presence of a certain 
expression was more challenging. Mäkelä et al (2001) tested normally sighted 
individuals on face recognition, presenting stimuli to their periphery at varying 
degrees of eccentricity, but also removed luminance cues such as hairline, colouring, 
and clothing. Performance on face identification tasks was maintained by altering the 
contrast appropriately for the different eccentricities. It was shown that peripheral 
processing of faces was approximately 66% worse than at the fovea (Mäkelä et al., 
2001). Not only do results support findings of the deficit in face processing in AMD, 
but they also indicate that altering the contrast of images may improve performance 
for AMD patients, rather than simply enlarging images. This has clinical implications 
as most AMD patients are recommended to use a magnifier, which will primarily 
benefit reading - a foveal task.  
Currently, standard clinical assessments include visual acuity, perimetry (used to 
assess visual field function), and more rarely contrast sensitivity, all of which are 
simple and easy to administer. Researchers have debated whether simply reading 
letters of varying size and contrast is a representative measure of an individual’s 
visual perception. For example, visual acuity assessments do not inform clinicians 
about many aspects of higher-level visual processing, which is more akin to day-to-
day perception, having to process objects and faces and navigate obstacles for 
example. The Caledonian Face Test, an ‘odd one out’ task, can be used to assess 
face discrimination in a more controlled manner (Logan, Wilkinson, Wilson, Gordon, 





the stimuli while testing in a quantifiable manner, as it considers participant’s 
individual thresholds. Faces are rid of any non-face cues such as clothing, different 
postures etc but also highly discriminative features. Given that some individuals may 
use these additional factors as an alternative strategy to aid recognition, removing 
these has allowed Logan et al to generate a much more controlled assessment of 
face discrimination specifically. When individuals do use their own compensatory 
strategies, they can generate responses unrepresentative of their actual visual 
perception. The Caledonian Face Test has been primarily used to assess face 
discrimination in normally sighted individuals, but the flexibility of the stimulus set has 
wider implications for clinical populations, including the visually impaired. Paired with 
functional MRI, this paradigm has the potential to aid our understanding of the 
impact of visual loss on face processing throughout the visual hierarchy (Thibaut, 
Delerue, Boucart, & Tran, 2016). 
1.5.2.2 Scene perception 
Behavioural evidence suggests AMD patients can process scenes in a particular 
manner. Scene gist recognition is plausible with only peripheral vision intact, 
suggesting scenes can be recognised using low level features such as orientation 
and texture, without needing to identify objects within a scene, for example. 
Evidence from computer vision as well as AMD patients’ ability to categorise scenes 
by naturalness supports this (Tran, Rambaud, Despretz, & Boucart, 2010). There is 
also evidence that scenes are processed implicitly in AMD; When objects were 
presented in a scene, either congruent or incongruent, participants performed better 
in congruent trials when asked to focus on the object, suggesting implicit scene 
processing was intact (Boucart, Moroni, Szaffarczyk, & Tran, 2013). The way in 
which a scene is explored also changes with sight loss; as well as performing 
significantly worse on an identification task compared to sighted controls, AMD 
patients show increased numbers of saccades and consequently, shorter fixation 
durations (Thibaut et al., 2016). Studies with sighted controls support this as when 
presented with an artificial scotoma, controls also showed increased number of 
saccades. Taken together, behavioural studies indicate that the manner in which 
AMD patients visually inspect, and process scenes is markedly different from 
controls, but they can still successfully do so. How this change in behaviour affects 





Research on sighted individuals has unveiled a series of cortical regions dedicated 
to processing visual scenes; the parahippocampal place area (PPA), retrosplenial 
cortex (RSC) and occipital place area (OPA – formally known as the transverse 
occipital sulcus, TOS) (Epstein, 2008; R. Epstein & Kanwisher, 1998; Maguire, 2001; 
Maguire et al., 1998; Nakamura et al., 2000). A recent study used fMRI to explicitly 
assess neural underpinnings of scene perception following AMD (Ramanoël et al., 
2018), but in a limited group (n = 4). Patients had to categorise scenes of high and 
low spatial frequencies as either indoor or outdoor; when images were presented 
with high spatial frequencies, patients showed an absence of activation in the PPA, 
as well as over a broad area of the occipital lobe, dedicated to both peripheral and 
central processing. Additionally, by increasing the luminance contrast of the images, 
performance with higher spatial frequencies improved and induced activation in 
occipital regions dedicated to peripheral processing (Ramanoël et al., 2018). This 
demonstrates that with improvements in visual perception (e.g., increasing contrast), 
higher order visual areas will respond as you would expect in sighted individuals, but 
this also refutes the idea of functional reorganisation further up the visual hierarchy.  
Research should continue to investigate performance in tasks involving more 
complex stimuli such as faces and scenes, as visual acuity alone does not inform us 
of everyday difficulties patients deal with. Visual acuity did not correlate with number 
of saccades and fixation times (Thibaut et al., 2016) or performance on 
categorisation tasks (Tran et al., 2010); additionally, contrast sensitivity is another 
measure of importance but more frequently, a decrease in visual acuity is thought to 
be more debilitating by clinicians than a reduction in contrast sensitivity. It is 
important to note that both visual acuity and contrast sensitivity decline in normal 
aging populations, however the deficit is much more pronounced following vision 
loss. Evidence shows that contrast sensitivity is important when making judgements 
in face recognition tasks (Ramanoël et al., 2018). Adding to the building 
psychophysics literature and developing paradigms using fMRI will inform our 
understanding of the extent of deficits in visual processing across a broader range of 
tasks.  
1.5.2.3 Resting state functional connectivity  
One of the biggest challenges facing vision researchers is finding methods which 





cases of anophthalmia, there are further difficulties assessing visual cortex when 
individuals have no form of light perception at all. Resting state fMRI allows for the 
opportunity to study the organisation of visual cortex in individuals without vision. 
Evidence from cases of microphthalmia (underdeveloped eyes) and anophthalmia (a 
condition in which the individuals never develop a functioning retina) have shown 
that the architecture underlying visual cortex remains largely the same, 
demonstrating typical retinotopic organisation despite no visual experience (Bock et 
al., 2015; Bridge, Cowey, Ragge, & Watkins, 2009; Striem-Amit et al., 2015). The 
consistency in organisation extends to representations of eccentricity, laterality, and 
elevation in primary and extrastriate visual cortices. This also extended to the higher-
level visual areas, whereby face and place selective regions exhibited the expected 
eccentricity biases (Striem-Amit et al., 2015). However, there were notable changes 
in terms of functional connectivity between primary visual cortex and other brain 
areas which suggest that there may be critical periods during which these 
connections are established (Striem-Amit et al., 2015). In addition to the reduced 
overall functional connectivity within visual cortex, resting state fMRI revealed a 
different pattern between visual and non-visual areas. Within primary visual cortex, 
representations of the central visual field and the peripheral visual field were 
impacted differently in the congenitally blind group, with central V1 showing 
increased connectivity to the non-visual areas involved in language processing. 
Contrary to this, more anterior V1 representing peripheral portions of the visual field 
exhibited stronger functional connectivity with the dorsolateral prefrontal cortex.  
Further support for this comes from a unique study examining functional connectivity 
within visual cortex in 27-day old neonates, and this study is of particular importance 
to the work presented in Chapter 5. Whilst research has shown that domain-specific 
connectivity is evident in the adult seeing brain, how it develops over time is 
unknown. Kamps et al., (2020)  examined how primary visual cortex connects with 
higher-level visual areas such as FFA and PPA, given that these areas are shown to 
have specific retinotopic biases (Hasson, Andric, Atilgan, & Collignon, 2016; Kamps, 
Hendrix, Brennan, & Dilks, 2020; Levy, Hasson, Avidan, Hendler, & Malach, 2001). 
Face processing is largely biased toward central visual processing, and scenes 
biased towards peripheral visual processing. The nature of the stimulus types 





Kamps et al have shown, however, that as early as 27-days old, domain-specific 
patterns of functional connectivity are observed in the face and scene networks, 
when examining functional connectivity between all combinations of FFA, OFA, PPA, 
RSC. Further to this, stronger functional connectivity was observed between OFA 
and the central representation in V1, and for PPA and RSC, functional connectivity 
was strongest with peripheral V1. Interestingly, the FFA - central V1 functional 
connectivity was not significant, but authors note there was a trend in the direction of 
a foveal bias. In Chapter 5 we will examine the same functional connections in 
individuals with either central or peripheral visual field defects, to see how the 
functional connections that are established early in life may be impacted by sight 
loss.  
More recently, studies have been investigating functional connectivity in partially 
sighted individuals (Frezzotti et al., 2014). Whilst the architecture is largely the same 
in congenitally blind patients, there is evidence of structural degeneration in those 
losing sight later in life (AMD, glaucoma). In glaucoma, there is evidence of 
decreased functional connectivity between the visual and working memory networks, 
as well as showing increased functional connectivity between visual and executive 
networks (Frezzotti et al., 2014). Such broad changes mirror the structural changes 
observed across the whole brain; this lends support to the idea that glaucoma should 
be considered a neurodegenerative disorder and demonstrates how fMRI could aid 
our understanding of disease progression.  Most of the work was largely exploratory, 
looking at connectivity over the whole brain, rather than just focusing on visual 
cortex. Considering visual deficits can be selective (as in AMD and glaucoma, 
affecting central and peripheral vision respectively) it would be informative to probe 
specific paths within visual cortex i.e., between the LPZ and other visual areas. 
Given that most of the work thus far has examined structure and function of visual 
cortex, primarily investigating the state of the LPZ, assessing connectivity between 
visual areas might be informative, particularly if fMRI shows deficits in higher-level 
visual areas. It may also help to explain why some individuals may exhibit LPZ 
responses, while others do not. A resting state fMRI paradigm was implemented in 





1.6. Evidence of behavioural and neural consequences of 
peripheral vision loss  
The focus of this thesis is on patients with forms of macular degeneration, however it 
is important to understand the consequences of peripheral vision loss on the 
posterior pathway as well, as it can tell us what is common across eye diseases, but 
also how they may differ. Glaucoma and retinitis pigmentosa will be discussed. 
1.6.1 Glaucoma 
Glaucoma describes a collection of neurodegenerative diseases which at first 
manifest as damage to the optic nerve, affecting both the retina and more anterior 
parts of the visual pathway. Like MD, glaucoma can manifest in different ways. 
Primary open-angle glaucoma (POAG) is characterised by raised intraocular 
pressure causing increased cupping of the optic disc (Figure 1.5), damaging the 
retinal ganglion cells and the optic nerve, causing loss of peripheral vision initially, 
and later extending to parafoveal regions. Normal-tension glaucoma is largely similar 
but characterised by optic nerve damage in the absence of elevated intraocular 
pressure. Due to the fact glaucoma impacts on the entire visual pathway, there are a 
wide range of deficits associated with the disease, affecting visual acuity, contrast 
sensitivity, as well as motion and colour processing.  As the disease progresses, 
degeneration extends to posterior parts of the visual pathway including subcortical 
areas – the lateral geniculate nucleus (LGN) – and cortical visual areas. Despite 
being the second most common cause of blindness in the western world, if caught 
early, most cases of vision loss due to glaucoma could be prevented (Quigley, 
2006). This highlights the importance of going for regular visual assessments. 
1.6.2 Retinitis pigmentosa 
Retinitis pigmentosa (RP) refers to a collection of rare inherited visual disorders, 
affecting approximately 1 in 4000 people worldwide (Berson, 1993; Machado et al., 
2017). RP is characterised by the progressive and irreversible loss of both the rod 
and cone photoreceptors (Figure 1.5); initially it impacts on peripheral locations and 
causes problems seeing in low light conditions, extending to the fovea as the 
disease progresses (Brown et al., 2016). The symptoms emerge typically in 
childhood, but this can vary from infancy to adulthood (Ferreira et al., 2017). Vision 
loss progresses over time, with the periphery being first affected and inducing what 





blindness, blue blindness, loss of central vision, eventually resulting in complete 
blindness (Berson, 1993; Ferreira et al., 2017). Like AMD, there is currently no cure, 
however research has focused on the use of retinal implants and gene therapy as a 
means of stabilising or restoring visual function (Chow, Packo, Pollack, & Schuchard, 
2003; Chow et al., 2004; Cunningham et al., 2015; Stingl et al., 2015; Tschernutter et 
al., 2005). 
 
Figure 1.5. Illustrations of the retina for retinitis pigmentosa (RP, top) and glaucoma 
(bottom) in contrast to normally sighted retinae. In cases of RP, pigment deposits emerge 
(dark spots) alongside evidence of atrophy of the retina. The macula is relatively well 
preserved until the later stages of the disease. Glaucoma is the result of increased 






1.6.3 Structural changes associated with peripheral vision loss 
In contrast to MD, many studies have examined structural abnormalities in glaucoma 
(Brown et al., 2016). As mentioned previously, glaucoma often goes unnoticed until 
symptoms become more severe and damage irreversible; the disease manifests 
itself along the whole of the visual pathway, affecting anterior (eye) and posterior 
(brain) pathways significantly. Studies examining smaller structures in two forms of 
glaucoma (primary open-angle glaucoma and normal tension) have shown a 
reduction in size of the optic nerve and chiasm, as well a reduction in the LGN (Chen 
et al., 2013; Gupta et al., 2009; Zhang et al., 2012). Volumetric differences are also 
apparent in anterior and medial occipital lobe, encompassing representations of the 
peripheral vision which has been lost – the LPZ. Studies using diffusion MRI have 
revealed an overall decrease in fractional anisotropy and increase in mean diffusivity 
within white matter tracts of visual processing, irrespective of glaucoma subtype (Li 
et al., 2014). Chen et al (2013) showed specific reductions in diffusivity along the 
optic radiations in late-blind glaucoma patients, further highlighting a reduction in 
integrity of the white matter tracts, more extensive than that observed in AMD 
(Yoshimine et al., 2018). The degree of the degeneration seemed to be determined 
by the extent of visual impairment; this pattern of results is also apparent in AMD, 
with the LPZ being most affected. The literature examining the IPZ is a bit more 
consistent for glaucoma compared to AMD; multiple studies have found evidence of 
an increase in grey matter volume in the regions adjacent to the LPZ which could be 
evidence of reorganisation or compensation for lost vision. Finally, given evidence 
for increases in grey matter in multiple cortical regions, not all related to visual 
processing, suggests cortical changes associated with glaucoma are broad and 
complex (Williams et al., 2013).   
Fewer studies examine the structural changes associated with retinitis pigmentosa 
(RP) and there are some discrepancies within the literature.  Some studies involving 
late blind RP patients with evidence of residual vision either found subtle differences 
when compared to sighted controls, or no difference at all (Ferreira et al., 2017; 
Machado et al., 2017). Further to this, when comparing patients with different 
disease severity, patients with more severe visual field defects had a thicker V1, 





form of compensation for the loss of retinal input. However, this did not emerge as 
significant when compared to the control group.  
Contrary to some RP studies but in line with glaucoma research, some groups have 
shown a reduction in cortical thickness in individuals with RP (Castaldi, Cicchini, 
Falsini, Binda, & Morrone, 2019; Park et al., 2009). Castaldi et al (2019) found a 
decrease in cortical thickness in V1 (capturing ~20deg of visual angle) in RP patients 
compared to sighted controls, but given the groups were not age-matched, the 
structural decline cannot be assumed to be related to the disease. Park et al also 
observed a reduction in cortical thickness in the pericalcarine ROI in contrast to both 
the sighted controls and congenitally blind group. In addition to cortical thickness, 
decreases in grey matter volume in the occipital cortex were observed in RP 
patients, and correlated positively with visual field defect (Machado et al., 2017). 
Cortical areas identified included bilateral calcarine, lingual gyrus, cuneus, and right 
occipital superior gyrus. It is possible this reduction in volume may be driven by this 
reduction in cortical thickness, like in cases of AMD (Hanson et al., 2019). Whilst this 
shows there may be a direct link between the extent of visual field loss and cortical 
changes (Machado et al., 2017), Castaldi et al did not find a significant correlation 
between cortical thickness in V1 and the degree of visual impairment. Together, this 
highlights how the consequences of RP on the structural properties of visual cortex 
are still a source of debate. As with the aging studies, differences in results may be 
attributed in part due to the various ways V1 has been defined. Given cortical 
thickness is deemed by many research groups to be a possible predictor of 
treatment effectiveness in both central and peripheral forms of vision loss, 
understanding the link between disease severity and anatomical changes in the 
posterior visual pathway may prove important (Castaldi et al., 2019; Hanson et al., 
2019; Plank et al., 2011).  
1.6.4 Functional consequences of peripheral field loss 
Deficits associated with glaucoma extend far beyond the retina, most notably 
involving the optic nerve, LGN and visual cortex (Boucard et al., 2009; Graham & 
Klistorner, 2013; Gupta & Yücel, 2007). Whilst most research has demonstrated 
structural changes in glaucoma, research investigating the functional consequences 
of the disease is somewhat lacking (Brown et al., 2016; Duncan, Sample, Weinreb, 





extensive structural changes described previously, one would assume that this might 
lead to some changes in function as well. Previous studies have used checkerboard 
stimuli to map visual cortex in glaucoma, with responses in primary visual cortex 
corresponding with structural changes in the eye, revealing the location of the LPZ in 
peripheral representations of V1 (Borges, Danesh-Meyer, Black, & Thompson, 2015; 
Duncan et al., 2007). Primary visual cortex showed more severe deficits compared 
to higher order visual areas, and interestingly, in some cases the deficits in visual 
cortex were apparent before the visual field deficit (M. C. Murphy et al., 2016).  
It is apparent that fMRI could be used to further assess the extent of damage caused 
by glaucoma (Duncan et al., 2007). While there is evidence that functional 
reorganisation is unlikely, some researchers have argued that in unilateral glaucoma, 
the fellow eye would compensate and perhaps prevent cortical reorganisation 
(Duncan et al., 2007). Additionally, Masuda and colleagues have already 
demonstrated that LPZ responses can be observed in retinitis pigmentosa because 
of task demands, which could be the case for glaucoma as well (Masuda et al., 
2010). Given that it impacts on the entire visual pathway, it would be useful to 
determine whether functional reorganisation is likely to occur. As with any form of 
eye disease, visual cortex needs to be viable and ideally remain unchanged in 
function and structure, to allow for the best chance of successful restoration.  
While evidence is also limited for RP, interesting results have emerged concerning 
functional changes. The anatomical changes associated with RP are quite mixed as 
described previously, therefore complicating our understanding of how disease 
progression impacts on the posterior visual pathway. Ferreira et al (2017) examined 
both structural and functional measures in primary visual cortex in RP patients and 
sighted controls. Interestingly, while they did not find any anatomical changes, they 
did provide evidence of visual field remapping in V1, whereby representations of 
spared central vision appear to be shifted to what were formally representations of 
peripheral visual fields. This may correspond with the thickening of representations 
of central vision in cases of advanced RP, but the link is not yet clear. Castaldi & 
colleagues examined a group of late-stage RP patients using a combination of 
methods to assess visual function. Patients exhibited minimal responses when 
presented with flashes of light and assessed using visual evoked potentials (VEP) 





BOLD response to flashes of light, significant BOLD responses were detected in 
primary visual cortex, as well as in extrastriate cortex (Castaldi et al., 2019). This 
suggests fMRI may be a more sensitive tool when assessing the extent of visual 
sparing in late-stage RP patients, compared to more standard ophthalmological and 
electrophysiological tests such as VEP and ERG. The common theme among the 
few studies presented here is that the magnitude and extent of the BOLD response 
to visual images seems to correlate with the extent of the visual field defect but does 
not necessarily correlate with cortical thickness.  
Individuals with glaucoma also report their quality of life is affected by the inability to 
recognise everyday objects and faces. Like MD, individuals in later stage glaucoma 
show deficits in face processing which could arguably be attributed to contrast 
sensitivity (Glen, Crabb, Smith, Burton, & Garway-Heath, 2012). Using the 
Cambridge Face Memory test, Glen et al found individuals with glaucoma had 
difficulties, particularly those with more advanced stage glaucoma. Despite this, 
patients with advanced forms of glaucoma tend to underestimate the extent of their 
deficits with face recognition, much like individuals with AMD (Friedman et al., 1999). 
In a study directly comparing performance on detection and categorisation tasks, 
Roux-Sibilon and colleagues observed impairments for both tasks with low contrast 
faces. Individuals with early stage glaucoma were not significantly different from 
sighted controls, however more advanced cases show stronger impairments (Roux-
Sibilon et al., 2018). This is an important finding as it demonstrates that peripheral 
vision loss still impacts on processing of stimuli in the intact central visual field – a 
finding not observed using standard perimetry tests. In support of this, when 
presented objects in the central intact part of the visual field, glaucoma patients show 
a deficit in categorisation compared to sighted controls, but only in the lower contrast 
condition (Lenoble, Lek, & Mckendrick, 2016). This suggests patients with glaucoma 
have deficits beyond what is reported by standard clinical assessments and 
highlights the importance of including more complex visual tasks, as it seems 
regions of the visual field that are perimetrically intact are still affected by the 
disease. 
1.7. Concluding comments  
It is evident there are many outstanding questions concerning the impact of vision 





functional changes and how these vary throughout disease progression. With much 
clinical work currently aiming to restore the function of the eye, researchers must 
also consider whether the brain is viable and able to process incoming information, 
as this could limit the success of the restoration attempts. Determining what the 
functional consequences are, how it relates to structural abnormalities, and over 
what time course changes occur, is important. If visual cortex has reorganised, as 
some have proposed, how can the brain process new information? Studies directly 
addressing the reorganisation debate, systematically varying stimulus, task and 
viewing conditions would be highly valuable. This will also allow us to determine 
whether signals observed in the LPZ are not only reliable, but also meaningful, 
containing contextual information that has been fed back from higher cortical areas. 
The aim of Chapter 2 is to better understand the extent of structural changes 
(focusing on cortical thickness and myelin density) occurring in visual cortex 
following bilateral central vision loss, but also to establish the time course of such 
changes in individuals who have had various forms of central loss for several years. 
It is evident from the literature that vision loss results in structural changes in both 
the grey and white matter when compared to sighted, age-matched control 
participants, however it is not known how structure changes within an individual, and 
whether changes progress at the same rate throughout the disease progression. 
Additionally, myelin has yet to be explored in the context of macular disease; the 
literature indicates myelin in the visual cortex remains stable even with natural aging, 
but the impact of vision loss remains unknown. We will also examine two cases 
before and after an AMD diagnosis which have given us a unique opportunity to 
explore how and when changes occur, but also how this relates to the extent of 
vision loss. In Chapter 3 white matter integrity - specifically in the optic radiations - 
will be explored over the same period in the same cohort of MD patients and sighted 
controls, to determine the rate at which white matter integrity declines both health 
and disease. Collectively, these chapters will further our understanding of when 
there might be an optimum time at which interventions should be implemented for 
AMD, during which restoration will be most successful. 
There is some evidence to suggest higher-level visual processing such as face and 
scene processing are affected after losing sight. However, evidence is largely limited 





thoroughly in the visually impaired. As extrastriate regions receive input from earlier 
visual areas (referred to as feedforward connections), it is important to understand 
how and whether information is relayed to higher-order visual areas when earlier 
regions in the visual pathway no longer receive normal visual input. Regions 
dedicated to face and scene processing are known to have a central and peripheral 
eccentricity bias respectively and since visual impairment can result in selective 
deficits, it would be interesting to explore whether higher-level visual areas with 
eccentricity biases matching that which is lost in V1 (LPZ) also show diminished 
neural activity. This will be explored in Chapter 5 using resting-state fMRI in patients 
with either peripheral or central retinal lesions.  
Finally, it is important to recognise the aging population, particularly within the UK. 
By 2037 almost a quarter of the population will be over 65 years old (Office for 
National Statistics, 2018). In turn, this will result in a rise in prevalence of the age-
related macular degeneration as it primarily affects individuals over 50 years of age. 
To fully understand the disease progression, exploring both ophthalmological and 
neural consequences would be informative. It is important to acknowledge that the 
viability of the visual brain may limit the success of visual restoration. Research 
focused on treating the eye is currently gaining pace, examining the effects of gene 
therapy, stem cell therapy, as well as retinal prostheses, in a bid to restore 
functionally useful vision. There is an assumption that visual areas will be able to 
process the restored retinal signals in an appropriate manner, but if the visual brain 
is no longer viable due to prolonged sensory deprivation, or if there is evidence of 
reorganisation of function, success will likely be limited. With various MRI protocols, 
we can non-invasively tease apart the consequences of sight loss on both the 






Chapter 2: Longitudinal effects of bilateral macular disease 
on cortical thickness and myelin density in visual cortex 
2.1 Abstract 
The focus of most ophthalmological research concerns physiological changes within 
the eye, aiming to treat eye disease and prevent further loss of vision. However, 
fewer studies have examined the consequences of eye disease on visual cortex. 
Macular Degeneration (MD) embodies a collection of disorders causing a 
progressive loss of central vision. Cross-sectional MRI studies have revealed 
structural changes in the grey and white matter in visual cortex in MD, however the 
rate at which changes occur is currently unknown. We explored the rate of change in 
cortical thickness and cortical myelin in four regions of interest in patients with 
bilateral MD and sighted controls. The occipital pole and central-V1 were used to 
capture the cortical representation of the retinal lesion. The calcarine sulcus and 
peripheral-V1 were used to represent the cortical representation of the intact visual 
field. Data acquired over a ~24month period revealed a decline in cortical thickness 
over time in all participants, presumably because of natural ageing. A significant 
reduction in grey matter was observed in patients in occipital pole, calcarine sulcus 
and central-V1. Whilst patients did not show a significant accelerated rate of change 
during this period, the pattern suggests a faster decline in the occipital pole and 
central-V1 in patients compared to controls. Myelin content, despite appearing to 
show higher values in the cross-sectional analysis for the patients compared to 
controls, showed a significant difference in the rate of change for both the occipital 
pole and central-V1, suggesting this too declines faster in MD. A unique opportunity 
to examine cortical thickness changes in two individuals before and after diagnosis 
of age-related MD unveiled that thinning is likely more acute early in the disease 
process. Taken together, our results support earlier work showing that MD leads to a 
thinning of visual cortex in the representation of visual field loss, but also highlights 
that cortical myelin is not immune to decline. Despite cross-sectional work appearing 
to show more myelin in the regions that have thinned, the rate of change suggests 







It is known that as we age, changes in cortical architecture occur; changes observed 
include reductions in cortical thickness, volume and surface area as well as changes 
in myelin particularly in prefrontal and association areas (Fjell & Walhovd, 2010; Fjell 
et al., 2009; Lu et al., 2011; McGinnis, Brickhouse, Pascual, & Dickerson, 2011; 
Salat et al., 2004; Schaie, 2005; Thambisetty et al., 2010). Anatomical changes in 
the grey and white matter are also shown to be driven by sensory deprivation, for 
example in visual cortex in cases of vision loss (Boucard et al., 2009; Brown et al., 
2016; Hanson et al., 2019; Hernowo, Boucard, Jansonius, Hooymans, & 
Cornelissen, 2011; Hernowo et al., 2014; Malania, Konra, Jägle, Werner, & 
Greenlee, 2017; Olivo et al., 2015; Doety Prins et al., 2016). The rate at which the 
structural changes occur in visual cortex is currently unknown in cases of 
longstanding bilateral macular disease (MD), but recent evidence has shown long-
term changes in cases of unilateral wet MD (Hanson et al., 2019). Understanding the 
time course of changes in individuals with established bilateral vision loss may prove 
important for visual restoration; if visual cortex is no longer viable and capable of 
processing new incoming information, the success of interventions aiming to restore 
functionally useful vision may be limited. Currently, we do not know whether 
treatment of the eye would in turn cause visual cortex to resume normal functioning 
and therefore prevent further atrophy. Additionally, we do not know at what point 
during disease progression interventions would be most effective at slowing atrophy 
in the entire visual pathway, allowing patients to maintain some form of functionally 
useful vision. 
Given the retinotopic organisation of visual cortex, when macular degeneration (MD) 
is present in both eyes, resulting in overlapping visual defects, the cortical 
representation of this part of the visual field lacks sensory input – this is referred to 
as the lesion projection zone (LPZ). Previous neuroimaging studies have reported a 
reduction in cortical thickness in the LPZ in both juvenile MD (JMD) and age-related 
MD (AMD) compared to age-matched sighted controls (Beer et al., 2020; Hernowo et 
al., 2014). Patients show a reduction in both grey and white matter within the 
posterior visual pathway, but primarily at the occipital pole - corresponding to the 
LPZ - the lateral geniculate nucleus (LGN) as well as the optic radiations which 





Malania et al., 2017; Plank et al., 2011). Evidence concerning the state of the intact 
projection zone (IPZ) – more anterior parts of the calcarine sulcus representing intact 
peripheral vision in MD patients – is somewhat mixed. Some argue there is evidence 
of thinning in the IPZ (Doety Prins et al., 2016), however others report that an 
increased reliance on peripheral vision induces cortical thickening (Burge et al., 
2016). As discussed in Chapter 1, some controversy remains however, concerning 
the nature of changes in visual cortex following retinal disease, and there is limited 
evidence assessing the time course of such changes as well as the impact of MD on 
cortical myelin content.  We know primary visual cortex is highly myelinated and 
seems to be more resistant to the effects of aging than prefrontal and association 
areas (Fjell & Walhovd, 2010; Lu et al., 2011; Williamson & Lyons, 2018), but the 
impact of MD on cortical myelin is yet to be explored. 
Our study aimed to track the decline in visual cortex in patients with bilateral MD 
(age-related and juvenile forms), compared to sighted controls, to extend the work of 
Hanson et al., (2019) who showed changes in the LPZ over time in cases of AMD 
with unilateral visual loss. We want to determine whether cortex continues to show a 
decline in thickness even in the later stages of disease progression, but also 
establish how cortical myelin is impacted by the disease. We measured cortical 
thickness and myelin over multiple time points in a ~24-month period, using 
structural MRI. Given the evidence from cross-sectional studies showing MD patients 
exhibit notable structural changes compared to sighted controls (Beer et al., 2020; 
Boucard et al., 2009; Burge et al., 2016; Malania et al., 2017; Doety Prins et al., 
2016), we predicted an accelerated rate of decline in cortical thickness in the LPZ 
(the occipital pole) compared to regions of visual cortex representing spared vision 
(anterior calcarine sulcus). Regarding cortical myelin, we predicted that during this 
brief 24-month period that perhaps we would not observe any significant changes in 
the LPZ, given the literature indicates myelin appears to be robust to changes 
associated with aging in visual areas. However, other age-related diseases such as 
Alzheimer’s disease do show degeneration in myelin within the prefrontal and 
association areas, but such changes may occur over a much broader timeframe than 
we are examining here (Bartzokis, 2004; Williamson & Lyons, 2018). It is possible 
that there is an interaction between the two measures of interest, as has been 





caused apparent cortical thinning (Natu et al., 2019). If changes in cortical thickness 
drive any changes in myelin density, we may expect to see an increase in myelin 
over time, alongside the well-established thinning of grey matter in MD patients 
(Glasser & Van Essen, 2011).  
Research focusing on visual impairments largely contrasts patients with sighted 
controls, comparing visual function and measures of both the structure and function 
of visual cortex (Boucard et al., 2009; Hernowo et al., 2014; Doety Prins et al., 2016).  
Whilst this allows researchers to determine how vision loss has impacted such 
measures in contrast to natural aging, something rarely reported are the changes 
that occur within individuals before and after a diagnosis affecting vision. Hanson et 
al (2019) established that in the first 3-4month period following diagnosis, there was 
no significant change in cortical thickness in the LPZ, but changes were found to 
have emerged ~5 years after diagnosis. It is therefore plausible any changes after 3 
months were too small to detect. We have had the unique opportunity to assess 
structural changes in visual cortex in two individuals before and after bilateral AMD 
diagnosis, allowing us to determine how visual cortex is impacted at disease onset in 
two very different cases: the first with sudden bilateral vision loss, the second with an 
AMD diagnosis, but no vision loss.  Such cases will provide insight into how early 
interventions should be in order to preserve the integrity of the posterior visual 
pathway, from eye to brain.  
2.3 Methods 
2.3.1 Participants 
13 individuals with macular disease (MD) were recruited from the Ophthalmology 
department at York Teaching Hospital and through advertisements in sight loss 
support groups in York (referred to as MD1-MD13; mean age = 71.42 years, age 
range = 28–87 years, full MD patient demographics included in Table 2.1). MD 
patients all had a diagnosis of bilateral macular disease; time since disease onset at 
the time of enrolment ranged from 9 months to 23 years, mean = 11.2 years. MD12 
was excluded from most analyses due to ill health preventing participation in follow 
up MRI sessions. 18 sighted controls (referred to as C1–C18, mean age = 55.33 
years, age range = 24-73 years) were recruited for this study through advertisements 





We acquired additional MRI data for two MD patients, who will be referred to as 
patient MD7 and MD13 throughout. MD7 has bilateral AMD, with a secondary bleed 
to one eye causing more severe sight loss (hand movements only). MD7 had 
participated in an MRI study prior to diagnosis and therefore, we included an 
additional set of MRI scans for MD7 to compute a detailed assessment of how visual 
cortex changed after diagnosis (see Figure 2.1A for timeline). We recruited another 
individual who had also regularly participated in neuroimaging studies at YNiC prior 
to an AMD diagnosis. This individual, referred to as MD13 has bilateral dry AMD but 
does not experience any vision loss, as assessed by visual acuity (see Figure 2.1B 
for timeline). 
Finally, an additional 15 sighted controls (referred to as C19-C33, mean age = 66.27 
years, age range = 48 – 83 years) were recruited through advertisements at YNiC. 
Despite being scanned under a different MRI protocol, they were included in the 
cross-sectional analysis to assess the relationship between our two measures: 
cortical thickness and myelin density. It was important for us to use additional data 
here to try and understand the nature of the relationship between the measures in 
normal aging and provide us with the necessary context when assessing the 
outcome for the MD patient group. Written informed consent was obtained from all 
participants. This study followed the tenets of the Declaration of Helsinki with 
approval granted by YNiC Research, Ethics and Governance Committee and the 








Table 2.1. MD participant demographics. Some missing data for time since diagnosis and visual 














2.3.2 MRI data acquisition 
Scanning was performed at the University of York Neuroimaging Centre using a 3 
Tesla HD MRI system (GE Signa Excite 3.0T, High resolution brain array, MRI 
Devices Corp., Gainesville, FL) with an 8 channel whole head High Resolution Brain 
Array. Patients were scanned between one and six times over a ~24-month period, 
whereas controls were scanned twice, approximately ~24 months apart (See Table 
2.1 for details). Some subgroups (C13-C18) have different T1 and T2 protocols due 
Figure 2.1. Timeline of events for two MD participants for whom data were acquired prior to AMD 
diagnosis. A: MD7 has bilateral AMD with severe vision loss after a secondary bleed to the left 
eye. B: MD13 has been diagnosed with bilateral dry AMD but has not reported any vision loss. 





to the fact we were replicating protocols from the first time points which were often 
conducted by different research groups. It was essential to keep protocols consistent 
within individuals to reduce the effect of scan type on the outcome measures. All T1 
and T2 images were gradwarped to correct for nonlinearities in the gradients. 
For our final set of control participants (C19-C33) scanning was performed on the 3T 
Magnetom Prisma MR scanner (Siemens Healthineers, Erlangen, Germany), using 
the 20-channel head / neck receive-array coil. Participants were scanned using the 
Human Connectome Project (HCP) recommended protocols.  
2.3.2.1 For MD1-MD12 and C1-C12 
For each time point for each participant, one 8-channel 3D T1-weighted anatomical 
image (TR = 7.88ms, TE = 2.99ms, TI = 600ms, voxel size = 1 x 1 x 1mm3, flip angle 
= 10°, matrix size 256 x 256 x 176, FOV = 256mm) and one T2-weighted anatomical 
image was acquired (TR = 2500ms, TE = 75.48ms, voxel size = 1 x 1 x 1mm3, flip 
angle = 90°, matrix size = 256 x 256 x 176, FOV = 256mm).  
2.3.2.2 For MD7(2 time points), MD13 and C13-C18 (all time points) 
At each time point for a subset of controls (n=6) and MD13 one 8-channel 3D 
FSPGR T1-weighted anatomical image was acquired (TR = 7.76ms, TE = 2.96ms, TI 
= 450ms, voxel size = 1.13 x 1.13 x 1mm3, flip angle = 20°, matrix size = 256 x 256 x 
176, FOV = 290mm).  
2.3.2.3 For MD7(1 time point), MD13 (1 time point) and C13-C18 (1 time point) 
One T2-weighted anatomical image was acquired (TR = 8940ms, TE = 201.704ms, 
voxel size = 1.13 x 1.13 x 1mm3, flip angle = 90°, matrix size = 256 x 256 x 176, FOV 
= 290mm). 
2.3.2.4 For C19-33 
One T1-weighted anatomical image was acquired using a 3D-MPRAGE sequence 
(TR = 2400ms, TE = 2.28ms, TI = 1010ms, voxel size = 0.8 x 0.8 x 0.8mm3, flip 
angle = 8°, matrix size = 320 x 320 x 208, FOV = 256mm) and one T2-weighted 
anatomical image was acquired (TR = 3200ms, TE = 563ms, voxel size = 0.8 x 0.8 x 





2.3.3 Longitudinal experiment 
2.3.3.1 Study Design (MD1-MD12, C1-C18) 
MD Participants were enrolled in the study for up to ~24 months with a maximum of 
6 MRI scans in the time period. MD patients were given the option to opt in for the 
sessions they wished to attend, hence not all participants completed all sessions 
offered. Control participants only completed 2 MRI scans ~24 months apart. See 
Table 2.1 for details of the number of sessions completed by each participant. Figure 
2.1 outlines the number of sessions and timeline for MD7 (Figure 2.1A) and MD13 
(Figure 2.1B). 
2.3.3.2 Cortical thickness analysis 
Due to participant ill health and only having one time point, MD12 was excluded from 
the longitudinal analysis. All T1 and T2 weighted data (where possible) were 
analysed using the automatic longitudinal processing stream (Reuter, Schmansky, 
Rosas, & Fischl, 2012) in FreeSurfer analysis suite (version 6, available 
at: http://surfer.nmr.mgh.harvard.edu/). To compute reliable estimates of the rate of 
change in cortical thickness, several processing steps were completed. Each 
individual data set was processed automatically using FreeSurfer; Cortical 
reconstruction and volumetric segmentation was performed, and segmentations 
were inspected and manually corrected where applicable (e.g., when pial (grey 
matter) surface extended too far into the cerebellum). Once individual time points 
were checked and processed, an unbiased within-subjects template space and 
image was created (Reuter & Fischl, 2011) using robust inverse consistent 
registration (Reuter, Rosas, & Fischl, 2010). Next, skull stripping, Talairach 
transforms, atlas registration as well as spherical surface maps and parcellations 
were initialised using common information for the within-subject template created. 
This is known to significantly increase the reliability of cortical thickness measures 
and in turn increase the statistical power (Reuter et al., 2012). Our regions of interest 
(ROIs) were defined using FreeSurfer’s Destrieux anatomical atlas (Destrieux, 
Fischl, Dale, & Halgren, 2010). Cortical thickness is calculated by taking the shortest 
distance (millimetres) between the white matter surface and the grey matter surface 
at each vertex across the cortex; measurements across all vertices within an ROI are 
then averaged (Figure 2.2). Rate of change in cortical thickness across all time 





anatomical atlas were the occipital pole (parcellation index = 42) and the calcarine 
sulcus (parcellation index = 44). Values were averaged across hemispheres. Given 
that both the occipital pole and calcarine sulcus ROIs defined here are not restricted 
to primary visual cortex, we generated a second set of ROIs by intersecting the 
occipital pole with V1 - Brodmann Area label created during initial recon-all 
processing (Fischl et al., 2008). This allowed us to generate two ROIs restricted to 
primary visual cortex which will be referred to as central-V1 (overlap between 
occipital pole and V1) and peripheral-V1 (areas of V1 not overlapping with occipital 
pole) throughout. The peripheral-V1 ROI includes more of the upper / lower meridian 
than the calcarine sulcus. 
 
 
2.3.3.3 Myelin Density analysis 
To compute cortical myelin density, T1 and T2 data were processed using the 
automatic pipeline developed by the Human Connectome Project (HCP, version 
4.0.0) which uses the T1w/T2w ratio to generate myelin maps (Glasser et al., 2014). 
The HCP MRI data pre-processing pipelines use tools from FreeSurfer (Van Essen, 
Glasser, Dierker, Harwell, & Coalson, 2012) and FSL (Jenkinson, Beckmann, 
Behrens, Woolrich, & Smith, 2012). The pipeline generates cortical myelin maps 
(example shown in Figure 2.3) in the subject’s native space (Glasser & Van Essen, 
2011). The ROIs used were the same as described above - occipital pole and 
calcarine sulcus from the Destrieux anatomical atlas and the central-V1 and 
Figure 2.2. Illustration of processed anatomical data from the sagittal view. Cortical thickness 
(yellow arrows) is calculated by taking the shortest distance (millimetres) between the white 
matter surface (green) and the grey matter/pial surface (magenta). Two example regions of 





peripheral-V1. As myelin was calculated using the HCP processing stream, each 
time point was effectively processed as if it were a separate individual, as there is 
currently no comparable longitudinal processing stream for generating myelin maps. 
However, as this was a FreeSurfer based analysis, the same ROIs could be 
computed for this separate data analysis. MD1-M11 and C1-C12 were included in 
this analysis. No T2-weighted images were acquired for C13-C18, and therefore 
estimates of myelin density could not be computed for these individuals, nor could 
they be computed for the first time point pre-diagnosis for MD7 and MD13.  
Rate of change was calculated for myelin density using the slope of a regression line 
based on the times measurements were taken (x-values), and what the myelin 
values were at each time point (y-values). This was done for every individual before 






Figure 2.3. Example unsmoothed myelin map for the left hemisphere of a sighted 
control using the HCP minimal processing pipeline (Glasser et al., 2011). Hotter colours 






2.3.3.4 Longitudinal analysis of cortical thickness in MD7 and MD13 
We calculated cortical thickness values for each time point in the within-subject 
template to visualise how cortical thickness changes over time, as well as computing 
the rate of change. Data were processed using the longitudinal stream as described 
above, but for this analysis for MD7, two additional time points were included. For 
MD13, only data acquired on the GE scanner was included in this analysis (MRI 1 
and MRI 3). See Figure 2.1 for details. 
2.3.3.5 Longitudinal analysis of myelin density in MD7 
We also had the opportunity to examine myelin density in MD7 post-diagnosis. No 
T2-weighted scans were acquired at the first time point, however the 6 post-
diagnosis timepoints did include a T2 scan. The 4th time point post-diagnosis (2.11 
years post diagnosis) was removed from this analysis due to issues generating a 
myelin map. As such, only 5 post-diagnosis time points are presented. As described 
above, the HCP processing pipeline was used to generate myelin maps for MD7 and 
a mean value for each ROI was plotted. A rate of change value was also computed 
in the same was as described for group data. 
2.3.4 Cross sectional cortical thickness and myelin density analysis 
In order to visualise the impact of group on both myelin density and cortical 
thickness, as well as the relationship between measures, we calculated group mean 
values for MD patients (MD1-MD11) and controls (C1-C18 for cortical thickness and 
C1-C12 for myelin density) for all four ROIs. We simply averaged across timepoints 
for each individual, before then computing a group average.  
C19-C13 were only scanned at a single time point and so do not contribute to the 
longitudinal analysis. Data were processed using the HCP minimal processing 
stream described above, after which the cortical thickness and myelin values were 
extracted from the subject’s native space. The ROIs were computed as described 
previously. C19-C33 were only included in the scatterplots along with C1-C12. 
Myelin density and cortical thickness were converted to Z-scores for this due to the 
fact data were acquired on different MRI scanners, and given the difference in 





2.3.5 Linear mixed effects for individual time points 
To assess the difference in cortical thickness and myelin density between groups 
and over multiple time points, values for both measures at each time point were 
analysed using a linear mixed effects model (Winter, 2013a, 2013b). The model 
used for each ROI were as follows (R syntax):  
(a) Thickness ~ 1 + Age + Group:Time + (1  | Participant) 
(b) Myelin ~ 1 + Age + Group:Time + (1  | Participant) 
Age at the time of recruitment, group and time were included as fixed effects, and 
participants as a random effect. By having this as a random effect, all participants 
have a different intercept, and this allows us to account for between-subject 
variability in cortical thickness and myelin density. We examined both measures for 
all four ROIs for both the MD and control groups. The model for each ROI was 
evaluated using restricted maximum likelihood (REML) estimation to ensure the 
model was robust. This is the optimal method for studies with smaller samples and 
uneven group sizes. The significance was assessed using t-tests which incorporated 
the Satterthwaite’s method to calculate our degrees of freedom and in turn control for 
possible type-1 errors.   
 
2.4 Results 
2.4.1 Cross-Sectional analysis 
2.4.1.1 Assessing the relationship between cortical thickness and myelin 
density in sighted group 
In order to understand the possible impact of macular disease on both of our 
measures, we pooled together sighted control data across studies, to enable us to 
visualise how the two measures may be related. Given data were acquired using 
different MRI scanners, we converted cortical thickness and myelin density values to 
z-scores separately before combining them, to allow us to interrogate the data on the 
same scale. Figure 2.4 shows data for all four ROIs for our control data (n=27). It 
appears there is a hint of a negative correlation between cortical thickness and 









2.4.1.2 Mean cortical thickness 
To establish whether results for this group of MD patients (MD1-M11) and sighted 
controls are consistent with previous cross-sectional studies, we calculated the mean 
cortical thickness values for each group for all ROIs. Values reported in Figure 2.5B-
E and H-K were averaged across hemispheres and then averaged across time 
points for each individual, before a group mean was calculated. In Figure 2.5B and 
C, we have calculated the mean group cortical thickness for all MD patients and all 
18 controls for the four ROIs. In Figure 2.5D and E we present just C1-C12 who 
have also contributed myelin data. Mean cortical thickness seems to be consistent 
across Figure 2.5B and D, even with fewer participants contributing to Figure 2.5D, 
with MD patients showing an overall thinner cortex than sighted controls, for both the 
occipital pole and calcarine sulcus. For our ROIs restricted to V1, while the figures 
Figure 2.4. A: Regions of interest in visual cortex for all analyses shown on an inflated 
cortical surface. Occipital pole = red, calcarine sulcus = blue, central-V1 = yellow, 
peripheral-V1 = purple. The table below the inflated surface is a summary of the correlation 
(R) and corresponding p-values for each of our ROIs. The only significant correlation was for 
the occipital pole (B). B-E: Scatterplots plotting myelin density against cortical thickness (z-





are lower overall in C and E, we generally see the same pattern, with MD patients 
having a thinner cortex. For E in particular, the difference between groups is far 
smaller. See Section 2.4.2.3 for the results of the linear mixed effects model. Table 
2.2 summarises the results for the linear mixed effects models. In summary, a 
significant effect of group was shown for the occipital pole, calcarine sulcus, central-
V1 but not peripheral-V1, indicating MD patients had, on average, a thinner cortex 
than sighted controls, particularly in the regions capturing the LPZ.  
2.4.1.3 Mean Myelin density 
For myelin density, we calculated the group means as described above. We 
observed a higher mean myelin density value for our MD patient groups compared to 
our sighted control group, and this occurred for all four ROIs (Figure 2.5F and G). 
Given the literature indicates that thinner regions of cortex often have a larger 
amount of myelin, this pattern of results seems unsurprising. Interestingly, as shown 
in Table 2.2, the linear mixed effects models revealed a significant effect of group for 
the calcarine sulcus and peripheral-v1 ROIs only, with MD patients having, on 
average, more myelin in the peripheral representation in visual cortex.  Example 
myelin maps and cortical thickness for an MD patient and sighted control are shown 
in Figure 2.6. Looking at cortical thickness and myelin together, the group data 
seems to support the negative correlation shown in the sighted control cohort (Figure 
2.4), whereby a reduction in cortical thickness appears to be accompanied by an 
increase in myelin.  
Next, we wanted to explore what would happen to both cortical thickness and myelin 
density over a period of time. Cross-sectional results show a difference between our 
sighted and MD groups, but it is unknown (a) whether these two measures will 
change in the same way over time with natural aging and (b) whether eye disease 







Figure 2.5. A: Regions of interest (ROIs) on the inflated cortical surface for MD patient (black bars) and sighted controls (white bars). Error bars = SEM. B-E: 
Mean cortical thickness (mm) for four ROIs as indicated at the top of each column. B&C: MD patients and C1-C18. D&E: MD patients and C1-C12, the subset of 
controls that contribute myelin data. F&G: Mean myelin density for MD patients and C1-C12 for all ROIs. H-K: Rate of change in cortical thickness (millimetres per 





Table 2.3: Results from the Linear Mixed Effects Models for cortical thickness and myelin density. Here we are reporting the fixed-effects ’s with 
the standard error (SE) for the predictors we used for each ROI. Age refers to the age of participants at the first time point. Group refers to MD 
patients and sighted controls. T-test results determine the significance of each of the predictors reported here. All significant results are in bold. 
Cortical Thickness
Predictor b (SE) t (df) b (SE) t (df) b (SE) t (df) b (SE) t (df)
Age 0.002 (0.001) 2.09 (25.76)*  -0.001 (0.001)  -0.76 (25.96) 0.003 (0.001) 2.19 (26.10)* 0.001 (0.001) 0.65 (26.00)
Group  -0.14 (0.04)  -3.52 (27.76)***  -0.10 (0.05)  -2.06 (26.92)*  -0.12 (0.06)  -2.12 (28.11)*  -0.05 (0.06)  -0.85 (27.04)
Time  -0.01 (0.01)  -2.34 (50.00)*  -0.02 (0.005)  -4.30 (50.07)***  -0.02 (0.01)  -2.28 (50.34)*  -0.01 (0.01)  -2.32 (50.11)*
Group:Time  -0.02 (0.01)  -1.56 (50.54) 0.02 (0.01) 1.64 (50.32)  -0.02 (0.02)  -1.08 (50.88) 0.001 (0.01) 0.09 (50.39)
Myelin Density
Predictor b (SE) t (df) b (SE) t (df) b (SE) t (df) b (SE) t (df)
Age 0.001 (0.001) 0.83 (20.78)  -0.002 (0.001)  -1.61 (20.67) 0.001 (0.001) 0.83 (20.03)  -0.001 (0.001)  -0.57 (20.68)
Group 0.03 (0.04) 0.78 (26.90) 0.11 (0.04) 2.71 (31.13)* 0.04 (0.05) 0.70 (24.55) 0.09 (0.04) 2.05 (31.39)*
Time 0.02 (0.01) 1.48 (45.20) 0.03 (0.01) 2.11 (45.58)* 0.01 (0.01) 0.67 (44.34) 0.02 (0.01) 1.63 (45.62)
Group:Time  -0.04 (0.02)  -2.16 (46.93)*  -0.05 (0.02)  -1.94 (48.63)  -0.05 (0.02)  -2.29 (45.66)*  -0.04 (0.02)  -1.85 (48.75)
*p <.05, **p <.01, ***p <.001; from t-tests, using Satterthwaite's method to correct degrees of freedom (df)
Calcarine Sulcus Central-V1 Peripheral-V1







2.4.2 Longitudinal Analysis 
2.4.2.1 Rate of change in cortical thickness 
As part of the longitudinal pipeline, rate of change in cortical thickness was calculated for 
all ROIs, allowing us to determine how cortical thickness values may change over the ~24-
month period in both groups. We predicted that patients would show an accelerated rate of 
decline in the occipital pole / central-V1 compared to controls given these ROIs capture 
the representation of the damaged visual field, but we did not predict a difference between 
groups for the calcarine sulcus, given that for both groups, this represents the intact 
projection zone. Figure 2.5 H & J show the rate of change in cortical thickness for our 
occipital pole and calcarine sulcus ROIs. Despite the reduced number of participants in 
Figure 2.5J, results are consistent. The general pattern observed is that irrespective of 
group, with time, cortical thickness declines. MD patients seem to show a faster decline in 
cortical thickness within the occipital pole and central-V1, whereas there seems to be a 
Figure 2.6. Example unsmoothed myelin maps (upper row) and cortical thickness maps 
(lower row) for an MD patient (column 1&2) and sighted control matched for age and gender 
(column 3&4). Regions of interest have been overlaid onto the myelin and thickness maps. 






smaller difference between groups in the calcarine sulcus and peripheral-V1. Differences 
between the groups were explored using a linear mixed effects model analysis (see 
Section 2.4.2.3). Again, the rate of change remained consistent for the sighted controls 
even when only including the 12 who also contributed myelin data (Figure 2.5I, K).  
2.4.2.2 Rate of change in myelin density 
The rate of change in myelin density was calculated for each ROI as shown in Figure 2.5 
L-M. The data appear to show a decline in myelin over time in MD patients across all 
ROIs, more so in those restricted to V1, but in contrast, a small increase was observed for 
the control group. This result for the controls appears to compliment the cross-sectional 
findings between the two measures and the increase observed could simply be explained 
by an artefact caused by the decrease in cortical thickness. For MD patients, this is not the 
case. Differences between the groups were explored using a linear mixed effects model 
analysis (see Section 2.4.2.3). 
2.4.2.3 Linear Mixed Effects Model: Cortical Thickness 
All results for the linear mixed effects models are reported in Table 2.2. Given the 
difference in the average age of our two groups, we wanted to account for the role it may 
play in any observed findings by including it as a fixed effect in our model. Age had a 
significant effect on cortical thickness in the occipital pole (t(25.76)=2.09, p=.047), but not 
for the calcarine sulcus (t(25.96)= -0.76, p=.453) however despite this, we still find a 
significant effect of group, suggesting any group differences are likely attributed to visual 
impairment, not age. MD patients have a thinner cortex overall compared to controls 
(significant effect of group; occipital pole: t(27.76)= -3.52, p<.001, calcarine sulcus: 
t(26.92)= -2.06 p=.050). In line with previous literature, all participants irrespective of 
group, show a decline in cortical thickness over time (significant effect of time in the 
occipital pole: t(50.00) = -2.34, p=.023 and calcarine sulcus: t(50.07)= -4.30, p<.001).  
For our V1 ROIs, age also had a significant effect for our central representation 
(t(26.10)=2.19, p=.038), but not for the peripheral-V1 (t(26.00)= 0.65, p=.524). Our group 
effects still emerged as significant for central-V1 (t(28.11)= -2.12, p=.043), however no 
significant differences emerged between groups for peripheral-V1. Irrespective of group, 
we still see a decline in cortical thickness over time for both of our ROIs (central-V1: 
t(50.34) = -2.28, p=.027 and peripheral-V1: t(50.11)= -2.32, p=.028). Finally, there was no 





suggesting MD patients did not decline at a significantly faster rate than controls during 
this time period.  
2.4.2.4 Linear Mixed Effects Model: Myelin Density 
As with cortical thickness, age was entered as a predictor into our model, however age 
was not a significant predictor of myelin density for any of our ROIs (see Table 2.2). In 
terms of group differences, overall MD patients overall had a higher mean myelin density 
value for both our peripheral ROIs compared to controls (calcarine sulcus: t(31.13)= 2.71, 
p=.011, peripheral-V1: t(31.39)= 2.05 p=.049). Interestingly, time was only a significant 
predictor of myelin content for calcarine sulcus (t(45.58)= 2.11, p=.041), again showing a 
significant increase with time. Looking at our rate of change plots, this is likely driven by 
the control data. In terms of group x time interactions, a significant effect emerged for both 
of our central representations, whereby patients are shown to be changing at a 
significantly different rate to controls. The estimates for this predictor being negative (-
0.04) indicates that MD patients decline faster than controls for both occipital pole 
(t(46.93)= -2.16, p=.036) and central-V1 t(45.66)= -2.29, p=.027). Whilst not significant, the 
calcarine sulcus result was close (p=.058), hinting that the decline in myelin may extend to 
regions beyond the representation of the lesion.  
2.4.2.5 Case studies: MD7 & MD13 
As well as assessing the group data, we also investigated changes in cortical thickness at 
each time point before and after an AMD diagnosis in our individual cases - MD7 and 
MD13. Figure 2.7 shows cortical thickness values for each individual time point for MD7 
(Figure 2.7A), illustrating a decline in all four ROIs over time, with a slightly steeper decline 
for the occipital pole and central-V1. A decline, albeit slower, was also observed for all 
ROIs for MD13 (Figure 2.7B).   
Rate of change was also calculated for both MD7 and MD13. Table 2.3 summarises the 
rate of change data from our MD patient group, sighted controls (n=18) and two cases for 
each of our ROIs. The rate of change for MD7 is most extreme, showing a faster decline 
compared to MD13 and both the MD patient and control groups. This was apparent for all 
ROIs indicating that cortical thickness may decline fastest in the earliest stages of the 
disease, but after vision is lost. Overall change is slower than MD7, which could be 
expected because MD13 reported no vision loss at the time. MD13 also shows a slower 
decline compared to the MD group for ROIs capturing the representation of central vision, 





compared to the MD group, much like MD7. Whilst the general direction of change in 
cortical thickness for MD13 seems similar to the control group, it is interesting that MD13 




















Figure 2.7. Mean cortical thickness measures (mm) in our 4 regions of interest for A: 
MD7 – bilateral AMD with bilateral vision loss and B: MD13 – bilateral AMD with no vision 
loss. Mean myelin density for the same ROIs for MD7 – post diagnosis timepoints only 







Finally, we were able to assess cortical myelin for MD7 for 5 out of the 6 time points after 
diagnosis. Unfortunately, T2-weighted scans were not acquired during the first time point, 
however it is interesting to observe how the individual time point values post-diagnosis 
may change over time. The cross-sectional data seemed to indicate that areas that thinner 
tend to have more cortical myelin. Given this, one would expect to perhaps see a 
complimentary increase in myelin in MD7 over the 5 time points post-diagnosis. However, 
this does not appear to be the case. The group MD data show an overall significant 
change in myelin compared to controls, and in the negative direction. MD7’s data seem to 
support this, showing a very slight decline in all regions over time which is supported by 
the rate of change values.  Changes in cortical myelin appear to be more subtle than those 
shown in cortical thickness, but it provides additional insights to other anatomical 
structures that may be degenerating as a result of eye disease. 
2.5 Discussion 
Our study aimed to assess the status of visual cortex in macular disease, by acquiring two 
anatomical measures: cortical thickness and cortical myelin density. We assessed four 
atlas-based anatomical ROIs, capturing both intact and lesion projection zones over 
multiple time points in a ~24-month period. Our results show that irrespective of group, 
there is a decline in cortical thickness during the time period of the study in all ROIs. This 
was expected given cross-sectional studies have highlighted reductions associated with 
natural aging, but also that MD affects not only the physiology of the eye, but also largely 
supports a thinning of cortex and reduction in volume in the posterior visual pathway 
(Boucard et al., 2009; Brown et al., 2016; Hanson et al., 2019; Hernowo et al., 2011, 2014; 
Malania et al., 2017; Olivo et al., 2015; Doety Prins et al., 2016). In terms of group effects, 
our results indicate that overall, our MD patients have a thinner cortex, with 3 out of 4 of 
our ROIs emerging significant – both central representations, plus the calcarine sulcus. 
Table 2.4. Summary of rate of change in cortical thickness for each ROI. 
Data presented for MD patient group, control group (n=18) and our two 





Whilst at first glance our rate of change plots suggest MD patients appear to decline at a 
faster rate compared to sighted controls in both central representations, this result did not 
emerge as significant. However, rate of change data did support our second prediction that 
there would be no difference in the rate of change in cortical thickness between groups for 
the two peripheral ROIs, given that in patients, this captures the representation of the 
intact visual fields. The group data for cortical thickness support earlier work in our lab; 
Hanson et al (2019) followed a group of unilateral AMD patients and found a decline in 
cortical thickness in the occipital lobe, driven by changes in the occipital pole. Here, we 
show cortical thinning has occurred in bilateral MD of different forms, even in patients who 
have had MD for several years, some spanning decades. 
Our cross-sectional results indicate there may be an interplay between cortical thickness 
and myelin measures, whereby thinner regions of cortex are generally more heavily 
myelinated. This is further supported by the literature which suggests that thinner but 
heavily myelinated regions, such as V1 are more robust to the effects of natural aging. 
This is reflected in the rate of change data for our control group; the decrease in cortical 
thickness over time is complemented by a relative increase in cortical myelin over time 
(Fjell & Walhovd, 2010; Lu et al., 2011; Natu et al., 2019; Williamson & Lyons, 2018). 
Based on the cross-sectional findings and the hint of an interplay between our measures, 
one would predict to see a greater increase in myelin for MD patients compared to controls 
in the rate of change analysis, given that on average, ROIs were thinner for the MD patient 
group. The effect of time seems to suggest that irrespective of group, myelin progressively 
increases, but was only significant for our calcarine sulcus ROI and appeared to be driven 
by the control group. Regarding group effects, our MD patients appear to have more 
cortical myelin in all ROIs, but again this only emerged significant for the peripheral 
representations. Interestingly, a significant group and time interaction was reported for the 
central representations only, whereby the MD patients’ myelin density declines more 
rapidly. Our cross-sectional data alone would lead one to believe that areas with a thinner 
cortex would have greater myelin density, but the longitudinal data highlights that while our 
MD group may appear to have more myelin, MD patients do appear to show a decrease 





It is likely that the proportion of cortical myelin relative to grey matter may be high in MD 
patients due to the reduction in grey matter we observe in this group rather than MD 
patients showing an increase in cortical myelin for which there would be no apparent 
explanation. A similar age dependent atrophy of cortex is accompanied by a relative 
increase in myelin in the longitudinal myelin density control data.  The observed reduction 
in myelin density over time in the MD patient data suggests therefore a likely pathological 
change in myelin density resulting from an absence of visual input. Figure 2.8 describes 
possible explanations for the interplay between total cortical thickness and myelin density. 
The developmental perspective (Figure 2.8B) shows how a decline in cortical thickness 
can be explained by a genuine increase in cortical myelin due to the shift in white matter 
Figure 2.8. A: T1-weighted anatomical image with an illustration of the grey matter, cortical 
myelin, and white matter tissue. The grey and white matter boundaries are indicated by the 
purple and green lines respectively. B-E: Illustrations of possible observations over time with 
cortical thickness and myelin density. B: Illustration of the developmental increase in myelin 
observed in Natu et al., (2019), causing a shift in the white matter surface C: Illustration of the 
pathological decrease in grey matter thickness while myelin density appears to increase. D: 
Pathological decrease in myelin density causes a shift in the grey matter surface, while cortical 





boundaries. The pathological decrease in grey matter thickness (Figure 2.8C) shows how 
myelin may remain unchanged, but register an increase in density, resulting from the 
overall reductions in cortical thickness. It is possible that overall cortical thickness may be 
explained by a pathological decrease in cortical myelin and not other tissues (Figure 2.8D) 
and finally, pathological decreases in both grey matter thickness and myelin density may 
contribute to a reduction in total cortical thickness (Figure 2.8E). Our results would suggest 
that a combination of C and E can explain our findings; the cross-sectional data suggest a 
decrease cortical thickness could register an increase in myelin density (as in Figure 
2.8C), but our rate of change data suggest that macular disease has a negative impact on 
both grey matter and cortical myelin density (as shown in Figure 2.8E).  
Whilst reductions in cortical thickness and volume are well documented in the literature, 
the functional consequences of a reduction in myelin density in macular degeneration are 
unknown. In the animal literature, there is evidence of sensory deprivation leading to 
selective demyelination in cortex; adult rats deprived of visual input to one eye for several 
days showed a decrease in cortical myelination specifically in the deprived region of visual 
cortex (Hill, Patel, Goncalves, Grutzendler, & Nishiyama, 2014; Murphy, Mancini, 
Clayworth, Arbabi, & Beshara, 2020; Timmler & Simons, 2019; Xin & Chan, 2020). 
Evidence of demyelination of either grey or white matter following vision loss in humans is 
much more limited (Timmler & Simons, 2019). Myelin production is not uniform across 
cortex, and is regulated over the lifespan, with post-mortem work highlighting that the 
process of myelination occurs well into our 30’s (de Hoz & Simons, 2015; Timmler & 
Simons, 2019). Areas involved in higher cognitive functions are the last to undergo 
myelination, with visual and other sensory areas myelinating early in life (de Hoz & 
Simons, 2015; Timmler & Simons, 2019). The main role of myelin is to regulate conduction 
speed, but it has also been implicated in metabolic processes and maintenance of fibers 
(Simons & Nave, 2016). A reduction in myelin may therefore negatively impact neural 
conduction, in turn causing a temporal delay. In multiple sclerosis, demyelination across 
the brain is thought to explain symptoms such as physical and cognitive decline (Bø, 
2009). Evidence from the psychophysical and electrophysiological literature in individuals 
with multiple sclerosis or demyelinating optic neuritis highlight that a possible consequence 
of demyelination in cortex is a decline in temporal aspects of visual processing (Raz, 
Shear-Yashuv, Backner, Bick, & Levin, 2015; Young, Braich, & Haines, 2018). Studies 
using critical flicker-fusion frequency experiments to determine the threshold where a 





responses in such patient groups. Other paradigms measuring visually evoked potentials 
(VEPs) report complementary findings, highlighting a possible loss of high temporal 
resolution of vision in demyelinating conditions. It may be possible to detect temporal 
delays in MD patients as well, for which there is some evidence already (Sabeti, James, 
Essex, & Maddess, 2013).  Exploring possible myelin changes beyond early visual cortex, 
for example, assessing changes in motion perception and corresponding myelin in area V5 
may provide further insights. Furthermore, in Chapter 5 we report a reduction in functional 
connectivity between central-biased portion of V1 and a ventral face-selective ROI; 
perhaps the reduced synchrony between these areas relates to structural changes, 
including those involving myelin. Knowing whether the decline in myelin (particularly in the 
grey matter) triggers changes in neural signalling or vice versa is yet to be fully understood 
in both natural and pathological aging. 
The results from both the cross-sectional and longitudinal data raise the question of when 
changes are happening in cortex. In addition to the interplay between measures described 
above, a thinner cortex overall in patients across ROIs could have been explained by the 
age gap between our participant groups. However, we accounted for this by including age 
at the time of enrolment into our model which despite showing that age was a significant 
predictor for cortical thickness, our group and time effects still emerged and therefore age 
cannot solely explain the thinner cortex in MD patients. This then begs the question of how 
patients have a thinner cortex in all ROIs when during this time period, they did not decline 
significantly faster. Patient MD7 sheds some light on this; we captured the changes in 
cortical thickness in the period during which MD7 lost a substantial amount of vision, due 
to bilateral AMD and a secondary bleed in one eye. We compared the changes associated 
with longstanding bilateral MD against MD7, predicting greater changes in MD7, given that 
we were able to capture the window immediately before, and the first few years after 
diagnosis. The data show a sharper decline over the time points immediately after 
diagnosis, and the rate of change for this participant exceeded that of both controls and 
other MD patients. This gives us an indication that perhaps cortical thinning occurs at the 
early stage of the disease (after sight loss) but stabilises over time. Given that MD7 
progressed quite rapidly compared to the MD patient group, it was important to assess the 
rate of change in MD13 who showed a much slower disease progression; despite a 
diagnosis of bilateral AMD, MD13 has retained vision and shows no deficit as yet. We 
therefore predicted changes akin to those observed in sighted controls, only showing signs 





accelerated rate of change, the pattern of results is more similar to the controls as 
calcarine sulcus declines faster than the occipital pole, and for our V1-restricted ROIs, the 
rate of change was quite similar. The trajectory for myelin appears to be similar; a steady 
decline emerged over time post diagnosis for MD7, further supporting the idea that while 
cortical myelin does seem more robust to change, there may be a pathological decline 
associated with macular disease. 
In MD7, we observed a faster decline in cortical thickness in all ROIs compared to controls 
and other MD patients. The accelerated decline in peripheral representations however is 
an interesting finding; it may be that changes in the representation of the intact visual field 
occur in the early stages of MD, but with prolonged vision loss this may stabilise, hence in 
the group data, we do not see an accelerated decline, and if anything, a stabilisation of 
cortical thickness with mean rate of change being close to zero for the calcarine sulcus (-
0.006 mm/year). Examining MD7’s individual time points more closely, we can see that the 
slope starts to flatten in peripheral ROIs but shows a steady decline in the central ROIs, 
suggesting the representation of the intact visual field is starting to stabilise like our MD 
patient group appears to be. To fully understand the nature of the changes, it is important 
to continue collecting measurements on individuals like MD7 and MD13 and track changes 
over a greater period; data captured during the first 24 months post diagnosis will help us 
to better characterise the time course of changes in visual cortex, but severity of the 
disease must also be considered as MD7 and MD13 have progressed very differently 
since their AMD diagnoses. Collectively, it seems the loss of vision, rather than diagnosis 
of the disease itself, is what triggers more rapid changes in the posterior visual pathway.  
We cannot ignore the fact patients with longstanding bilateral MD are still showing a 
decline in visual cortex. This tells us that interventions need to be implemented as early as 
possible as there is evidence that changes occur throughout the disease progression, 
even in the later stages. This also suggests perhaps late-stage individuals would not be 
ideal candidates for visual restoration; whilst a lot of research is geared towards curing eye 
disease and restoring the function of the eye, one must consider if the brain is even 
capable of processing new incoming information. Data from MD7 suggests that the 
optimum time to intervene would be as early as possible, given the steeper decline in 
cortical thickness in the pre and post diagnosis time points compared to post diagnosis 
time points only. Further to this, data from MD7 and MD13 suggest that structural and 
functional changes within the anterior visual pathway seem to be necessary to drive the 





vision and appears not to have declined as fast as MD7. We have also shown that cortical 
myelin is affected, giving further reason to adopt more neuroprotective strategies going 
forward. 
For this study, we included two sets of ROIs to capture the anatomical representations of 
the central retinal lesion and the intact peripheral fields. As discussed in Chapter 1, the 
way in which they have been defined does vary across studies, and we suspect this may 
explain some of the differing results, particularly concerning the intact representation. For 
some, these are defined functionally using retinotopic mapping procedures either on the 
patients themselves, or on a group of sighted controls which are then transformed into the 
appropriate subject space. Others have opted for anatomical based atlases. To keep 
consistent within our lab and to follow on from the work by Hanson et al. (2019), we used 
the occipital pole (lesion) and calcarine sulcus (intact visual field) from the Destrieux atlas 
in FreeSurfer. These ROIs are anatomical and are not restricted to primary visual cortex 
(V1). We reasoned that since previous work often uses V1 parcellated into central and 
peripheral representations, we should also restrict the occipital pole and calcarine sulcus 
to V1 and examine how the responses might vary.  Our results were consistent across our 
two sets of ROIs; the pattern of the results remained the same, whereby increases or 
decreases in cortical thickness or myelin observed in the occipital pole and calcarine 
sulcus were generally seen in the central-V1 and peripheral-V1, and while the rate of 
change remained in the same direction, the absolute values did differ. This was to be 
expected given that for the occipital pole restricted to V1, we are reducing the size of the 
ROI. For the peripheral-V1, the ROI did not occupy the full length of the calcarine sulcus 
and so did not capture the far peripheral representations compared to the calcarine sulcus, 
but it did include more of the upper and lower bank of the calcarine, representing the 
vertical meridian.   
Deciding on how to define ROIs can be difficult. Using anatomical atlases has many 
advantages, since they can be used in all participant groups, irrespective of whether they 
have sight or not. This ensures that we are indeed comparing data from the same regions 
of cortex across individuals and groups. Functional based ROIs do however allow for more 
accurate mapping of the representation of the lesion and can be corroborated with 
measures of retinal function too. Our MD patients vary considerably in terms of duration of 
disease and how advanced the vision loss is. We also have some patients undergoing 
treatment for wet-AMD while others have no treatment options available. With a 





within an individual so that we could get a reliable measure of the rate of change in cortical 
thickness and myelin density. Furthermore, measures of visual function could not be 
acquired for all participants, meaning we would not be able to use scotoma size to guide 
our measure of the lesion projection zone (LPZ). Using anatomical ROIs, as well as using 
the longitudinal within-subject processing stream for cortical thickness measures, allowed 
for greater consistency in both MD patients and controls.  
As we are an aging population, we need to understand the nature of the eye and cortical 
changes in age-related diseases such as AMD. Recent reports indicate that by 2037, 
approximately 24% of the population will be over 65 years old (Office for National 
Statistics, 2018). Though changes in the eye in AMD are regularly monitored, determining 
what is causing changes in the posterior visual pathway is important to understand, as this 
will likely affect restoration attempts – something that will require more attention given the 
projections for increasing numbers of elderly population and in turn, the prevalence of 
AMD. We need to know whether it is sufficient to treat the eye alone, or whether we need 
to incorporate additional neuroprotective strategies to prevent or slow the cortical changes. 
Evidence already indicates the latter is necessary. Given that age-related changes are 
known to occur throughout the whole brain (Lu et al., 2011), it is fundamental to tease 
apart what is part of the normal aging process, and what may be a biomarker for age-
related decline that is attributed to some form of pathology, as aging is a risk factor for 
AMD as well as Alzheimer’s disease. 
Recent advances in protocols for in vivo MRI allow for much more reliable data, as has the 
development of longitudinal processing streams, but what is also encouraging from this 
study is that non-HCP standard T1 and T2-weighted imaging protocols acquired on our GE 
scanner (1mm isotropic images) were processed adequately using the minimal processing 
pipeline. We verified this in our first analysis with our two control cohorts, one who had GE 
1mm isotropic images, and one cohort with HCP protocols on the Siemens scanner with 
0.8mm isotropic images. Despite the differences, we observed the same pattern of results 
and hence were able to verify the GE data. Going forward, it is highly desirable to continue 
to acquire data using the HCP protocols and compare in vivo MRI myelin maps with post-
mortem data to give us further insights into the nature of the structural changes we are 
observing in health and disease. Histological studies assessing cortical myelin changes 
are largely limited to animals and in humans, to diseases associated with demyelination 
such as multiple sclerosis and optic neuritis. Multiple sclerosis affects both grey and white 





grey and white matter differently (Bø, 2009). Some argue histological work is less sensitive 
to changes in more superficial cortical layers, but studies are still able to provide sufficient 
evidence of demyelination. As yet, there are no histological studies exploring myelin 
density changes in eye disease in humans. Furthermore, a shift to more longitudinal 
designs to assess measures of change more reliably within individuals will help to shed 
more light on disease progression. We have already shown how it may differ in two 
individuals with a similar pathology. 
Beyond the grey matter and cortical myelin, examining changes in the integrity of the white 
matter tracts, for example projections from the lateral geniculate nucleus (LGN) to the 
lesion and intact projection zones will provide a more complete picture of the changes in 
the posterior visual pathway, alongside measures of cortical thickness and myelin. There 
is a limited amount of cross-sectional evidence showing degradation of these white matter 
tracts – the optic radiations (Beer et al., 2020; Hernowo et al., 2014; Malania et al., 2017; 
Ogawa et al., 2014; D. Prins et al., 2011; Sullivan, Rohlfing, & Pfefferbaum, 2010; 
Yoshimine et al., 2018) - but those examining white matter using diffusion MRI (dMRI) do 
reveal changes specifically in the projections from the LGN to the lesion projection zone in 
primary visual cortex (Yoshimine et al., 2018). Most studies using traditional methods such 
as voxel-based morphometry are not sensitive enough to detect subtle changes in white 
matter integrity (Yoshimine et al., 2018). The time course of such changes is currently 
unknown, and this will be discussed further in Chapter 3 with the same participants 
included in this study. 
Techniques such as magnetic resonance spectroscopy (MRS) will allow us to investigate 
neurochemical changes occurring in visual cortex in both health and disease, which may 
be able to indicate whether the cortical changes are reversible of not by looking for 
markers of types of cell death: necrosis versus apoptosis (Hanson et al., 2019). 
Collectively, such measures will allow us to capture the window in which the greatest 
changes occur, and where they occur, providing insight into the optimum intervention 
window for restoration to have the most chance of success. 
We conclude that there is accumulating evidence of the thinning of visual cortex in 
individuals with MD, which continues throughout the disease progression, as shown in 
cases of long-standing bilateral macular disease in this study. We have provided new 
insights with two individual cases who we have had the unique opportunity to assess 





disease progression, but this appears to be largely triggered by the onset of visual loss. 
Cortical myelin is also showing possible signs of decline in visual cortex and more so in 
the representation of the lesion, something which has not been demonstrated before. 
Monitoring the entire visual pathway in individuals in the earliest stages of the disease will 
provide valuable insight into the time course of changes, as well as establishing the link 
between changes in the anterior and posterior visual pathways, further highlighting the 






Chapter 3: Assessing the integrity of the optic radiations in 
bilateral macular disease 
3.1 Abstract 
The advent of diffusion MRI has allowed for in vivo assessments of the micro and 
macrostructure of the brain. Reductions in cortical thickness, volume and surface area 
have been widely observed in individuals with macular disease, however fewer 
investigations of the visual white matter have been conducted in this population. The aim 
of this study was to assess the structural integrity of the optic radiations in individuals with 
bilateral vision loss as a result of juvenile (JMD) and age-related (AMD) forms of macular 
disease. The optic radiations were divided into two bundles – fibers projecting to the 
occipital pole (anatomical representation of central vision) and fibers projecting to the 
calcarine sulcus (anatomical representation of peripheral vision). Recent work has shown 
selective deficits in only the fibers projecting to the location representing the visual field 
defect in largely unilateral AMD patients, and only in a portion of this tract. We replicate 
these findings in our bilateral patient group, observing reductions in fractional anisotropy 
(FA), and respective increases in radial diffusivity (RD), in middle portions of the tract 
projecting to the occipital pole. However, we also see this pattern in the calcarine sulcus 
projection, suggesting more widespread alterations in the white matter in bilateral MD. We 
also evaluated changes in FA over time in the portion of the tracts significantly reduced in 
our MD group; results indicate in the time window of the study, no significant changes 
occurred in either sighted controls or MD patients. The same measures were reported for 
two individuals before and after an AMD diagnosis; reductions in FA in the same portion of 
both projections in the optic radiations were evident for both cases before and after 
diagnosis, suggesting that perhaps structural changes in the posterior visual pathway 
emerge prior to functional vision loss. Finally, volume measures revealed no significant 
differences between groups or across time. Individual AMD cases however indicate 
reductions in projections to both central and peripheral representations may still occur in 










In Chapters 1 and 2, the changes observed in cortical thickness, volume and surface area 
as a result of the natural ageing process were discussed (Salat et al., 2004). In cases of 
vision loss, multiple neuroimaging studies, including the work presented in Chapter 2, have 
reported atrophy of the posterior visual pathway, greater than that observed with ageing. 
Reductions in grey and white matter volume, as well as a reduction in cortical thickness in 
regions representing the visual field defect have been reported, with effects being more 
pronounced in cases of bilateral vision loss in both age-related and juvenile forms of 
macular degeneration (Baseler et al., 2011; Beer et al., 2020; Burge et al., 2016; Hanson 
et al., 2019; Hernowo et al., 2014; Lemaitre et al., 2012; Prins et al., 2011; Salat et al., 
2004). Whilst a large proportion of structural changes observed in the literature concern 
the cortical representation of the retinal defect, there is some evidence of more 
widespread atrophy, particularly in age-related macular degeneration (AMD). Structural 
changes in AMD extend beyond primary visual cortex and appear to be more generalised, 
affecting both white and grey matter, even in frontal regions (Hernowo et al., 2014).  
The development of diffusion weighted imaging has allowed for the evaluation of subtle 
changes in microstructure, macrostructure and anatomical connectivity in vivo, making it a 
valuable technique to use when exploring the impact of natural aging, disease and injury 
on the white matter tracts (Olivo et al., 2015; Reislev, Dyrby, Siebner, Kupers, & Ptito, 
2016; Thomason & Thompson, 2011; Yeatman, Dougherty, Myall, Wandell, & Feldman, 
2012; Yoshimine et al., 2018). Fractional anisotropy (FA) is used to measure the structural 
integrity of white matter tracts and allows inferences to be made about the alignment of 
fibers within a tract. Axial diffusivity (AD) concerns diffusion in the direction parallel to the 
tract - the principal orientation. Radial diffusivity (RD) is a measure diffusion in directions 
that are perpendicular to the tract’s principal direction. Finally, mean diffusivity measures 
the average diffusion of water over all directions. A combination of diffusion properties can 
help clarify the state of white matter tracts in both health and disease (Rokem et al., 2017). 
The white matter tracts of most interest in vision loss research are the optic tracts, which 
project from the optic chiasm to the lateral geniculate nucleus (LGN), and the optic 
radiations, which project from the LGN to early visual cortex (Primarily V1 and V2).  
Given there are far fewer diffusion studies exploring the effects of blindness, it is not 
surprising that there are some inconsistencies within the literature. Generally, it is agreed 
that the severity of the visual field defects correlate with diffusion properties, but age of 





anophthalmia, where individuals are both without one or both eyes, indicate there are 
severe changes in both the optic radiations and the optic tracts, including a reduction in 
volume and increase in RD as a result of visual deprivation (Bridge et al., 2009; Pan et al., 
2007; Reislev et al., 2016; Shu, Li, Li, Yu, & Jiang, 2009). Ogawa et al., (2014) have 
shown that the optic radiations are affected in rarer forms of central vision loss - leber 
hereditary optic neuropathy (LHON) and cone-rod dystrophy (CRD). Reductions in FA in 
the optic radiations and optic tracts were consistent across groups and did not depend on 
whether certain layers of the retina were damaged by the disease. LHON causes damage 
to the retinal ganglion cell layers whereas CRD affects the photoreceptor layer, but both 
lead to progressive loss of central vision (Ogawa et al., 2014). Others have reported 
greater changes in late onset vision loss compared to early and/or congenital cases, 
suggesting this is perhaps due to a reduction in plasticity in older patients. The important 
point is that regardless of age of onset, changes (to varying degrees) in the visual white 
matter can be observed, even in cases of partial vision loss (Dietrich, Hertrich, Kumar, & 
Ackermann, 2015; Hofstetter et al., 2019; Pan et al., 2007; Reislev et al., 2016; Wang et 
al., 2013).  
Regarding acquired vision loss, multiple glaucoma studies have revealed an overall 
decrease in FA and increase in mean diffusivity and RD in visual white matter tracts; the 
extent of the change also seems to be correlated with disease severity and ophthalmic 
measures (Li et al., 2014; Tellouck et al., 2016). Furthermore, Chen et al., (2013) found 
specific reductions in diffusivity along the optic radiations in a group of late-blind glaucoma 
patients; the reduction in integrity of the white matter tracts was more extensive than that 
observed in AMD (Yoshimine et al., 2018). Whilst some report reduced FA in clusters 
(driven by an increase in RD) of the optic radiations and optic tracts in individuals with 
retinitis pigmentosa (RP) (Hofstetter et al., 2019; Ohno et al., 2015), others find no 
significant difference between RP patients and sighted controls (Schoth, Burgel, Dorsch, 
Reinges, & Krings, 2006). Differences in protocols, analysis techniques as well as the 
state of the disease in the RP patients can all contribute to such differences and highlights 
the need for consistency when addressing questions concerning structural changes, to 
ensure the results are meaningful and show legitimate changes associated with the 
disease. 
Yoshimine et al., (2018) evaluated the integrity of the optic tracts and optic radiations in 
individuals with wet AMD (6/8 had unilateral AMD) and age-matched sighted controls 





on any measures of the optic tracts,  patients with AMD had localised deficits within the 
optic radiations, specifically in the fiber bundles projecting to foveal representations (0°- 3° 
visual angle) but no significant changes were observed in either the mid-periphery (15° - 
30°) or far periphery (30° - 90°). Furthermore, it was only a subsection of the foveal fiber 
bundle that differed significantly between groups. Measures were taken at multiple 
locations along the tract from LGN to portions of V1, and the greatest difference between 
groups appeared to be in the middle of the tract, edging towards V1. This suggests that 
only fiber bundles projecting to the representations of the visual defect were significantly 
affected in the patient group.  
Despite anatomical studies demonstrating few differences between juvenile MD (JMD) and 
AMD populations, Olivo and colleagues were also able to detect more subtle changes in 
both the grey and white matter in JMD compared to previous studies focusing more on 
volumetric changes. A reduction in FA was observed in more posterior regions of cortex 
but was not limited to purely visual areas. The reduction in FA suggests white matter 
integrity is somewhat compromised (Olivo et al., 2015). Furthermore, notable differences 
did emerge between groups when assessing white matter in frontal regions in AMD. This 
has been attributed to the difference in age, or perhaps the comorbidity between AMD and 
other age-related ailments such as mild cognitive impairment (Beer et al., 2020; Hernowo 
et al., 2014). There is growing evidence linking AMD with other neurodegenerative 
conditions such as Mild Cognitive Impairment and/or Alzheimer’s disease, suggesting that 
perhaps the changes observed outside visual cortex may not be driven by sensory loss, 
but may reflect the overlap in diseases (Beer et al., 2020; Ikram, Cheung, Wong, & Chen, 
2012). 
What is currently unknown is over what time scale changes occur in the visual white 
matter in MD. As shown by Ogawa et al., (2015), while the outcome may be the same in 
terms of reductions in FA in the visual white matter across AMD and JMD, the extent of the 
damage differed between the groups.  Whilst changes in the volume of visual cortex are 
well established in AMD, assessments of white matter in a larger group have been limited. 
It is generally accepted that atrophy of grey matter and the white matter tracts may limit 
the success of restorative treatments, particularly if such changes are irreversible. 
Assessing the long-term effects of MD on visual cortex will provide valuable insights into 
the biological changes in white matter as a result of eye disease; such methods have 
already been successfully implemented in other neurodegenerative diseases such as 





Diffusion weighted imaging was utilised for the current study to reconstruct and measure 
the optic radiations, in the same group of MD patients and sighted controls described in 
Chapter 2. We have already found evidence of a decline in cortical thickness and myelin 
density in early visual cortex, which appears to emerge in the early stages of bilateral MD. 
Next, we wanted to assess whether alterations to the white matter could be observed in 
the same group of patients. We predicted that for the cross-sectional analysis, we would 
see a reduction in FA and increases in RD in the patient group in contrast to the sighted 
controls, but specifically in the fiber bundles projecting to the occipital pole - the anatomical 
representation of the retinal lesion (as described in Chapter 2). This is a different way of 
defining the foveal representations, but we anticipate replicating findings from Yoshimine 
et al., (2018). We also predict group differences in radial diffusivity and possible changes 
to AD; when RD increases or AD decreases, it indicates axons are less tightly packed 
together, therefore allowing for more free diffusion in the radial axis as shown in Figure 
3.1. Since significant changes in AD are not always found, particularly in glaucoma and RP 
studies described (Hofstetter et al., 2019; Tellouck et al., 2016), it is likely if changes are 
observed, they may be subtle. In terms of the change over the ~24-month time window of 
the study, we may see subtle changes in the aforementioned direction in the patients, 
particularly for the individual case study (MD7 as described in Chapter 2) for whom we 
have data before AMD diagnosis, but we do not anticipate seeing age-related changes 
over this brief time window in the sighted controls, or MD13 - our second case for whom 
we also have before and after diagnosis data, but who has not experienced any functional 
vision loss. For volume, we predict changes in the same direction as described for FA 
whereby the MD patient group may exhibit selective reductions in volume, as well as 







3.3 Methods  
3.3.1 Participants 
13 individuals with macular disease were recruited from the Ophthalmology department at 
York Teaching Hospital and through advertisements in sight loss support groups in York 
(participant demographics included in Table 2.1). MD patients all had a diagnosis of 
bilateral macular disease; time since disease onset at the time of enrolment ranged from 9 
months to 23 years, mean = 11.2 years. MD12 was excluded from longitudinal analyses 
due to ill health preventing participation in follow up MRI sessions. 18 sighted controls 
were recruited for this study through advertisements at the York Neuroimaging Centre 
(YNiC), University of York. Written informed consent was obtained from all participants. 
One control participant was excluded from the analysis due to poor data quality, leaving us 
with 17 in all analyses. This study followed the tenets of the Declaration of Helsinki with 
approval granted by YNiC Research, Ethics and Governance Committee and the NHS 
Research Ethics Committee (IRAS: 158456).  
3.3.2 MRI data acquisition 
Scanning was performed at the University of York Neuroimaging Centre using a 3 Tesla 
HD MRI system (GE Signa Excite 3.0T, High resolution brain array, MRI Devices Corp., 
Gainesville, FL) with an 8 channel whole head High Resolution Brain Array. Patients were 
Figure 3.1. Schematic of our predictions for the fiber bundles in the optic radiations projecting to the 
occipital pole. Cross-section of a fiber bundle for controls (green) and patients with macular disease 
(blue). In controls, we predict higher FA and AD, and lower RD compared to patients. Lower FA and 





scanned between one and six times over a ~24-month period, whereas controls were 
scanned twice, approximately ~24 months apart. For full details of the high resolution T1 
and T2 anatomical images, please refer to Section 2.3.2.  
3.3.2.1 Diffusion MRI protocol 1 for MD1-MD12 and C1-C12 
Two diffusion weighted MRI scans were acquired in each session, with opposing phase 
encoding directions. These were identical, with just the phase encoding direction changing 
(P/A to A/P). The duration of the individual dMRI scans was ~6 minutes. A single-shot 
pulsed gradient spin-echo echo-planar imaging sequence was used with the following 
parameters: b = 1000 s/mm2, 21 unique diffusion directions, 47 slices, FOV = 192mm, TR 
= 12s, TE = 88.5ms (minimum full), voxel size = 2 x 2 x 2 mm3, matrix= 96 × 96, flip angle 
= 90deg. 3 volumes without diffusion weighting (b0) were acquired at the start of each 
scan.  
3.3.2.2 Diffusion MRI protocol 2 for MD7(2 time points), MD13 and C13-C18 (all time 
points) 
Two diffusion scans were acquired in one session. The reversal scan was shorter (~2 
minutes versus ~11 minutes) as it was used to correct for distortion only, hence only 6 
diffusion sampling directions were acquired for this scan. Broadly, protocols were:  b = 
1000 s/mm2, 45 directions, 58 slices, FOV = 192mm, TR = 12s, TE = 87.1ms (minimum 
full), voxel size = 2 x 2 x 2 mm3, matrix size = 96 x 96, flip angle = 90deg. 3 volumes 
without diffusion (b0) were acquired at the start of the diffusion sequence. As we were 
replicating protocols from the first time points which were conducted by different research 
groups for one subgroup of participants, it was essential to keep protocols consistent 
within individuals to reduce the effect of scan type on the outcome measures. Due to an 
error in the first time point for the phase-encoding reversal scan whereby up-sampling was 
not turned off, two participants have slightly different parameters (voxel size 0.75 x 0.75 x 
0.75mm3 , matrix size = 256 x 256).  
3.3.3 Longitudinal experiment design 
As described in Section 2.3.3.1, participants were enrolled in the study for up to ~24 
months with a maximum of 6 MRI scans during this time period. We acquired additional 
MRI data for two MD patients, referred to as patient MD7 and MD13. These are the 
individuals for whom we can make before versus after AMD diagnosis comparisons. All 





not all participants completed all sessions. Control participants completed 2 MRI sessions 
over approximately 26 months. 
3.3.4 Pre-processing diffusion data 
Before running any pre-processing steps, any data with an odd number of slices had to be 
padded with an additional slice for the susceptibility- induced distortion correction to work. 
This affected 12 MD patients and 12 controls scanned under protocol 1. This was taken 
from the b0 image for each acquisition and applied to all subsequent b1000 images. 
Additionally, due to an error during data acquisition for two participants (described in 
Section 3.3.2.2), we have 2 scans within a session with a different field of view and 
different voxel size. To fix this, we applied a transformation to the DTI phase encoding 
reversal scan, bringing it into the same space as the main diffusion scan (using this as a 
reference image).  Data could then be analysed in the same manner as all other data from 
this point forward. 
All diffusion data were pre-processed which included using eddy-current distortion 
correction and motion correction with the FDT v5.0, part of FSL (v5.0) - FMRIB's Software 
Library (Smith et al., 2004). Data were split across time (Using FSLsplit) and the b0 
volumes (with no diffusion) were extracted from the DTI files. The b0 volumes from each of 
the scans (A/P and P/A phase encoding directions) were combined into a single file to 
estimate the amount of distortion present in the two scans. Topup (Andersson, Skare, & 
Ashburner, 2003; Smith et al., 2004) was used to correct for the susceptibility-induced 
distortion which primarily affects the inferior frontal and inferior temporal regions – regions 
known for having air pockets present e.g. sinus cavities. Having a second scan which 
reads out the images in the opposite phase encoding direction also helps to correct for this 
distortion and improves anatomical accuracy. This distortion field is then applied to the 
original distorted DTI scans, which are then combined, giving us a single, undistorted set 
of images. After correction for distortion, BET (Smith, 2002) was used to exclude non-brain 
tissue. Finally, DTIFIT was used to apply the diffusion tensor model at each voxel and 
generate a fractional anisotropy (FA) map estimate and vector fits; FA, RD and AD were 
calculated by fitting a tensor model to each voxel; FA describes the coherence of diffusion, 
taking AD and RD into consideration. AD is measured along the primary axis of the model 
within each voxel, and the RD is average of the diffusivity measured in the two other 
(minor) axes of the tensor model. While DTIFIT is not necessary to run the probabilistic 
tractography, it allowed us to manually check to see if the data seemed sensible in relation 





3.3.5 Region of interest (ROI) selection 
Given findings from Yoshimine et al., (2018), we predicted that the fiber bundles in the 
optic radiations projecting to the anatomical representation of the visual field defect may 
be selectively impaired in our bilateral MD group, compared to sighted controls, whereas 
projections to the representation of the intact peripheral visual field may remain unaffected. 
To test this hypothesis, we used an anatomical atlas to define our ROIs - the occipital pole 
and the calcarine sulcus. These were taken from FreeSurfer’s Destrieux Atlas (parcellation 
index 42 and 44 respectively - see Section 2.3.3.2 for details) whereby the occipital pole 
was used to capture central regions of the visual field (compromised in MD) and the 
calcarine sulcus was used to capture the more peripheral visual fields. These were first 
converted from fsaverage6 surface labels into a volume using FreeSurfer command 
mri_label2vol, before being transformed from the fsaverage space into MNI152 1mm 
space using FSL’s FLIRT (Jenkinson, Bannister, Brady, & Smith, 2002).   
3.3.6 Probabilistic tractography 
Probabilistic fiber tracking allows for automatic extraction of the white matter tracts of 
interest in both hemispheres, and we did this using the FSL (v6.0) toolbox Xtract 
(Warrington et al., 2020). Before running Xtract, we fit the crossing fibers model (Jbabdi, 
Sotiropoulos, Savio, Graña, & Behrens, 2012) to the corrected diffusion data using FDT’s 
bedpostx (Bayesian Estimation of Diffusion Parameters Obtained using Sampling 
Techniques). This calculates the number of crossing fibers within each voxel. All default 
parameters were used when running this model with the exception of drawing 10,000 
streamlines (or samples) in each voxel (default is 5000). We then registered our FA data 
from the subject's native diffusion space to a standard 1mm3 space using FNIRT nonlinear 
registration (Andersson, Jenkinson, & Smith, 2007). The target image used was the 
FMRIB58_FA which is in the same space as the MNI152 standard space image. The 
registration steps that are part of the full Tract-Based Spatial Statistics (TBSS) (Smith et 
al., 2006), which is part of FSL (Smith et al., 2004), have been optimised, and so we used 
the TBSS scripts to avoid doing manual registrations.  Xtract also requires the inverse 
warp that would allow data to go from MNI standard space back to the native diffusion 
space, so to generate this we used FSL’s invwarp command on the transformation 
generated in the prior step.  
Probabilistic tractography is run on the bedpostx output; the aim of probtrackx2 (Behrens, 
Berg, Jbabdi, Rushworth, & Woolrich, 2007; Behrens et al., 2003) is to produce 





fulfil criteria such as passing through a waypoint (the occipital pole or calcarine sulcus). 
Exclusion points are also included to filter out any irrelevant projections. For our study, 
exclusion points included the midline sagittal plane to avoiding fibers crossing through the 
midline to the other hemisphere, the brainstem, a region posterior to the LGN to ensure 
only fibers that follow the signature curve up and away from the LGN are included, and 
regions anterior of the LGN to ensure fibers project in the posterior direction. It is possible 
that longitudinal fibers could be tracked without this exclusion criteria (Warrington et al., 
2020). Our seed and exclusion points are shown in Figure 3.2. 
 
 
3.3.7 Fiber tract cleaning 
Before extracting our diffusion measures, we cleaned up the tracts to help reduce noise 
induced by complex fiber orientations. First, we set a threshold to exclude voxels where 
fewer than 20% of fibers passed through. Doing this gives us greater confidence that fibers 
are indeed part of a genuine white matter tract. We normalised our data and divided it into 
equally spaced bins (0-100) and extracted summary statistics from the central 80% of the 
tract; 10% of locations at the start (closer to the LGN) and end (early visual cortex) of the 
tracts were discarded to remove any noise and avoid partial-voluming effects. It is known 
that these locations have fibers going in many directions and the increased angle and/or 
curvature of the fibers adds to the noise. Similar methods have also been employed by 
previous work (Malania et al., 2017; Yeatman, Wandell, & Mezer, 2014; Yoshimine et al., 
2018). 
Figure 3.2. Example exclusion points and seed regions for the left optic radiations overlaid on the 
NI152_1mm standard brain. The lateral geniculate nucleus (LGN) was our seed region in each 
hemisphere (left shown in orange). Our exclusion masks included: Region anterior to the LGN to 
avoid longitudinal fibers being included (blue), the brainstem (yellow), the midline (green) and a 
region posterior to the LGN (purple) to help capture the curvature of the optic radiations close to the 





3.3.8 Calculating tract volume 
In addition to FA, RD, and AD measures, we wanted to assess the volume of our two optic 
radiation bundles, projecting to the occipital pole and the calcarine sulcus. To normalise 
our data and make them more interpretable, we counted the number of voxels in the 
density files (which captures the fiber probability distribution) and divided this by the 
number of valid streamlines for a control tract - the forceps major - an easily identifiable 
posterior tract that runs through the corpus callosum, for which we did not anticipate any 
meaningful variation across subjects and time. The forceps major was identified using 
probabilistic tractography methods described above (Section 3.3.6).  This was computed 
on an individual basis and within session e.g., Occipital pole tract for a given participant for 
their first time point was normalised using the forceps major identified in the same session 
for that individual. Normalisation is important because it helps to deal with the known 
differences in the ability to track white matter structures across subjects, scan sessions 
and even hemispheres, which can vary within subjects (Arrigo et al., 2016). Normalising to 
a control tract removes any broader differences in the ability to track without compromising 
any possible anatomical differences in our tract of interest, in this case, the two projections 
within the optic radiations. The resulting output is a more interpretable, scaled value. We 
did not trim the tract or threshold the tracts prior to normalisation. Both cross-sectional and 
longitudinal analyses were computed, to assess group differences, as well as changes 
over the period of the study. Normalised units for this measure are arbitrary, and therefore 
we will refer to this simply as normalised volume (Bartsch, Biller, & Homola, 2009). 
3.3.9 Longitudinal analysis - linear mixed effects model 
We wanted to determine if during the period of the study, there were any changes in FA 
over time in portions of the optic radiations that emerged significantly reduced in MD 
patients. In order to assess changes over time, we employed the same linear mixed 
effects model (Winter, 2013a, 2013b) as described in Section 2.3.5. The model used for 
each of our tracts (project to either occipital pole or calcarine sulcus) were as follows (R 
syntax):  
Fractional Anisotropy ~ 1 + Age + Group:Time + (1  | Participant) 
The FA value for each subject for each time point is entered into the model, which allows 
us to assess any changes over time. This model allows us to investigate the role of age (at 
baseline), group (MD patient versus controls) and any interactions between group and 
time, which were all included as fixed effects in the model. As before, participants were 





The model for each of our tracts was evaluated using restricted maximum likelihood 
(REML) estimation to ensure the model was robust - this is the optimal method for studies 
such as this with smaller samples and uneven group sizes. The significance was assessed 
using t-tests which incorporated the Satterthwaite’s method to calculate our degrees of 
freedom and in turn control for possible type-1 errors. This model was also applied to the 
volume data as described above. 
3.4 Results 
Tracts projecting from the LGN to the occipital pole and the LGN to the calcarine sulcus 
were identified in 12 MD patients and 17 control participants in both hemispheres. 
Fractional anisotropy (FA), axial diffusivity (AD) and radial diffusivity (RD) were plotted for 
multiple locations along each tract. Data were averaged across hemispheres.  
3.4.1 Cross-sectional analysis of tract profiles 
In Figure 3.3, tract profiles are plotted for each individual MD patient against the control 
group average. For each individual, we averaged across scans from all time points 
(between 1 and 6 across a ~24-month period) and plotted the mean FA for each location 
along the tract. What can be seen from most individuals is that a reduction in FA values 
emerges for both fiber bundles, and largely in the middle portion of the tract. There are a 
couple of exceptions, notably MD6, MD9 and MD11. MD6 and MD11 have the highest 
visual acuity scores (as shown in Table 2.1) and both have a form of JMD. MD9 seems to 












Figure 3.3. Cross sectional fractional anisotropy (FA) data averaged across all time 
points and hemispheres. Individual tract profiles for MD patients for fiber bundles 
projecting to the occipital pole (red) and calcarine sulcus (blue). Sighted control group 





Next, we wanted to determine if there were group differences at certain locations along the 
tracts for our fiber bundles projecting to a) the occipital pole and b) the calcarine sulcus, 
and whether these would only occur in the former, given this captures the anatomical 
representation of the visual field defect. After averaging across time points (as shown in 
Figure 3.3), we then averaged across participants to generate group tract profiles for MD 
patients and sighted controls (Figure 3.4). A mixed ANOVA revealed a significant 
interaction between ROI (projecting to the occipital pole or calcarine sulcus), group (MD vs 
controls) and location along the tract (F(80,2160) = 1.371, p = .018) for our mean FA data. 
To tease apart these main effects, we ran two one-way ANOVAs correcting for multiple 
comparisons, reporting Welch’s F values to accommodate unequal variances. For the tract 
projecting to the occipital pole, we found significant differences in 34 locations along the 
tract (all p≤.039). For the tract projecting to the calcarine sulcus, we also observed 
significant differences in 39 locations (all p≤.049). All significant locations are shown in 
Figure 3.4, indicated by the light grey blocks. Data suggest that there is a consistent drop 
in FA in a portion of the tracts closer to early visual cortex. For a detailed report of the 
inferential statistics for FA, AD and RD, see Appendix A (A1-A3).   
  
Figure 3.4. Mean fractional anisotropy (FA) measures for controls (black line) and MD 
patients (red and blue lines). Standard deviation is shown in the shaded region (grey for 
controls, red/blue for MD patients). Mean FA is significantly different between groups in the 





Whilst FA gives us a sense of the structural integrity of the tracts of interest, it cannot tell 
us about the nature of the changes observed. It is therefore important to also examine AD 
and RD to determine what may be driving the FA decrease observed in our patient group. 
As with FA measures, we ran two one-way ANOVAs, correcting for multiple comparisons 
and reporting Welch’s F values. For AD, it appears there are few differences between 
sighted  controls and MD patients; only 7 locations were significantly different between 
groups for the occipital pole projection (all p≤.044), and for the calcarine sulcus projection, 
it was 2 locations (p≤.045). All significant locations are illustrated by grey shaded blocks in 
Figure 3.5A.  
Figure 3.5. Mean axial anisotropy (AD) measures for controls (black line) and MD patients 
(red and blue lines). B: Mean radial diffusivity (RD) measures for controls and MD patients. 
Standard deviation is shown in the shaded region (grey for controls, red/blue for MD 





We observed significant differences in RD between groups in locations that largely 
overlapped with those which emerged significant when assessing FA; this is true for both 
the occipital pole projections (34 locations, all p≤.042) and the calcarine sulcus projections 
(28 locations, all p≤.048). Shaded blocks in Figure 3.5B show the locations where MD 
patients showed significantly greater RD measures compared to sighted controls. 
3.4.2 Linear mixed effects model - assessing group changes over time 
Having identified the location of the tract where FA was significantly lower in MD patients 
compared to sighted controls, we next wanted to determine whether we see a change in 
FA over time in this portion of the tract. To assess possible changes, we entered data for 
each individual time point into a linear mixed effects model in the same manner as 
described in Chapter 2 for cortical thickness and myelin density measures.   
As shown in Table 3.1, age at baseline was as a significant predictor of FA for the 
subsection of the projections to the occipital pole, as well as the calcarine sulcus, however 
despite this, group also emerged as a significant predictor for both projections. There was 
no significant effect of time, nor were there any group x time interactions for either the 
occipital pole or calcarine sulcus projections, indicating that during the time window of the 
study (between 6 and 24months depending on number of sessions completed), there was 








3.4.3 Assessing the relationship between visual acuity fractional anisotropy 
To assess if FA measures in our patient group (MD1 -11 only) could be predicted by acuity 
measures, we entered Early Treatments Diabetic Retinopathy Study (ETDRS) letter 
scores for the worse eye and the better eye into a hierarchical regression, with mean FA 
(for the portion of the tracts that emerged significantly different between groups) for both 
the occipital pole and calcarine sulcus projections. Despite a correlation between our two 
Table 3.1. Results for the linear mixed effects model, assessing changes in fractional 
anisotropy (FA) in the portion of the tract where groups significantly differed. All significant 
results are shown in bold. 
Predictor b(SE) t(df) b(SE) t(df)
Age -0.002 (0.0004) -6.546 (24.994)*** -0.002 (0.0004) -6.236 (25.126)***
Group -0.030 (0.0138) -2.208 (26.148)* -0.029 (0.0137) -2.113 (26.376)*
Time -0.002 (0.0015) -1.258 (49.116) -0.002 (0.0015) -1.043 (49.258)
Group: Time -0.004 (0.0031) -1.284 (49.428) -0.001 (0.0031) -0.542 (49.594)
Occipital Pole Calcarine Sulcus






visual acuity predictors (Pearson’s R = .646, p=.016), collinearity statistics suggest this 
may not be problematic for our model (Tolerance = .582, VIF = 1.718). Worse eye was 
included in the model first as we deemed this a more likely predictor of FA.  
Worse eye acuity scores did not significantly predict our mean FA measures for the 
occipital pole (F(1,9) = 2.476, p=.150) or the calcarine sulcus projections (F(1,9) = 3.063, 
p=.114). Adding in our better eye acuity score did not improve the model for either the 
occipital pole (F(2,8) = 1.108, p=.376) or calcarine sulcus projections (F(2,8) = 1.384, 
p=.305). Details of the linear model are shown in Table 3.2. 
 
3.4.4 Assessing volumetric changes between groups and over time 
The final metric we examined for our tracts was normalised volume. Generally, irrespective 
of group, the occipital pole bundle was lower than that of the calcarine sulcus, which is 
expected given the occipital pole ROI is smaller, therefore meaning there are likely fewer 
fibers reaching it compared to the calcarine sulcus (Figure 3.6A). To assess group 
Occipital Pole
b (95% CI) Std Error b b p
Step 1
Constant .482 (.405, .559) 0.034 .000
Worse Eye VA .001 (.000, .002) 0.001 0.464 .150
Step 2
Constant .489 (.315, .664) 0.076 .000
Worse Eye VA .001 (-.001, .003) 0.001 0.494 .263
Better Eye VA .000 (-.003, .003) 0.001 -0.045 .914
Calcarine Sulcus
b (95% CI) Std Error b b p
Step 1
Constant .469 (.397, .541) 0.032 .000
Worse Eye VA .001 (.000, .002) 0.001 0.504 .114
Step 2
Constant .457 (.294, .621) 0.071 .000
Worse Eye VA .001 (-.001, .003) 0.001 0.456 .286
Better Eye VA .000 (-.003, .003) 0.001 0.074 .858
R
2
 = .216 for Step 1, R
2
 = .217 for Step 2. All p>.150
R
2
 = .254 for Step 1, R
2
 = .257 for Step 2. All p>.114
Table 3.2. Linear model of predictors of mean fractional anisotropy (FA) for a 






differences as well as changes over time, we again used a linear mixed effects model. 
There was no significant effect of age at baseline, group, time, and no group x time 
interactions for either the fiber bundle projecting to the occipital pole or the calcarine 
sulcus. All results from the linear mixed effects model are reported in Table 3.3. To 
visualise the data, the rate of change in normalised units per year was also computed 
using the slope of a regression line based on time measurements were taken with respect 
to the baseline (x-values) and the volume at each time point (y-values). This was 
calculated for each participant who are plotted as dots in Figure 3.6B. With the exception 
of one outlier in the MD patient group, it is clear that minimal change occurred within the 
time period of the study, and groups (as shown by the lack of group x time interactions in 







Predictor b(SE) t(df) b(SE) t(df)
Age 1.640e-04 (1.289e-04) 1.272 (26.58)  0.0007 (0.0005) 1.591 (25.33)
Group 2.462e-03 (4.909e-03) 0.502 (28.80) 0.0104 (0.0173) 0.602 (27.21)
Time  -2.157e-06 (8.694e-04)  -0.002 (49.83) 0.0012 (0.0023) 0.508 (49.53)
Group: Time  -9.108e-04 (1.785e-03)  -0.510 (50.74)  -0.0009 (0.0048)  -0.194 (50.04)
Occipital Pole Calcarine Sulcus
All t-tests using Satterthwaite's method to correct for degrees of freedom (df) are p>.124
Table 3.3. Linear mixed effects model for volume. Fixed effects reported with the standard 
error (SE) for predictors for each fiber bundle. Age = age at baseline, Group = MD patients 
and sighted controls. Volume is reported in arbitrary units following data normalisation. 
Figure 3.6. A: Cross sectional analysis of volume for MD patients (black dots) and sighted 
controls (white dots) for our fiber bundles projecting to the occipital pole and calcarine sulcus. 






3.4.5 Assessing changes before and after sight loss 
To give some insight into changes before and after a diagnosis of AMD, we have analysed 
data for MD7 for 7 time points - 1 prior to an AMD diagnosis and 6 post diagnosis (up to 
2.5 years after diagnosis). For MD13 we have 2 time points – 1 before diagnosis and one 
1.42 years after diagnosis. Figure 3.7 shows the time point before and latest time point 
after diagnosis for MD7 (Figure 3.7A) and MD13 (Figure 3.7B). What is interesting is that 
even at the time point before AMD diagnosis, MD7 appears to show reductions in FA in 
Figure 3.7. Comparing FA along the tracts for individual cases before and after diagnosis 
against sighted control and MD patient groups. A: Individual time point FA data for MD7 
plotted against sighted control (black line) and MD group means (red for occipital pole 
projections, and blue for calcarine sulcus projections. Shaded regions represent 1 
standard deviation for each group (grey = controls, red/blue = MD patient group). MD7 
baseline data (before diagnosis) are shown in purple (left) and teal (right). Last time point 
(2.25 years after diagnosis) is shown in magenta (left) and cyan (right). B: Same as A, but 
for MD13 data. Second time point for MD13 (1.42 years post-diagnosis) is shown in 





various points along the tract, in the projections to both the occipital pole and the calcarine 
sulcus.  
MD13 also follows this pattern despite not experiencing any functional vision loss. In line 
with our group data, we computed a mean FA score in the portion of the tracts where a 
significant reduction in FA was observed between our MD patient and control groups, and 
report values for each time point for both MD7 and MD13 alongside controls and a subset 
of the MD group in Table 3.4. Only 5 MD patients who all completed a baseline, 12 month 
and 18 month follow ups were included to ensure averages were computed from the same 
subset of individuals for each time point and making the changes across time more 
meaningful. It is interesting to see that at baseline, for both the occipital pole and calcarine 
sulcus projections, MD7 has a mean value lower than the control group, and similar to the 
MD group, whereas MD13 is closer to control group mean, particularly for the calcarine 
sulcus. With time, mean FA values seem relatively stable within this time window for all 
groups, with very little change. See Appendix A (A4-A5) for axial and radial diffusivity data 
along the tracts for MD7 and MD13.  
         
Occipital Pole                 
  Time (years) 
  0 0.69 1.00 1.17 1.50 1.75 2.00 2.25 
Controls 0.592  -  -  -  -  - 0.589  - 
MD group (n=5) 0.523  - 0.513  - 0.512  -  -  - 
MD7 0.509 0.503 0.518 0.517 0.542 0.533  - 0.500 
MD13 0.554  -  -  - 0.583  -  -  - 
Calcarine Sulcus               
Controls 0.583  -  -  -  -  - 0.580  - 
MD group (n=5) 0.509  - 0.497  - 0.501  -  -  - 
MD7 0.504 0.502 0.512 0.505 0.533 0.521  - 0.494 
MD13 0.588  -  -  - 0.627  -  -  - 
 
Finally, we assessed the normalised volume of each of our optic radiation bundles in both 
cases, shown in Figure 3.8. For MD7, there is a noticeable downward trend for both 
occipital pole and calcarine sulcus projections, more so for the latter. MD13 shows a 
Table 3.4. Mean fractional anisotropy (FA) for the locations along the tract that showed 
significant reductions in MD group. Mean FA at different time points between 0 and 2.25 
years. Subset of MD patients has been reported here (n=5) that all had baseline, 1 year 
and 1.5-year data. For MD7 and MD13, time = 0 is the pre-diagnosis scan. For controls 





different pattern, whereby no change is observed in the projection to the occipital pole, and 
a slight increase is seen for the calcarine sulcus projection, although only having two time 




The aim of this study was to explore how bilateral MD impacts different fiber bundles within 
the optic radiations. Given our MD patients have partial vision loss, we divided the optic 
radiations into two bundles – one projecting to the occipital pole, the second projecting to 
the calcarine sulcus. For our cross-sectional analysis, we predicted that greater reductions 
in FA would be observed in the central projection (occipital pole), in line with findings from 
Yoshimine et al., (2018). We also predicted this would be accompanied by an increase in 
RD and possible decrease in AD. For our longitudinal analysis, while we predicted 
changes may be subtle in this short time window, we predicted a selective accelerated 
decline in FA over time in our patient group for the occipital pole projection. With our 
individual MD case data, we anticipated greater changes in FA, and perhaps RD and AD 
for MD7 compared to MD13, much like we have seen for our cortical thickness measures 
in Chapter 2. This was because of the difference in the severity of the visual loss between 
the two patients, with MD7 having more advanced AMD. In terms of volume, we predicted 
group differences in the same direction described for FA, whereby MD patients would 
Figure 3.8. Volume measures for individual AMD cases (MD7 left, MD13 right) before and 





exhibit selective reductions in the occipital pole projection compared to controls, and this 
may also reveal a greater decline over time in the longitudinal analysis. Each of these 
predictions and corresponding results will be discussed in turn.  
Our findings largely correspond with those reported by Yoshimine et al., (2018) whereby 
MD patients showed a significant reduction in FA in the optic radiations in a portion of the 
tract projecting to the central representation (occipital pole). We also show that this is likely 
driven by an increase in RD, which emerged significant in overlapping portions of the tract. 
However, one key difference is that we also observed this in the projection to the calcarine 
sulcus - capturing representations of peripheral (intact) vision. There are several reasons 
why this may be the case. Firstly, different atlases were used to divide up early visual 
cortex into central and peripheral representations. Yoshimine and colleagues used the 
Benson atlas (Benson, Butt, Brainard, & Aguirre, 2014; Benson et al., 2012), and divided 
V1 into 3 portions capturing the fovea, mid-peripheral and far periphery. as with the 
Benson atlas, there is more flexibility in that you can specify the eccentricity range of 
interest for your ROIs. The occipital pole and calcarine sulcus ROIs we used from the 
FreeSurfer Destrieux atlas are not restricted to V1 (as discussed in Chapter 2), but we also 
collapsed across a larger portion of the peripheral field representations, without leaving 
any gap between ROIs. Yoshimine and colleagues jumped from a foveal representation 
capturing 0°- 3° visual angle, to a mid-peripheral representation capturing 15°- 30°.  
Looking at their data more closely, it does appear that AMD patients on average exhibited 
lower FA in the peripheral representations in a portion of the tract, however it did not reach 
significance (Yoshimine et al., 2018). Our patient group, while larger, also consists of 
individuals with bilateral vision loss. The consensus within the literature is that severity of 
vision loss may affect the extent of changes observed. Malania et al., (2017) noted that it 
was not just the central projections that were showing a reduction in FA in patients with 
central loss in their cohort, suggesting more widespread changes to the visual white 
matter, as we have shown here. Finally, we opted for the Destrieux atlas ROIs to keep 
consistent across studies; in Chapter 2 we used the same ROIs to explore cortical 
thickness and myelin density changes in the same patient and control groups.  
The reduction in FA observed in our MD group and individual cases seems to be driven by 
an increase in RD, where largely the same locations along the tract that were significantly 
lower for FA, were significantly higher for RD in patients. This pattern, alongside AD 
showing little change on average, coincides with findings from previous work on partial 





Tellouck et al., 2016; Yoshimine et al., 2018; Zhou et al., 2017). For the rate of change in 
FA, no significant group x time interactions emerged, meaning the MD patient group did 
not show an accelerated rate of decline. This also applied to the individual MD case data 
shown in Table 3.4, where there was little change within the time window of the study for 
MD7, MD13, our MD patient subgroup and controls. Furthermore, we did not observe an 
accelerated decline in volume for the fiber bundles projecting to the occipital pole or the 
calcarine sulcus, highlighting the importance of exploring multiple metrics when 
determining the consequence of eye disease on the brain.  
Volume measures can be difficult to interpret particularly in structures that are harder to 
track; discerning whether differences between groups or within individuals across several 
time points are meaningful can be a challenge. Diffusion measures are susceptible to 
many sources of noise, and so errors can result from poor quality dataset, distortions in 
the images, inadequate protocols, anatomy, poor preprocessing pipelines or models that 
do not represent the data well. These, and many other sources of error can all contribute 
to noisy data and correcting for this is not always straightforward (O’Donnell & Westin, 
2011). At present there is no gold standard when it comes to measuring volume of white 
matter tracts, and it is important to remember that it is not possible to get quantitative 
measures of, for example, the number of axons in a fiber bundle (Nooij, Hoving, van 
Hulzen, Cornelissen, & Renken, 2015). Probabilistic tractography is shown to have 
superior reliability compared to deterministic tractography, particularly when resolving 
complex fiber orientations within individual voxels (Arrigo et al., 2016; Bartsch et al., 2009). 
Data acquired in patients with brain lesions is also better suited to probabilistic 
tractography when reconstructing tracts for this reason. The optic radiations can be tricky 
to reconstruct, especially when dividing it up into smaller bundles as we have in the current 
study. However, given that we know the structures exist, we can make our measurements 
more interpretable by normalising the data for each individual subject for the tracts of 
interest to a control tract. Doing this, we remove the differences in global trackability 
without affecting the possible structural differences in the optic radiations - this was 
particularly important for this study given we anticipated possible reductions in volume for 
our patient group. Going forward, one way to help interpret diffusion data more generally is 
by validating that which is acquired in vivo with post-mortem data ex vivo (Nooij et al., 
2015). 
MD7, having lost a lot of vision within a relatively short space of time, provides an 





approximately 9 months prior to diagnosis. MD13, who has no functional vision loss but a 
bilateral AMD diagnosis, follows suit but to a lesser extent, whereby mean FA values in the 
smaller portion of the two projections are more comparable to those observed in controls. 
However, for the occipital pole projection, while greater than values reported for MD7 and 
the MD subgroup, mean FA for MD13 is lower than that for the controls. For volume, MD7 
shows a general downward trend over time for both projections, but MD13 seems to show 
no change for the occipital pole projection, and a slight increase for the calcarine sulcus. 
One must be wary with MD13 given they only have 2 data points, and as can be seen from 
MD7, individual data can fluctuate between time points. This seems to support our findings 
from Chapter 2, whereby MD7 showed greater decline in cortical thickness compared to 
MD13, and this appeared to happen in the early stages of the disease, after functional 
vision loss and more extensive structural decline in the retina. The timeline shown in 
Chapter 2 (Figure 2.1) highlights that while MD7 did not get diagnosed until May 2017, 
they did report noticing changes to their vision in the February of that year, ~6 months 
prior to the baseline scan. This, along with results from MD13, point to the idea that 
changes in the posterior visual pathway may be occurring earlier than expected, and that 
structural changes in the eye, even before functional vision loss, may be driving the 
changes observed in the brain. This has important implications for the timing at which 
potential neuroprotective strategies may be most effective. 
In this study, we report the rate of change of specific metrics (FA versus volume), but 
Ogawa and colleagues have highlighted that there may also be differences in the rate of 
change for different diseases. Despite both LHON and CRD patients having comparable 
vision loss, the time since disease onset did differ between groups, whereby CRD patients 
had the condition for ~20 years, compared to ~5 years for LHON, indicating that changes 
happen faster in patients with LHON (Ogawa et al., 2014). This study would benefit from 
longitudinal assessments to see when changes emerge, much like we have started to do 
with our individual MD cases. As mentioned previously, timing of these structural changes 
is important to assess because there are implications for potential treatment strategies, but 
also this highlights that different disease types may benefit from different intervention 
times. For example, more comprehensive assessments of how JMD and AMD patients 
may be differently affected over time could be interesting, as these have largely been 
collapsed into one group, as in this study and Malania et al., (2017). Unfortunately having 
only two JMD patients recruited to this study means we do not have sufficient data to 





Despite being frequently reported, it is not always clear what may be driving changes in 
diffusion measures. For example, FA can be affected by numerous things, such as RD and 
AD, but can also be influenced by volume, crossing fibers and partial voluming. To ensure 
it is not the latter two, it is important to apply preprocessing steps to deal with geometric 
distortions and use tools that can accurately and reliably determine if a white matter tract is 
genuine, and not a result of noise. It is also important to acknowledge that perhaps visual 
white matter tracts may be affected differently by visual deprivation. For the majority of the 
literature, a reduction in FA is typically coupled with an increase in RD in the optic 
radiations (Hofstetter et al., 2019; Tellouck et al., 2016; Yoshimine et al., 2018; Zhou et al., 
2017), however for Malania et al., (2017) et al., this was not the case. Authors report 
reductions AD and no change in RD for the optic radiations, but the opposite was found for 
the optic tracts, whereby RD significantly increased, and AD remained unchanged. With 
the optic tract, others either report no significant differences between patient and control 
groups (Yoshimine et al., 2018) or find the FA reduction to be driven by a decrease in AD 
(Ogawa et al., 2014). The discrepancy seems to occur more for the optic tract 
assessments, which could be explained by the size; being much smaller than the optic 
radiations, only certain protocols may be sensitive enough to detect changes in such a 
small structure. It would be interesting to explore white matter connections between other 
visual areas, to determine just how widespread alterations may be following eye disease; 
we provide evidence in Chapter 5 that functional connections between primary visual 
cortex and higher level regions with known eccentricity biases (e.g. fusiform face complex) 
are compromised in MD patients and so complementary structural assessments would be 
valuable. 
One important consideration with diffusion data is whether to calculate mean FA, RD, and 
AD measures for multiple locations along the tract, or whether to extract one measurement 
for the whole tract. The latter is not always useful but has been adopted by earlier work. 
For example, when exploring changes in the optic radiations in individuals with RP, Schoth 
et al., (2009) failed to find any significant differences between RP patients and sighted 
controls. While this study may lack sensitivity because of a small sample (n=5), generating 
tract profiles provides more meaningful data, particularly as not all fibers are of equal 
length and therefore may not extend fully between the seed and termination point in the 
grey matter, in turn reducing FA values. This is evident in the individual MD patient plots in 
Figure 3.3 – the end of the tract (even though we have trimmed 10% off) still drops off 





orientation is more complex and crossing is more likely) and plotting multiple measures, 
we, and others, have been able to show that only specific portions of the tracts are 
impacted by eye disease (Malania et al., 2017; Ogawa et al., 2014; Ohno et al., 2015; 
Yeatman et al., 2012; Yoshimine et al., 2018). Treating any white matter tract as one 
single entity and averaging across the whole length loses valuable information. 
While it is surprising that our visual acuity measures did not seem to correlate with our 
mean FA in the portions of the tracts that were significantly lower for our MD patients, 
there are some possible explanations for this. Not all the acuity measures were collected 
by the same researcher, meaning participants could be tested under different conditions 
(corrected or uncorrected) and using different charts. For 3 of our volunteers who did not 
come through the eye clinic at York Hospital, we were relying on self-reports of medical 
history, and so the measures given may not have been as accurate. We did however ask 
for their most recent assessments, but in some cases, this was some time before the 
baseline MRI appointment. More reliable and complete ophthalmic examinations to assess 
visual function (e.g. microperimetry), alongside detailed assessments of the scotoma size 
(using optical coherence tomography) would perhaps be better predictors of FA. It is also 
possible that the optic radiations genuinely do not correlate this with measure; Ohno et al., 
(2015) found that residual visual field area did not correlate with FA in the optic radiations 
in a group of RP patients. Authors note this may have been due to the fact patients were at 
various stages of the disease, had a broad age range and so the speed of disease 
progression may have varied heavily between patients. Collectively, these could be 
confounding factors, and it is not dissimilar to the current study in that regard – we too 
have a range of disease severity, age as well as having a combination of AMD and JMD 
patients. Time since disease onset could be a better predictor of FA in this instance. 
Unfortunately for this study, we do not have a disease duration information for all 
participants, and so we could only explore this in a subset of participants. An additional 
line of enquiry would be to see whether perhaps acuity measures correlated more with the 
metrics reported in the optic tracts. Malania et al., (2017) reported a lack of relationship 
between retinal nerve fiber layer (RNFL) thickness and diffusivity in the optic radiations, 
but RNFL thickness did correlate with optic tract diffusivity.  
When considering the consequences of diseases such as macular degeneration, it is 
important to use techniques such as diffusion imaging to probe the consequences on 
microstructure in addition to cortical thickness, myelin density, surface area and overall 





projections to the central representations in MD patients when examining FA, and these 
changes also appear at the earliest stages of the disease, as shown by our individual 
cases before and after diagnosis. With analysis techniques and protocols advancing 
rapidly, more sensitive measures of diffusion properties can be acquired, allowing for more 
reliable evaluation of the visual white matter, including the optic tracts which are more 
difficult to measure with lower resolution protocols. There is growing evidence suggesting 
that many additional visual disorders such as developmental prosopagnosia, amblyopia 
and cases with retinal ganglion cell damage are all associated with white matter changes 
(Millington, Ajina, & Bridge, 2014; Rokem et al., 2017). FA could potentially be used as a 
biomarker for disease severity, making it a useful clinical tool to help characterise eye 
disease alongside other standard ophthalmic measures. Understanding how visual 
disorders affect different parts of the visual pathway will allow for more targeted and 
refined potential treatment strategies. This may be particularly useful for 
neurodegenerative diseases such as glaucoma, as well as AMD (Li et al., 2014; Tellouck 





Chapter 4: Feasibility of a longitudinal neuroimaging and 
neurostimulation study with elderly, visually impaired 
participants 
4.1 Summary 
Longitudinal neuroimaging studies provide researchers an opportunity to collect highly 
valuable within-subject data which in patient populations, can offer new insights into 
disease progression that may not be possible to assess under current healthcare 
pathways. By monitoring structural and functional changes in the brain in a clinical 
population, alongside the changes occurring as a result of natural aging, we can tease 
apart what attributes are associated with the disease / pathology. This type of data could 
help determine at what point interventions would be most successful. Longitudinal 
research does however pose some additional difficulties including (and not restricted to) 
managing recruitment, building the relationships with returning participants and dealing 
with attrition rates. The aim of this chapter is to give an overview of the challenges faced 
when running a longitudinal neuroimaging study with neurostimulation procedures, 
exploring the issues faced during this project. Protocol amendments implemented to 
improve the recruitment rate will be discussed and evaluated in terms of how this impacted 
on the number of accruals. Next, neurostimulation procedures and contraindications will be 
discussed, focusing on medication use which appeared to be the most limiting factor 
(locally) for the neurostimulation procedures. Finally, it will discuss the wider implications 
for neuroimaging and neurostimulation studies and how they can be successfully 
implemented in the context of this study. 
4.2 Overview of the research project 
Chapters 2 and 3 describe findings from the longitudinal study discussed in this chapter. 
The study was very different at the outset and changed extensively due to recruitment 
barriers which will be discussed in turn. To recap, research in our lab following individuals 
with macular disease has reported a thinning of grey matter particularly in the occipital 
pole - the region representing the damaged retina - but reassuringly there is no evidence 
to suggest this region of visual cortex undergoes any large-scale remapping of function in 
cases of acquired retinal lesions (Baseler et al., 2011; Boucard et al., 2009; Hanson et al., 
2019; Hernowo et al., 2014; Doety Prins et al., 2016). In Chapters 2 and 3 we have shown 
that as well as the grey matter, cortical myelin, and visual white matter show evidence of 





focusing on restorative treatments of the retina, there is an assumption that visual cortex 
will be able to process the restored signals in an appropriate manner, which would in turn 
allow for functionally useful vision. Given that there is already evidence to suggest various 
forms of structural decline, the success of visual restoration may be compromised. For 
further discussion on neuroimaging research in the context of visual restoration, see 
Chapters 1 - 3.  
The initial aims of our longitudinal project were twofold: First, we wanted to determine the 
time course of anatomical changes in visual cortex, and assess the functional 
consequences following macular disease. Second, we aimed to use a neurostimulation 
technique – transcranial direct current stimulation (tDCS) – to see if we could slow or 
possibly prevent the anatomical degeneration and loss of neural sensitivity in visual cortex, 
specifically in the region representing the damaged retina – the lesion projection zone 
(LPZ). The results of this project could provide valuable information; it would be one of the 
first longitudinal studies to examine changes in visual cortex in patients with age-related 
macular degeneration (AMD), characterising the time course of the reported decline in 
primary visual cortex. This is, we believe, fundamental to the success of restorative 
treatments as it will inform clinicians of the viability of visual cortex and potentially highlight 
the most suitable candidates for restoration treatments. The sensitivity of the regions that 
exhibit structural decline is not yet known and is an important question to address again 
within the context of visual restoration. We can use a non-invasive neurostimulation 
technique called transcranial magnetic stimulation (TMS) to determine this. By using TMS, 
we can bypass the damaged retina and stimulate visual cortex directly, causing a 
phosphene - artificial flash of light (Halko, Eldaief, & Pascual-Leone, 2013; Lang et al., 
2007). Recording the minimum power required to induce a phosphene will inform us about 
the function of the LPZ – the less power required, the more functional the LPZ (Gothe et 
al., 2002). Finally, we aimed to assess the feasibility of tDCS as an intervention for 
patients with age-related macular disease. It has been widely used in rehabilitation of 
clinical populations for example, stroke patients experiencing language and motor 
difficulties (Baker, Rorden, & Fridriksson, 2010), however this was the first time to our 





We aimed to recruit 30 participants with the dry form of AMD who would be enrolled in the 
study for ~12 months. The original inclusion and exclusion criteria are shown in Table 4.1.  
 
During the 12-month period, participants would have up to 29 research appointments. The 
clinical visits would take place at the hospital, the MRI, fMRI and TMS procedures would 
take place at the university, and the tDCS procedures could either take place at the 
university, or if the participant preferred, in their own home. As the tDCS kit is portable, we 
could reduce participant burden by having the researcher perform the procedures in their 
homes. The procedures included in the original protocol for this study are outlined in Table 
4.2 and the proposed schedule of events is shown in Table 4.3. 
Table 4.1. Inclusion and exclusion criteria for the original 12-month study. 





By using multiple procedures to probe the state of the eye and the visual brain, we could 
track the rate of change in both the eye, but also monitor any neural consequences of 
macular disease; by having two groups, receiving either active stimulation or sham 
stimulation during the tDCS sessions, we could also assess the effectiveness of the 
intervention. 
 
4.3 Barriers for recruitment 
4.3.1 Study Design 
Multiple barriers for recruitment were identified throughout the recruitment phase of the 
study. This primarily included (but was not restricted to) the burden of the original study 
design and type of procedures used. Using the criteria described in Table 4.1 and the 
schedule outlined in Table 4.3, recruitment proved very difficult and participants were 
discouraged by the number of visits before even determining eligibility.  It also proved very 
difficult to find individuals who fell into this narrow inclusion criteria. The dry form of AMD, 
despite being the most common and accounting for 85-90% of AMD cases, is not treatable 
(Singer & Bahadorani, 2017). This means the number of patients coming through the 
regular eye clinics at the hospital is far lower than the number attending with neovascular 
AMD. As described in Chapter 1, the neovascular or wet form of AMD can be treated with 
anti-vascular endothelial growth factor (anti-VEGF) injections every 4 - 12 weeks, 
depending on their treatment plan. Whilst this does not cure the disease, it does slow 
down the progression and help maintain visual function. A summary of the number of 
participants screened and their eligibility are in Figure 4.1B. Information has been grouped 
to show how amendments impacted on the recruitment rates – the timeline for key events 
Table 4.3. Study timeline for each participant. Each procedure is listed as well as the frequency of 
visits. MRI and fMRI would be conducted in the same session whereas all other procedures would 





are outlined in Figure 4.1A. Our first amendment concerned the inclusion criteria. It was 
clear when screening potential participants that the narrow inclusion criteria were making 




Figure 4.1. Timeline for key milestones in the study, including amendments to the study 
protocol and documentation, as well as recruitment dates. B: Summary of the amendments 
to the study protocol and the number of volunteers screened. Volunteers were grouped into 
3 categories: Eligible and recruited, eligible & not recruited, and ineligible or declined. For 
those who were eligible but not recruited, this was primarily because the participants 
seemed eligible at screening, but other contraindications emerged when speaking to 






The final study procedures (Table 4.4) were significantly altered to successfully recruit for 
the study. As well as cutting the duration of the study by six months, TMS procedures were 
removed, and all other appointments (MRI, tDCS and hospital visits) became optional, 
allowing participants to just enrol in the MRI procedures, for example. Initially, we 
suspected it was due to the narrow criteria concerning the eye condition, however it was 
primarily due to the contraindications for neurostimulation procedures. Both issues will now 
be discussed in turn.   
 
4.3.2 Inclusion criteria concerning the patient’s eye condition 
In the original study design (Table 4.1), the inclusion criteria were deliberately narrow as 
we were trying to recruit individuals who had recently been diagnosed with dry AMD in the 
second eye (within 18 months of diagnosis), and who did not exhibit any other forms of 
eye affecting diseases or injury. The rationale for this was that we wanted to establish the 
rate of change in visual cortex as close in time to the onset of visual loss, which would 
theoretically be the period in which changes would most likely be observed, as opposed to 
when patients have prolonged visual deprivation. Additionally, we hypothesised that this is 
the period during which tDCS might have the greatest impact in preventing or slowing any 
degeneration of visual cortex. In Figure 4.2 we outline the most common reasons for 
patients failing screening. The most frequent issues arising during screening were other 
eye-involving disease or injury, visual acuity falling outside of the desired range or patients 
having unstable vision, as determined by a change of more than 10 letters on the ETDRS 
chart within the three most recent clinic appointments.  
 
Table 4.4. Final study timeline after amendments to the study design and 






4.3.3 Contraindications for neurostimulation procedures 
Transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) 
are non-invasive brain stimulation procedures that are used in multiple research groups in 
psychology and cognitive neuroscience, to probe the function of the brain by temporarily 
modifying the state of the brain (Halko et al., 2013). Stimulation can occur in two forms: 
online or offline. Online stimulation sessions constitute a task being performed while 
stimulation is being applied, whereas during offline stimulation, no task is performed 
(Filmer, Dux, & Mattingley, 2014).  
TMS is a safe, non-invasive technique used to modulate cortical excitability using 
changing magnetic fields applied to the brain, which in turn causes an electric current in a 
region of interest (Rossi, Hallett, Rossini, & Pascual-Leone, 2009). TMS has been used to 
probe the function of different brain areas by either causing an increase in activity, or 
conversely, reducing activity by inducing a temporary cortical lesion.  
TDCS delivers a constant low intensity electrical current to the brain, applied through the 
skull with small saline-soaked surface electrodes (Antal, Nitsche, & Paulus, 2006; Brunoni 
et al., 2012). Stimulation is delivered by a DC battery and can increase or decrease the 
cortical excitability in regions nearest the electrodes, depending on the type of stimulation 
used (Lang et al., 2007; Romero Lauro et al., 2014). Anodal stimulation increases the 
membrane potential of neurons and depolarises them, whereas cathodal stimulation 
Figure 4.2. Reasons volunteers failed screening and classed ineligible for the study. 
Unstable vision was measured by reviewing visual acuity scores from the last three 
appointments at the eye clinic. Vision was deemed unstable if a change of >10 letters 
occurred in this time window. For more details about Other eye disease/injury criteria, see 
Appendix B1. 















decreases the resting membrane potential, in turn hyperpolarising neurons (Poreisz, 
Boros, Antal, & Paulus, 2007). TDCS is a cheap form of brain stimulation, which is non-
invasive, well tolerated with minimal adverse effects reported (Hummel & Cohen, 2006). 
However, protocols and safety guidelines can vary drastically between institutions and 
research groups. This in turn affects the feasibility of some studies as it will depend on the 
guidelines proposed by the host institution. This will be discussed in more detail later.  
Both TMS and tDCS are increasingly being used to assess their effectiveness in 
rehabilitating patients with different clinical conditions who may be drug-resistant, for 
example. Over the last 20 years the number of studies using TMS for therapeutic 
applications has significantly increased and it has been used successfully in treating case 
of treatment-resistant depression (Cole et al., 2019; Concerto et al., 2015; Fox, Buckner, 
White, Greicius, & Pascual-Leone, 2012; Leggett et al., 2015; Pascual-Leone, Bartres-Faz, 
& Keenan, 1999; Pascual-Leone, Rubio, Pallardó, & Catalá, 1996; Philip, Barredo, Aiken, 
& Carpenter, 2018) and has shown promise for rehabilitating Parkinson’s disease and 
stroke patients (Baker et al., 2010; Dionísio, Duarte, Patrício, & Castelo-Branco, 2018;  
Fregni et al., 2004; Fregni & Pascual-Leone, 2007; Gandiga, Hummel, & Cohen, 2006). 
TDCS has also been adopted for a wide range of clinical studies not only because of the 
direct effects on cortical excitability, but also because it can be used in conjunction with 
other treatments (Brunoni et al., 2012). Historically, electrical currents have been utilised 
as a means of relieving epilepsy and headaches, but even as early as 1804, Aldini was the 
first to report using this method of treatment, particularly for psychological disorders (Stagg 
& Nitsche, 2011). Results were highly varied and often severe adverse effects were 
reported but this was prior to the establishment of more controlled protocols and rigorous 
safety testing; later studies adopted a similar method of treatment, using much lower DC 
currents. More recent work incorporating tDCS aims to use it as a means of treating 
various neurological and psychiatric conditions such as depression, epilepsy, chronic pain, 
Parkinson's disease, stroke rehabilitation and migraines (Berlim, Van den Eynde, & 
Daskalakis, 2013; Brunoni et al., 2011; Poreisz et al., 2007; Shiozawa et al., 2014). From a 
safety perspective, there is little evidence to suggest tDCS will lead to any serious adverse 
effects. For example, despite 20% of stroke patients reporting seizures during recovery, 
there is no direct evidence to suggest that tDCS would induce seizures even in 
compromised cases with atypical cerebrovascular structure (Bikson et al., 2016). Another 





phase post-stroke; understanding how tDCS may interact with these will help researchers 
to define what is actually a direct serious advert effect as a result of tDCS.  
Arguably the biggest hurdle for recruitment to our study was finding individuals eligible for 
both neurostimulation procedures. Both procedures come with an extensive list of 
screening questions and safety checks to ensure an individual is safe to participate in such 
procedures, shown in Appendix B (B2-B3). For this reason, neurostimulation studies can 
also be difficult to implement in a clinical population outside of a hospital environment and 
without an M.D. present. The inclusion and exclusion criteria are virtually the same for both 
TMS and tDCS in our department and because of the two techniques being judged as 
largely identical in  risk recruitment was limited. The main concern with neurostimulation is 
the safety of the participant, as the procedures present an increased risk of seizure, which 
is magnified if a participant is in a certain state, feeling unwell or taking a range of 
medications (Rossi et al., 2009). The effects are also dependent on the parameters set, 
such as the duration for which the stimulation is applied and the intensity of the 
stimulation.  
Despite tDCS being deemed low risk and having an increasing number of clinical studies 
involving tDCS procedures in conjunction with drug treatments, the safety guidelines 
employed in our department do prohibit most of the elderly population from being recruited 
to a neurostimulation study. As part of the natural aging process, we do become more 
vulnerable to particular health conditions (e.g. neurodegenerative disease, respiratory 
disease, heart disease, cancer & diabetes (Age UK, n.d.), however evidence suggests 
comorbidities appear to be more prevalent in wet AMD patients compared to age-matched 
sight controls (Zlateva, Javitt, Shah, Zhou, & Murphy, 2007). Notwithstanding, it is 
important to disentangle the increased risk of seizure caused by pre-existing health 
conditions versus the overall risk of an adverse reaction to the neurostimulation itself in 
patient groups, as well as the elderly more generally, as this population would likely benefit 
most from such interventions. A recent review of the safety of tDCS concluded there is no 
current evidence from over 40 studies, which included testing of 600 older adults, that 
aging subjects have an increased risk of a serious adverse event (Bikson et al., 2016). 
This was also irrespective of their cognitive abilities or health status. Recent pilot data 
investigating the possible therapeutic effects of tDCS in individuals with a visual 
impairment who experience visual hallucinations caused by Charles Bonnet Syndrome 
(CBS) have shown some promising results; four of the six patients with CBS found the 





CBS can occur in any form of visual impairment, but with AMD being the current leading 
cause of blindness in the UK, a large proportion of patients affected are elderly. This 
promising finding along with the success of other more established clinical studies 
warrants the re-evaluation of the site-specific tDCS guidelines, to allow for more research 
like this to be undertaken, where the possible therapeutic benefits are greater than the risk 
posed by tDCS.  
The main reason for ineligibility in our study we believe concerned medication use. Our 
target population was initially just individuals with AMD and as the name suggests, it is an 
age-related disease and prevalent in the elderly. Approximately 2.4% of 50+ year olds, 
4.8% of 60+ year olds and 12.2% of 80+ year olds are diagnosed with AMD (NICE, 2018). 
Furthermore, the older you get, the more likely you are to be taking one or more 
prescribed medications for other health conditions associated with aging as mentioned 
previously. A recent healthy survey for England highlighted the proportion of the population 
on prescribed medications, broken down into different age brackets (Moody, Mindell, & 
Faulding, 2016). Figure 4.3 illustrates the findings from the survey and highlights that even 
in the youngest age group (55-64 years), over 60% of individuals reported taking one or 
more prescribed medications. It should be noted that this does not include any over-the-
counter medication. This data alone highlights how difficult it would be to conduct 
neurostimulation studies on AMD patients with such stringent safety criteria; older people 
are more likely to have AMD but are also highly likely to be on prescribed medications 
which are prohibited in the context of neurostimulation procedures. Figure 4.4 breaks 
down the most common forms of prescribed medications taken by individuals over 55 
years of age, many of which render individuals ineligible for both TMS and tDCS (Rossi et 
al., 2009). It is at least encouraging to see this data support our recruitment data in Figure 
4.1B, highlighting the vast amount volunteers excluded. Upon relaxing the criteria where 







Figure 4.3. Data from Health Survey for England for 2016 on prescribed medicines. Percentage of the 
population taking prescribed medications in our target age groups. Black bars: percentage of 
population in each age bracket taking more 1+ prescribed medications. White bars: percentage taking 
more than three prescribed medications. Note this does not included any over-the-counter medication 
or non-prescribed medications. Prescribed medicines exclude smoking cessation products and 
contraceptives. 
Figure 4.4: Data taken from the Health Survey for England 2016 on Prescribed medicines. 
Percentage of the population taking most prevalent forms of prescribed medications in the age 
range our study was targeting. Note this does not included any over the counter/non-prescribed 
medication. Anti-hypertensive medications lower blood pressure. Lipid-lowering medicines 
include statins to lower cholesterol, and fibrates which take care of fatty acids and triglycerides.  
Proton pump inhibitors are a group of drugs that reduce stomach acid production. Analgesics 
and NSAIDS (non-steroidal anti-inflammatory drugs) constitute painkillers. Antidepressants 
combat clinical depression. Medicines for asthma or COPD (chronic obstructive pulmonary 
disease) can include bronchodilaters which are usually combined with glucocorticosteroids. 
Antiplatelet medicines are a group of blood-thinning drugs to reduce chances of heart attack and 
stroke, for example. Antidiabetic medicines are used to control diabetes. See Appendix B4 for 






When conducting a longitudinal study with neurostimulation procedures, there are multiple 
factors that need to be considered for it to be successful. It is evident that stringent 
inclusion criteria, which includes the many contraindications listed for the neurostimulation 
procedures (notably medication), was by the far the most limiting factor when recruiting for 
this particular study. Evidence from our own observations in conjunction with data from the 
Health Survey England 2016 highlights the proportion of individuals on medications over 
the age of 55 years – our target population with age-related macular degeneration – is 
vast. Additionally, this only captures the prescribed medications and as such, the number 
of individuals taking over-the-counter medication will inflate the statistics further. Studies 
have been conducted in conjunction with drug treatments, and so in this instance, the main 
issues were the limitations imposed by the site-specific safety guidelines being stricter 
compared to other institutions. It appears that in order to successfully conduct studies 
examining the impact of neurostimulation procedures on clinical populations, it would 
require procedures to be undertaken where an M.D. is on site e.g. hospitals. Therefore, if 
this resource is not available, the design is unfortunately not feasible in such populations.  
Establishing appropriate inclusion criteria is crucial to successful recruitment for any study. 
As discussed previously, our initial design was highly specific, to include individuals with 
dry AMD who were diagnosed in the second eye within the 18 months prior to recruitment. 
Dry AMD patients do not frequently attend the eye clinic, as there are currently no effective 
treatment plans compared to those with the wet form. In order to find such individuals, we 
were relying on them either attending clinics for an annual check-up at the time we were 
recruiting, or for them to have become members of local sight loss charities and support 
groups where we were also advertising our study in the later stages. Finding such 
individuals within such a tight time window was difficult without more help in the clinic.  
To increase the chances of recruiting in clinic, we expanded our criteria to include wet-
AMD patients. Despite being the less common form of AMD, we would encounter far more 
patients in the clinic since treatment is readily available. However, it was after this change 
in criteria that contraindications for neurostimulation procedures became the next hurdle to 
overcome. As we were still recruiting from the older population, medication issues were 
still prevalent. An additional factor to consider is a change in medication over the time 
course of the study, but also the use of temporary medications for example those who are 
taking medications for hay fever in the summer months. Antihistamines are named as an 





therefore also crucial to avoid undertaking data collection during the time of year where 
individuals will be on medication making them ineligible. Given longitudinal studies 
typically span more than 12 months, this is difficult to overcome. This is an important 
consideration for future neurostimulation studies because as a nation, we are an aging 
population. It is predicted that by 2037, almost a quarter of the population will be over 65 
years of age (Office for National Statistics, 2018).  With that, we will see an increase in the 
prevalence of AMD as well as other age-related diseases. Neurostimulation procedures 
are promising non-pharmacological interventions for conditions which largely affect the 
elderly, and yet it cannot always be utilised in the population who could benefit most.  
Our final step to widen the inclusion criteria was to drop the age of the participants to 18 
years of age and seek out individuals with any form of central vision loss. This would again 
increase the participant pool but also would help alleviate some of the problems faced with 
contraindications for the neurostimulation procedures. The important thing to consider in 
terms of the research question was that vision loss was bilateral and overlapping – age of 
onset or disease type would become irrelevant to the question at this stage. However, 
lowering the age unfortunately did not cause an influx of participants; individuals included 
were now of working age and therefore many of them in full time employment were unable 
to commit to a study that required multiple visits or testing within standard 9-5 working 
hours. While we broadened our pool, we did not necessarily increase recruitment 
opportunities. By the time recruitment had closed, we only had two individuals of working 
age enrolled in the study.  
Upon reflection, it is clear our original study design was labour intensive for both 
participant and researcher. It is understandable that, particularly for the elderly, 29 visits 
within a 12-month period is burdensome, but also would have been difficult to manage for 
one researcher 29 visits for potentially 30 participants. Whilst this design was optimised for 
the research question, it was not inviting to the participants. Even with the option to have 
the tDCS procedures in the participant’s home (which would make up 16 of the 29 visits), it 
is still a large time commitment. It is important to bear in mind that once the study opened 
up to wet AMD patients, we would have to fit in all the research visits around their regular 
eye clinic appointments which could be as often as once a month. Having multiple MRI 
appointments was less of an issue; of our original 12 patients enrolled in this study, 7 
joined the extended project for between 6 and 18 months beyond the initial study period. 





some participants consented to follow-up scans and attended an additional three 
appointments shows that multiple visits were acceptable within reason.  
Since completing the study, we have conducted a short survey to establish what current 
participants’ views on the number of required visits for future research. Results from the 
survey indicate that a design involving 8 visits over a 4-year period would be perfectly 
reasonable. Further to this, the acceptable duration of each individual visit was 1 to 2 
hours for 5 out of 12 respondents, however the remaining 7 out of 12 thought 2+ hours an 
acceptable duration per appointment. The results of this survey also highlight the 
importance of incorporating patient and public involvement in our research at the very 
outset, to optimise the study and improve the quality of both the science and the 
experience for the participants themselves. See Appendix B (B5) for a summary of the 
survey.  
The final iteration of our study was as follows: 12 MD patients (10 with AMD and 2 with 
juvenile MD) were recruited for the 6-month period, 3 of whom had tDCS procedures. Due 
to the small sample, we decided to focus on the MRI element of the study and applied for 
ethical approval to extend the MRI portion of the study to include 3 further appointments: 
12, 18 and 24 months from baseline. We wanted to track the rate of change in anatomical 
measures (cortical thickness, myelin density and integrity of the white matter in visual 
cortex) over this time period in cases of established MD. We were also able to include a 
sighted control group by inviting back participants from a study which used the same MRI 
protocols, ensuring their data were comparable. We had 18 control participants of a similar 
age who were scanned between 22 and 26 months apart. 
To conclude, this longitudinal neuroimaging and neurostimulation study proved a 
challenge, and several reasons for the difficulties faced have been discussed. Establishing 
a feasible inclusion and exclusion criteria is essential. Opting to include individuals who 
would be less likely to frequent the eye clinic was problematic, as was having such 
stringent criteria. The design of the study was deemed unfavourable by potential 
participants due to the frequency of appointments and burden, but also unachievable by 
the small research team at that time. The rate at which patients failed to pass the safety 
screening for neurostimulation procedures was a major concern. Due to many 
contraindications as determined by the safety questionnaires used, as well as the 
likelihood of finding AMD patients who were not taking any prescribed medication, protocol 





procedures and acquire useful data. Eventually, the study was altered to focus on the 
anatomical changes in the brain in a broader group of central vision loss patients. Our data 
still contribute new original findings to the field whilst also highlighting challenges faced in 









Chapter 5: Assessing resting state functional connectivity 
between V1 and higher visual areas in cases of selective 
central or peripheral loss 
5.1 Abstract 
Previous studies have shown specific changes within visual cortex in cases of selective 
central or peripheral vision loss, notably reductions in cortical thickness and absence of 
functional responses in the region representing the lesioned retina. Here we used resting 
state fMRI to explore functional connectivity within visual cortex, examining specific 
connections between regions with matching eccentricity biases; (1) central visual field 
representations in V1 and foveal biased ventral visual areas (overlapping face-selective 
regions), and (2) peripheral visual field representation in V1 and peripheral biased ventral 
visual areas (overlapping place-selective regions). We tested individuals with selective 
central or peripheral vision loss as well as sighted controls, exploring connections between 
areas defined using atlas-based multimodal parcellations of cortex. Our second aim 
concerned viewing conditions; with known fixation instability in partially sighted 
populations, all participants completed the experiment twice, once with eyes closed and 
once with eyes open, fixating on a full screen fixation cross. Due to early termination of the 
study, our results focused on the central loss and sighted control groups only. Results 
revealed selective deficits in the central loss group, whereby the group showed reduced 
connectivity between regions with foveal biases (central V1 - face area) compared to 
sighted controls, whereas no such difference emerged in the peripheral biased regions 
(peripheral V1 - place area). This result was evident in both the eyes open and eyes 
closed conditions but was only observed in the right hemisphere, supporting the 







Resting state functional MRI allows for the opportunity to study the organisation of visual 
cortex in individuals with partial or complete blindness. It allows researchers to examine 
interactions between cortical regions and establish functional connectivity between regions 
of interest (ROI), without the need for stimuli or task demands. In cases of complete 
absence of vision, research has shown that the architecture underlying visual cortex 
remains largely the same, demonstrating typical retinotopic organisation despite no visual 
experience (Bock et al., 2015; Bridge et al., 2009; Striem-Amit et al., 2015). As described 
in Chapters 1 to 3, there is evidence of structural atrophy, or perhaps even degeneration, 
in visual cortex in cases of macular disease, affecting grey matter, cortical myelin and the 
visual white matter.  A key study from Yoshimine and colleagues highlighted evidence of 
specific deficits in white matter projecting to the anatomical representation of the retinal 
deficit in individuals with age-related macular degeneration (Yoshimine et al., 2018). This 
begs the question of whether functional connectivity may follow suit, with observed 
changes being restricted to connections with the representation of damaged visual fields in 
partial vision loss. The function of the cortical representation of the lesion is also of 
interest; as discussed in Chapter 1 and later in Chapter 6, in cases of acquired vision loss 
there is debate over whether functional responses can be reliably detected in the cortical 
representation of the lesion at all, but also what this may represent. Assessing the 
functional connectivity between the cortical representation of the retinal lesion and higher-
level visual areas may help give us some insight into the communication between visual 
areas. 
Few studies have assessed functional connectivity in cases of partial vision loss, for which 
the onset is often later in life. Previous work has largely focused on individuals with 
complete blindness and been exploratory in nature, examining connectivity over the whole 
brain as opposed to focusing on functional connectivity within visual cortex (Frezzotti et al., 
2014; Sabbah et al., 2017). However, there is evidence of decreased functional 
connectivity between the visual and working memory networks in individuals with 
advanced primary open-angle glaucoma, which, as described in Chapter 1, results in 
gradual peripheral vision loss. As well as reductions in functional connectivity, this study 
also found enhanced connections in visual and executive networks (Frezzotti et al., 2014). 
As for central vision loss, Sanda et al., (2018) explored changes in cortical entropy using 
resting state fMRI to explore connective properties in various parts of the occipital lobe. 





the mid fusiform sulcus (MFS) which are shown to have more of a peripheral bias (Sanda 
et al., 2018).  The extent of the changes observed seemed to correlate with the severity of 
vision loss and this is important because it highlights the potential value of looking at other 
clinically relevant measures such as fMRI (Duncan et al., 2007; Frezzotti et al., 2014). 
There is some evidence suggesting higher-level face and scene processing are affected 
by sight loss, however, this is largely limited to behavioural studies (Peyrin, Ramanoël, 
Roux-Sibilon, Chokron, & Hera, 2017; Roux-Sibilon et al., 2018). As extrastriate regions 
receive input from earlier visual areas, it is important to understand how and whether 
information is fed forward to higher-order visual areas when earlier regions in the visual 
pathway no longer receive visual input. Likewise, understanding any remaining interaction 
between areas of deprived input and later processing stages is important.  
Cortical regions in the ventral visual pathway that are selective for face and scene 
processing are known to have a central and peripheral eccentricity bias respectively 
(Glasser et al., 2016; Hasson, Levy, Behrmann, Hendler, & Malach, 2002; Levy et al., 
2001; Malach, Levy, & Hasson, 2002; Striem-Amit et al., 2015).  Neuroimaging studies 
examining the relationship between the functional representations (task-based fMRI & 
functional connectivity) and underlying architecture of cortex (myelin content, cortical 
thickness, cortical folding & white matter connectivity) have shown an overlap between 
domain specificity maps and eccentricity biases. Using a multi-modal approach, the 
Human Connectome Project (HCP) has identified 180 areas per hemisphere, which 
correspond with regions identified with post-mortem data (Glasser et al., 2016). In terms of 
the ventral visual stream, they have shown in a large participant group, that the regions 
referred to as the fusiform face complex (FFC) and the posterior inferotemporal (PIT) 
correspond with the two main clusters of activation in a face-based fMRI study; these 
largely capture the functional regions known as the fusiform face area (FFA) and the 
occipital face area (OFA). Grill-Spector and colleagues have also examined the structure 
of the ventral visual stream, exploring the relationship between anatomical and 
topographic representations (Grill-Spector & Weiner, 2014; Weiner et al., 2014; Weiner & 
Zilles, 2016). Divisions between face and/or foveal representations are shown to be 
separated from place and/or peripheral representations by the mid fusiform sulcus - MFS 
(Grill-Spector & Weiner, 2014; Weiner et al., 2014). Lateral to the MFS, Weiner and 
colleagues showed there are biases towards foveal representations, face-selectivity and 
animacy for example, whereas on the medial side, they observed a peripheral eccentricity 





Weiner & Zilles, 2016). The division also corresponded with transitions between white 
matter connectivity with faces (lateral) and places (medial), and myelin content. This 
coincides with the FFC and PIT regions identified by the HCP multi-modal parcellation 
(HCP-MMP1.0) described above, and the parahippocampal place area (PPA) ROI 
generated by Grill-Spector and colleagues - see Section 5.3.5.2 for more detail on how this 
was generated. Areal boundaries in the ventral visual pathway have been consistent with 
previous work focusing on just one property of cortex - typically functional organisation 
principles. Identifying these boundaries allows for identification of ROIs using parcellations 
of cortex that do not rely on having functional localiser data; this is particularly helpful in 
cases of partial or complete blindness. 
Whilst previous work has shown that domain-specific connectivity is evident in sighted 
adults, how it develops over time and when this specificity emerges, is largely unknown. 
Kamps et al., (2020) provide greater insight after examining how portions of primary visual 
cortex connect with higher-level visual areas including the FFA, OFA, PPA and 
retrosplenial cortex (RSC), given that these areas are shown to have specific retinotopic 
biases (Hasson et al., 2002; Kamps et al., 2020; Levy et al., 2001) and retinotopic 
organisation is evident from birth (Arcaro, Schade, Vincent, Ponce, & Livingstone, 2017). 
Kamps et al have shown as early as 27-days old, stronger functional connectivity was 
observed between OFA and the central representation in V1, and for PPA and RSC, 
functional connectivity was strongest with peripheral V1. Interestingly, the FFA and central 
V1 functional connectivity was not significant, but authors note there was a trend in the 
direction of a foveal bias (Kamps et al., 2020). In cases of congenital blindness, functional 
connectivity analysis has also shown that FFA and PPA differ in terms of their eccentricity 
preferences, and this did not differ significantly between blind and sighted groups. 
Similarly, congenitally blind individuals do show FFA responses to auditory stimuli, for 
example expressing emotion through voice (van den Hurk, Van Baelen, & Op de Beeck, 
2017) and to haptic stimuli, for example 3D printed faces (Murty et al., 2020). Collectively, 
the neonate and congenitally blind studies highlight that both retinotopic organisation as 
well as category selectivity in the occipital temporal cortex develop independently, and 
without visual experience. Whilst this division is evident in the absence of vision and visual 
experience, we do not know to what degree this may change in acquired or late-onset 
vision loss, particularly because connectivity with non-visual areas is where groups 





As discussed in Chapter 1, one of the most common complaints from those with central 
vision loss, such as age-related macular degeneration (AMD) is difficulty identifying 
familiar faces and interpreting facial expressions. This is not surprising given that faces 
contain a lot of highly complex information which requires high acuity to scrutinise - 
something that is progressively lost with AMD. Considering visual deficits can be selective 
(as in AMD and glaucoma, affecting central and peripheral vision respectively), we want to 
know how the functional connections that are established early in life may be impacted by 
acquired sight loss. Determining whether higher-level visual areas with eccentricity biases 
matching the affected portion in V1 (anatomical representation of the retinal damage) also 
show reduced connectivity with this region was our main aim. Previous work using resting 
state functional connectivity with groups of selective central and peripheral loss found 
increased local connections from the unaffected early visual cortex, and increased remote 
connections with the portion of early visual cortex no longer receiving visual input (Sabbah 
et al., 2017). It is interesting to see perhaps there is a diversion to higher-order functions 
outside of the visual cortex, but how this would compensate areas with a loss of visual 
input is not clear. What happens to more specific functional connections within visual 
cortex is currently unknown, and something we aim to investigate in the current study. 
When designing a resting state fMRI study, it is important to consider the state of the 
participant, and what will be expected of them during the scan. Typically, research will be 
conducted in one of three ways: 1) participants will be asked to close their eyes (2) 
participants are asked to keep their eyes open and (3) participants are asked to keep their 
eyes open but are presented with a simple fixation cross to help maintain attention (Patriat 
et al., 2013; Zhang et al., 2015; Zou & Long, 2009). The latter is generally considered 
optimal, as there is evidence of subtle improvements to the resting state functional 
connectivity compared to the alternatives, with the exception for visual networks showing a 
slight preference for eyes open without fixation (Patriat et al., 2013). Having something to 
attend to during the scan improves participant focus, however for visually impaired and/or 
completely blind participants, having a visual stimulus on which they fixate can be 
problematic, depending on the severity of the vision loss and fixation stability. 
For this study we had two aims. First, we wanted to determine how much resting state 
fMRI is affected by having eyes open or closed in partially sighted populations, as well as 
sighted controls. In the eyes open condition, we opted for a large black fixation cross on a 
mid-grey screen which extended to the full width of the screen, ensuring the patients would 





which could modulate spontaneous activity within the visual network (Yang et al., 2007; D. 
Zhang et al., 2015; Zou & Long, 2009). We recruited participants from three groups in this 
study: sighted controls, individuals with central vision loss and individuals with peripheral 
vision loss. Following a similar set up to Kamps et al., we wanted to investigate whether 
the type of visual impairment (central vs peripheral loss) impacted on functional 
connections differently. Figure 5.1 illustrates the connections of interest. We predicted that 
connections between the V1 ROI capturing the anatomical representation of the affected 
visual field and the ventral visual area with the same eccentricity bias, will be most 
affected. For example, for central vision loss this would be central V1 and regions involving 
face processing, and for peripheral vision loss, this would be peripheral V1 and regions 
involving place processing. In the absence of functional localisers, we have opted to use 
atlas-based ROIs; the Benson atlas for portions of V1, the HCP-1.0MMP parcellations for 
FFC and OFA to create our face area and the PPA ROI from Grill-Spector’s lab for our 
place area. There is evidence of a lateralisation of function for face processing, with the 
right hemisphere being more dominant in face processing (Kanwisher, McDermott, & 
Chun, 1997; McCarthy, Puce, Gore, & Allison, 1997) and therefore we have not collapsed 
across hemisphere in our analysis to determine whether functional lateralisation is evident 
in the functional connectivity data. In terms of our eyes open versus eyes closed condition, 
we predict that perhaps this will make the biggest difference to our patient groups, 











27 participants were recruited for this study; 16 sighted controls (6 females, mean age = 
65.06 years, range = 47 - 82 years old ), 7 individuals with central vision loss (2 females, 
mean age = 70.29 years, range = 53 to 84 years old) and 4 individuals with peripheral 
vision loss (4 females, mean age = 58.25 years, range = 48 to 65 years old) were recruited 
through advertisements in local sight loss support groups in York and the York 
Neuroimaging Centre (YNiC) Participant Pool, University of York. One sighted control was 
excluded due to poor image quality caused by dental braces, and 1 central vision loss 
participant was excluded due to poor quality structural images which FreeSurfer struggled 
to process despite further intervention. This left us with 15 sighted controls, 6 central loss 
and 4 peripheral loss participants. Written informed consent was obtained from all 
participants. This study followed the tenets of the Declaration of Helsinki with approval 
granted by YNiC Research, Ethics and Governance Committee. 
5.3.2 Scanning Procedure 
All participants took part in a single scanning session lasting ~45 minutes. The only 
instructions given to participants were for the two resting state scans (~6 minutes each), 
referred to as ‘Eyes Closed’ and ‘Eyes Open’. For the first resting state scan, participants 
were instructed to close their eyes through the two-way communication system. For those 
Figure 5.1. Illustration of functional connections of interest. A: Normally sighted representation. 
Kamps et al., 2020 showed within eccentricity correlations (e.g., Central V1 and face areas) are 
higher than between eccentricity correlations (e.g. central V1 and place areas). B&C: Predictions 
for central and peripheral vision loss groups only concern within eccentricity correlations – grey 
box indicates the region of V1 affected by vision loss, and the grey arrow with a red cross 





who were hard of hearing, written instructions were presented on the screen in the 
scanner and participants were asked not to open their eyes again until the sound of the 
scanner stopped – we confirmed they could indeed hear that the scans had finished. We 
determined an adequate size and style of font for the instructions prior to going into the 
scanner, which was particularly important for the visually impaired participants. 
Participants were also asked to verbally confirm when they had closed their eyes. For the 
second scan, participants were instructed to keep their eyes open for the duration of the 
scan and attend to the fixation cross presented on screen. 
5.3.3 Stimulus Presentation 
A black cross spanning the full width and height of the screen was presented on a mid-
grey screen to participants during the ‘Eyes Open’ condition; this was presented full screen 
using Microsoft PowerPoint. This is deemed the optimum set up for resting state scans to 
ensure participants are alert and have something to focus their attention on. The fixation 
cross was presented to participants using the PROPixx DLP LED Projector (VPixx 
Technologies), with 1920x1080 Native resolution (HD), 120 Hz refresh rate and a custom 
in-bore acrylic rear projection screen subtending 40 x 23 degrees of visual angle. 
5.3.4 MRI Data acquisition 
All structural and functional data were acquired at the University of York Neuroimaging 
Centre on the 3T Magnetom Prisma MR scanner (Siemens Healthineers, Erlangen, 
Germany), using the 20-channel head / neck receive-array coil. For T1 and T2-weighted 
structural scans, we opted for the Human Connectome Project (HCP) recommended 
protocols (Glasser & Van Essen, 2011). 
One T1-weighted anatomical image was acquired using a 3D-MPRAGE sequence (TR = 
2400ms, TE = 2.28ms, TI = 1010ms, voxel size = 0.8x0.8x0.8mm3, flip angle = 8°, matrix 
size 320x320x208, FOV = 256mm) and one T2-weighted anatomical image was acquired 
(TR = 3200ms, TE = 563ms, voxel size = 0.8x0.8x0.8mm3, flip angle = 120°, matrix size = 
320x320x208, FOV = 256mm). 
For the functional MRI, we acquired two resting state scans (each ~6 minutes in duration), 
along with a field map matching the resting state scan parameters (~2 minutes duration) to 
help correct distortions caused by inhomogeneity in the magnetic field and improve 
registration. Two scans using echo planar imaging (EPI) sequence (TR = 1500ms, TE = 
31ms, voxel size = 2x2x2mm3, flip angle = 52°, matrix size 120x120, 64 slices, FOV = 





5.3.5 Data Analysis 
5.3.5.1 Structural data 
T1 and T2-weighted anatomical scans were processed using the HCP minimal processing 
stream for structural data (HCP, version 4.0.0). The HCP MRI data pre-processing 
pipelines use tools from FreeSurfer (Van Essen et al., 2012) and FSL (Jenkinson et al., 
2002) and are also described in Section 2.3.3.3. 
5.3.5.2 Generating Regions of Interest (ROIs) 
Primary Visual Cortex 
For each hemisphere, we divided V1 into two parts: a central V1 ROI capturing <5 degrees 
of visual angle, and a peripheral V1 ROI capturing beyond 5 degrees (Figure 5.2A, B). We 
used a surface-based atlas approach which does not require any functional data, only a 
standard FreeSurfer output directory for each participant for the cortical surface 
registration. The retinotopic organisation of visual cortex (particularly V1 to V3) is 
consistent across individuals and when using the cortical surface topology alignment 
methods (to reduce geometric distortions), there is further evidence to suggests 
consistency in the size and location of V1 across subjects (Dougherty et al., 2003; 
Henriksson, Karvonen, Salminen-Vaparanta, Railo, & Vanni, 2012; Hinds et al., 2008). 
Benson and colleagues have developed a mapping approach that can accurately predict 
the organisation of visual cortex (primarily V1-V3) simply by registering anatomical data to 
the cortical surface atlas space (Benson et al., 2012).  We applied the Benson atlas 
(Benson et al., 2014) and restricted V1 based on eccentricity templates provided. 
Higher-level Visual Cortex: 
To find anatomical ROIs capturing face-selective and place-selective regions, we have 
incorporated both the Human Connectome Project Multi-modal parcellation version 1.0 
(HCP-MMP1.0 from Glasser et al., 2016) and used the version projected onto the 
FreeSurfer Average Surface Space (https://figshare.com/articles/HCP-
MMP1_0_projected_on_fsaverage/3498446). Recent attempts using architectural (myelin 
content, cortical thickness, cortical folding) as well as functional (task-based fMRI, 
functional connectivity) information to find areal boundaries in the ventral visual pathway 
have been consistent with previous work focusing on just one property of cortex - typically 
functional organisation principles. Including a multi-modal approach, the HCP have 
identified 180 areas per hemisphere. In the ventral visual stream, they have shown regions 





correspond with the two main clusters of activation in a face-based fMRI study; these aim 
to capture the functional regions - the fusiform face area (FFA) and the occipital face area 
(OFA). For the place-selective and peripheral biased representation, we used a 
parahippocampal place area (PPA) ROI generated by the Grill-Spector group in the 
FreeSurfer average surface space (http://vpnl.stanford.edu/PlaceSelectivity/). Consistent 
with the functional literature, this ROI was situated on the collateral sulcus (CS), medial to 
the mid fusiform sulcus (MFS). This ROI also was consistent with the parahippocampal 
parcels identified in the HCP-MMP1.0 (Weiner et al., 2018). All ROIs were converted from 
FreeSurfer average surface space to each individual subject’s native anatomical space 
and an example viewed on the inflated surface can be seen in Figure 5.2C.  
Figure 5.2. Regions of interest (ROIs) for one example participant, displayed on the 
FreeSurfer inflated cortical surface. A: Two V1 ROIs generated using the Benson Atlas, 
overlaid on the eccentricity map. B: The V1 ROIs in each hemisphere were divided in 
two – one portion capturing the central visual field (0-5deg) and one portion capturing 
the peripheral visual field (>5deg). C: Our higher-level visual ROIs shown on the ventral 





5.3.5.3 fMRI Preprocessing 
Functional MRI data were analysed using FEAT (FMRI Expert Analysis Tool) Version 5.0, 
part of FSL (FMRIB's Software Library, www.fmrib.ox.ac.uk/fsl). First, given than functional 
data acquired with EPI sequences are susceptible to distortions caused by 
inhomogeneities in the magnetic fields, field maps were prepared by applying FUGUE - an 
FSL toolbox (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FUGUE/Guide#SIEMENS_data). This 
process requires a magnitude image, phase image and the difference of echo times, which 
was 2.46ms for this protocol. Brain extraction was performed using BET (Smith, 2002) on 
the magnitude image to remove all non-brain voxels. It is important to get a conservative 
extraction, and so we eroded the image as an extra precaution. Examples of the various 
stages of analysis are shown in Figure 5.3. 
Preprocessing in FEAT FSL (Worsley, 2001) included standard procedures: motion 
correction using MCFLIRT (Jenkinson et al., 2002), brain extraction using BET (Smith, 
2002), grand-mean intensity normalisation, B0 unwarping (using field maps described 
above) and spatial smoothing (Gaussian kernel, 4mm (double voxel size) FWHM). The 
data were high pass filtered (gaussian-weighted least squares straight line fitting with 
sigma =50.0s) and registration to high resolution anatomical space was carried out using 
FLIRT (Jenkinson et al., 2002).  Nuisance regressors were included to help clean up the 
signal. This included six motion parameter estimates and noise from the white matter and 
ventricles; to do this, we calculated the mean time series from the white matter and 
ventricles, creating masks converted to functional space from the FreeSurfer parcellation 








Figure 5.3. Preparing and applying a field map to fMRI data. Top row: Example magnitude 
and phase images, and brain extracted magnitude image overlaid onto the original 
magnitude image. This shows how it has been ‘eroded’ to ensure all non-brain tissue is 
excluded from the mask. Second row: Processed field map. Light colours highlight regions 
with greater inhomogeneity of the magnetic field. Third row: Example fMRI data before 
applying B0 unwarping with the field map. Bottom row: Example fMRI after B0 unwarping. 






Given our ROIs are generated on the surface, we projected the functional data volume 
onto the cortical surface as well, using bbregister to generate the appropriate registration 
file (Greve & Fischl, 2009). 
5.3.5.4 Statistical Analysis 
For each participant, the mean time series was extracted for each ROI (central V1, 
peripheral V1, face area and place area), hemisphere and for each condition (eyes open 
and eyes closed). 8 correlations were calculated for each participant in total - 4 
correlations in each hemisphere. All correlations were transformed into Fisher’s Z scores 
before running statistical analyses. Given our hypotheses concerned within eccentricity 




Recruitment for the study terminated early due to the global pandemic and having only 
recruited 4 individuals for the peripheral vision loss group, we decided not to include them 
in the statistical analysis. Here we report some of the descriptive statistics for each 
hemisphere in turn. One of our hypotheses was that we would see reductions in functional 
connectivity for specific within-eccentricity correlations in each patient group. For central 
loss patients, we expected to see the central V1 – face correlations to drop, whereas for 
peripheral loss patients, we expected to see a decline for the peripheral V1 – place 
correlations. While we acknowledge the lateralisation of face processing, seen repeatedly 
in the right hemisphere, there were no expectations concerning hemisphere for place 
Figure 5.4. Example white matter and ventricle masks generated to remove noise from 
the functional data. The mean timeseries from each mask was calculated and included 





processing. Mean Fisher’s Z scores and corresponding SEM are shown in Tables 5.1 and 
5.2 for left and right hemispheres respectively.  
In the left hemisphere, it appears that on average, our two patient groups are more similar, 
with sighted controls exhibiting higher Z scores compared to both patient groups for the 
central V1 – face correlations, with central loss patients showing the lowest values in the 
eyes open condition. For the peripheral V1 – place correlations, on average our peripheral 
loss group has higher Z scores compared to sighted controls, and similar to central loss in 
the eyes closed condition, but lower in the eyes open condition. 
 
For the right hemisphere, a similar pattern emerges with the two patient groups showing 
similar results for the central V1 – face correlations, with a lower average Z score 
compared to sighted controls. In the peripheral V1 – place correlations, we again see 
greater values for the central loss group, and while the peripheral loss group mean is 
higher than that of controls, it is important to note the larger SEM for both conditions in the 
peripheral loss group. Inferential statistical analyses are required to determine if any group 
differences in the descriptive statistics reported above are meaningful. 
 
 
Table 5.1. Mean Fisher’s Z scores for within eccentricity correlations, with SEM shown in 
brackets. Results for the left hemisphere for all participant groups, for both conditions (eyes 
closed and eyes open).  
Table 5.2. Mean Fisher’s Z scores for within eccentricity correlations, with SEM shown in 
brackets. Results for the right hemisphere for all participant groups, for both conditions 





In Table 5.3 we report the Z scores for each individual peripheral loss patient, calculated 
using the mean Fisher’s Z scores and standard deviation for the sighted control group. We 
wanted to see if participants were indeed consistent. What we can see for both 
hemispheres is that the majority of the negative Z scores are reported for the central V1 - 
face correlations. This is interesting because our prediction was that we would observe 
this for the peripheral V1 - Place correlations instead. Possible reasons for this will be 
discussed later however, what we can see from Table 5.3 is that we do not have enough 
information to make any convincing conclusions, especially as RP4 seems to behave quite 
differently in the right hemisphere peripheral V1 - place correlations. 
 
We proceeded with a 2x2x2x2 mixed ANOVA to investigate effects of hemisphere (left vs 
right), condition (eyes open vs eyes closed), within eccentricity correlation (central V1 – 
face vs peripheral V1 – place) and group (sighted controls vs central loss). This highlighted 
a 4-way interaction between all of our factors listed above; F(1,19) = 4.946, p=.038, as well 
as an interaction between hemisphere and condition (F(1,19) = 36.284, p<.001) and main 
effects of hemisphere (F(1,19) = 34.859, p<.001) and condition (F(1,19) = 4.493, p=.047) 
as well. To investigate this further, we broke our analysis down into 4 separate 2x2 mixed 
ANOVAs to explore the results by hemisphere and condition separately. That way, we 
could determine if there were effects of within eccentricity correlation, or group for each 
condition and for each hemisphere. As mentioned previously, a functional lateralisation for 
face processing is also evident in the literature, whereby a bias for face processing is 
Table 5.3. Comparison of individual peripheral loss patients (labelled RP1-4) with the 
sighted control group data (mean fisher’s Z score with standard deviation shown in 
brackets). Z scores of the Fisher’s z transformed correlations were calculated to see how 





consistently shown in the right hemisphere (Kanwisher et al., 1997; McCarthy et al., 1997), 
warranting the separate analysis for each hemisphere. 
There were no significant main effects for correlated ROI or group, nor were there any 
interactions for either the eyes open (all p>.065) or eyes closed conditions (all p>.168) in 
the left hemisphere. For the right hemisphere, in the eyes closed condition we observed a 
correlated ROI x group interaction (F(1,19)=5.564, p=.029), but no main effect of either 
group or correlated ROI alone (both p>.174). For the eyes open condition in the right 
hemisphere, we observed a significant correlated ROI x group interaction again 
(F(1,19)=6.418, p=.020), a significant main effect of correlated ROI (F(1,19)=5.493, 
p=.030), but no significant main effect of group (F(1,19)=3.549, p=.078). Looking at Figure 
5.5 and Table 5.2 , the interaction between group and correlated ROI shows central loss 
patients have lower overall Z scores in the central V1 – face correlation, whereas groups 
are similar for the peripheral V1 – place correlation, with central loss patients showing a 
slightly higher mean Z score. This applied to both the eyes open and eyes closed 








Figure 5.5. Correlations transformed into Fisher’s Z scores. Each dot represents a single participant: white = sighted controls, grey = central 
loss. Top row: Results for the within eccentricity correlations for Eyes Closed condition. Bottom row: Results for within eccentricity 






One of the aims for this study was to explore how selective visual field deficits impact on 
functional connectivity within visual cortex, by examining specific connections between 
areas with similar eccentricity biases. We predicted that those with central vision loss 
would show a deficit in functional connectivity between the central visual field 
representation in primary visual cortex (V1) and the atlas-based ROI capturing the foveal 
biased and face-selective region in the ventral visual pathway. We also predicted the 
corresponding Peripheral V1 and place-selective, peripheral biased region medial to the 
mid fusiform gyrus (MFS) would remain unaffected, since this represents the portion of the 
visual largely intact in this patient group. For the peripheral loss group, we expected to see 
the reverse, with the peripheral V1 – place connectivity being most affected, and central 
V1 – face connections remaining intact.  
Kamps et al (2020) showed that functional connectivity seemed to precede visual 
experience in the developing brain, meaning that the connections between regions in 
visual cortex sharing the same eccentricity bias may be prewired. With this in mind, we 
have explored what happens to these well-established connections as a result of selective 
vision loss. For central vision loss at least, we have observed selective deficits in 
functional connectivity in the right hemisphere. The interaction observed between group 
and correlation was interesting; the central loss group showed a deficit in the central V1 – 
face area correlation as predicted, but for correlations between the peripheral V1 – place 
area, central loss patients were similar to the controls, and on average showed greater 
correlations. This supports findings from another resting state fMRI study which explored 
cortical entropy; greater cortical entropy was reported in a region named FG1 – situated 
medial to the MFS – in central loss patients compared to sighted controls (Sanda et al., 
2018). This appears to overlap with peripheral biased representations described in our 
study and may be situated on or near our PPA ROI. Interestingly, this study seems to 
highlight possible compensation in the peripheral representations in the absence of central 
vision. Furthermore, both behavioural and neuroimaging literature suggest that scene 
processing is relatively well preserved in cases of age-related macular degeneration 
(AMD) (Peyrin et al., 2017; Tran et al., 2010) and the functional connectivity results seems 
to support this, further demonstrating that deficits are largely selective in visual cortex in 
cases of selective central vision loss. This also lends support to the structural literature 
and results from Chapter 2, showing a greater preservation of structure in the calcarine 





capturing representation of the peripheral visual field – in individuals with macular disease 
(MD). In terms of compensation, continuing recruitment for this study would allow us to 
determine if patients show significantly greater functional connectivity between peripheral 
biased regions over time.  
Unfortunately, due to unforeseen circumstances recruitment was terminated early limiting 
the number of patients in the peripheral loss group.  In turn this made inferential statistical 
analyses largely irrelevant. It would be interesting to explore this hypothesis for a selective 
deficit further with a larger group of peripheral loss patients and determine if the reverse of 
what we observed in the central loss group could be observed, whereby peripheral V1 – 
place area correlations would be most affected in the peripheral loss group.  
Whilst we only can comment on the descriptive statistics of a small cohort, it is interesting 
to see that the central and peripheral loss groups were fairly similar in the central V1 – 
face area correlations and although central loss patients showed the greatest deficit, the 
peripheral loss group had, on average, lower correlations compared to sighted controls. If 
this result were to be observed on a much larger scale study, it could be explained by the 
fact peripheral loss patients had retinitis pigmentosa (RP) which while largely affects 
peripheral vision, in the much more advanced stages of the disease, this can impact on 
central vision too (Ferreira et al., 2017). Behavioural work has shown that even in patients 
with glaucoma, face processing is affected, despite preserved central vision (Friedman et 
al., 1999; Glen et al., 2012; Roux-Sibilon et al., 2018). In addition to behavioural deficits, a 
recent fMRI study exploring functional properties of V1 in advanced cases of RP 
highlighted a possible remapping of visual field representations in V1, whereby regions 
formally representing peripheral visual fields took on the role of processing remaining 
central vision (Ferreira et al., 2017). This finding has implications for the functional 
connectivity we are exploring in the current study; if this remapping has indeed occurred in 
some or all our participants, we may not see the expected deficit in peripheral V1 – place 
correlations. Assessing individuals with RP at different stages of the disease may help to 
tease apart when and if remapping of V1 is occurring, and in turn how this may impact on 
the functional connections we are investigating here. 
Previous work has also highlighted some interesting changes to connectivity within visual 
cortex that we have not explored for this study; another region of interest was the lateral 
occipital cortex (LOC) which is implicated in object and shape processing and is thought to 





functional localisers), similar findings emerged whereby more peripheral based 
representations in early visual cortex (not restricted to V1), showed greater connectivity 
with LOC in individuals with central vision loss as a result of Stargardt’s disease (Sabbah 
et al., 2017). Similarly, Sanda et al., (2018) found that central loss patients showed an 
increase in cortical entropy in area hOc4la (using probabilistic cytoarchitectonic maps – 
this is thought to correspond with the functionally defined regions LO2) compared to 
sighted controls. This suggests an increase in the synaptic complexity points in a region 
also associated with object and shape processing. Again, authors collectively suggest this 
could be a compensatory increase as a result of selective vision loss, increasing 
connectivity to maintain effective processing of objects and shapes.  
Determining how much resting state fMRI is affected by participant viewing conditions in 
partially sighted populations, as well as sighted controls was our second aim. The 
literature suggests asking participants to keep their eyes open is generally optimal, but this 
is in sighted populations (Patriat et al., 2013). Given potential fixation instability in partially 
sighted groups, for our ‘Eyes Open’ condition, we presented a large fixation cross 
occupying the full width and height of the screen to give participants a greater chance of 
finding something to fixate on. We predicted therefore that the biggest difference would 
emerge in our central loss group, since unstable viewing can lead to spontaneous 
activation, particularly in the visual network. Our results were very similar across eyes 
open and eyes closed conditions however, so in this particular cohort, it did not have a 
large effect. Despite little change, in order to guarantee spontaneous fluctuations are 
avoided, it seems opting to have participant’s eyes closed is the best choice. Other studies 
exploring resting state fMRI in partially or completely blind individuals (with a sighted 
control group) do often report having eyes closed and sometimes blindfold participants to 
reduce any light perception (Aguirre et al., 2017; Dai et al., 2013; Sanda et al., 2018).  
One issue in the way we recruited our participants was the fact we relied on volunteers to 
give us details of their visual impairment. An objective measure of the extent of the vision 
loss in both groups would have been ideal, acquired through visual field tests (perimetry or 
microperimetry). This could then guide our ROI selection and help refine it further. Having 
said this, Sabbah et al., (2017) also opted for a more general approach when selecting 
ROIs; their representations of early visual cortex were not restricted to V1, whereas ours 
were. For this study, we recruited participants through charities and sight loss support 
groups as opposed to through the NHS; given the time frame of the study and time needed 





very good connections with local organisations. Volunteers were asked about their 
diagnosis upon expressing interest in the study. While this is not the most desirable way of 
grouping our participants, it was the best solution during what became a short recruitment 
window. Going forward, any further work should include assessments of visual function to 
objectively measure the extent of vision loss in both groups and refine our V1 ROI 
definition.  
In the absence of functional localiser scans, atlases such as the HCP-MMP1.0 provide an 
opportunity for researchers to examine functional properties in ROIs that can be generated 
easily in all participants, simply relying on a FreeSurfer output directory. The multi-modal 
approach to creating this atlas has highlighted a remarkably consistent organisation in the 
functional representations of faces and places relative to the mid fusiform sulcus (MFS) is 
therefore meaningful and reliable (Glasser et al., 2016); the surface ROI for the PPA 
generated by Grill-Spector’s lab seemed to be aligned consistently with the collateral 
sulcus and medial to the MFS in all participants, and follow the cortical folding as predicted 
(Weiner et al., 2018). When time or funding is an issue and functional localisers are not 
possible, atlases prove to be an excellent resource. 
In addition to highlighting any pathological changes in the function of visual cortex 
associated with vision loss, resting state fMRI may also help us to understand why some 
patients go on to develop Charles Bonnet Syndrome (CBS), and why some do not. CBS is 
characterised by the experience of visual hallucinations in individuals with visual 
impairment. It affects people with various forms of vision loss, both central and peripheral, 
and occurs in the absence of any psychological illness (Santhouse, Howard, & Ffytche, 
2000). Approximately 50% of the visually impaired population experience hallucinations at 
some point in their lives, and experiences of it vary. For some, visual percepts are simple 
lines, patterns or geometric shapes of varying colours, while for others it can be more 
disturbing, featuring distorted and disembodied faces or figures in elaborate costumes 
(Santhouse et al., 2000). Alarmingly few people are aware of the condition, but once 
patients learn that what they are seeing is not real, the experience becomes significantly 
less distressing (Cox & Ffytche, 2014). Previous fMRI studies have shown that during 
active hallucinations, an increase in spontaneous activity is observed along the ventral 
visual stream; the content of the hallucinations determined which specific region showed a 
spike in percent signal change, for example perceiving colour elicited activation in area V4, 
whilst perceiving faces would elicit activity in the middle fusiform gyrus, in or around the 





visual cortex, further work examining the functional connectivity within visual cortex in 
those who do and those who do not experience CBS is important. In a recent study, a 
single case of CBS was compared against a group of sighted controls as well as late-blind 
subjects who did not report experiencing CBS; findings suggested changes in functional 
connectivity in the CBS patient, even when they were not actively hallucinating (Martial et 
al., 2019). Interestingly, the networks showing an increase in connectivity in the CBS 
patient compared to controls actually revealed a decrease in connectivity in the late-blind 
subjects; authors suggest this may link CBS to hyperactivity in the posterior visual pathway 
(Martial et al., 2019). Following how changes in function as well as structure link with CBS 
symptoms over time may help answer how and why some patients are affected by the 
condition. 
The advent of resting state fMRI has allowed for greater exploration of visual cortex in 
individuals with partial or complete vision loss (Nir, Hasson, Levy, Yeshurun, & Malach, 
2006). Assessing both the structure and function (both task based and resting state) of 
visual cortex in various forms of vision loss is important to understand how and when 
changes occur, which in turn will aid the efforts of visual restoration. It also provides 
another tool to help understand the relationship between structure and function in the 
posterior visual pathway; for example, whilst it is understood that the underlying 
architecture and retinotopic organisation in visual cortex remains intact even in cases of 
congenital vision loss, it does not mean that if vision were to be restored, that normal 
vision would be possible. Visual cortex has also elicited responses to other sensory 
modalities in congenitally blind cases, and so we do not know how visual cortex would 
respond if vision were restored. Similarly, CBS is another important consideration as 
described above, and understanding how it manifests may help to find ways of alleviating 
the symptoms, or at least manage them. Understanding why in some cases the condition 
resolves itself is also important. Finally, the differences observed in task based as well as 
resting state fMRI suggest functional properties are indeed altered in the absence of visual 
experience as well as in acquired or late-stage vision loss. The importance of 
understanding how and if reorganisation of visual function occurs in acquired vision loss 






Chapter 6: Assessing functional reorganization in visual cortex 
with simulated retinal lesions 
6.1 Abstract 
Macular degeneration (MD) causes central vision loss, removing input to corresponding 
representations in the primary visual cortex. There is disagreement concerning whether 
the cortical regions deprived of input can remain responsive, and the source of reported 
cortical responses is still debated. To simulate MD, normally sighted participants viewed a 
bright central disk to adapt the retina, creating a transient ‘retinal lesion’ during a functional 
MRI experiment. Participants viewed blocks of faces, scrambled faces, and uniform grey 
stimuli, either passively or whilst performing a one-back task. To assess the impact of the 
simulated lesion, participants repeated the paradigm using a more conventional mean 
luminance simulated scotoma without adaptation. Our results suggest our attempt to 
create a more realistic simulation of a lesion did not impact on responses in the 
representation of the simulated lesion. While most participants showed no evidence of 
stimulus-driven activation within the lesion representation, a few individuals (22%) 
exhibited responses similar to a participant with juvenile MD who completed the same 
paradigm (without adaptation). Reliability analysis showed that responses in the 
representation of the lesion were generally consistent irrespective of whether positive or 
negative. We provide some evidence that peripheral visual stimulation can also produce 
responses in central representations in normally sighted participants while performing a 
task. This suggests that the ‘signature of reorganization of visual processing’, is not found 
solely in patients with retinal lesions, consistent with the idea that activity may be driven by 






Macular degeneration (MD) is a progressive eye disease which causes the loss of vision in 
the central part of the visual field. Following degeneration of the retina, the corresponding 
representations in primary visual cortex (V1) are deprived of input. This has led to a 
number of studies exploring whether the region deprived of cortical input, known as the 
‘lesion projection zone’ (LPZ), might reorganise and take on a new role, processing inputs 
from intact retina (Baker et al., 2008, 2005; Baseler et al., 2011; Dilks et al., 2009; 
Hoffmann, Tolhurst, Moore, & Morland, 2003; Sunness et al., 2004)(C. I. Baker et al., 
2008, 2005; Baseler et al., 2011; Dilks et al., 2009; Hoffmann et al., 2003; Sunness et al., 
2004). Determining the source of any LPZ responses is important; if there is evidence of 
remapping, or a more permanent reorganization of visual processing, this could interfere 
with the success of visual restoration (Baseler et al., 2011; Morland, 2015). Successful 
visual perception can only occur if the parts of the visual brain which previously processed 
input from the macula remain available, and capable of processing new incoming 
information. However, there is debate concerning the state of visual cortex following visual 
loss, primarily within the LPZ (for a review, see: Brown et al., 2016). The inconsistency 
within the literature is partly attributed to differences in how cortical reorganization is 
defined, but also by what mechanism it occurs (Morland, 2015). Reorganization can refer 
to structural changes occurring in the brain following acquired or congenital eye disease, 
but more frequently, it refers to functional changes, whereby patterns of neural activation 
differ from those observed in healthy individuals. For this study, reorganization refers to 
patterns of activity within the LPZ that cannot be explained by (a) known properties of the 
visual system and (b) the absence of visual input (Engel, Morland, & Haak, 2015; Morland, 
2015). 
Irrespective of the way in which reorganization is defined, there is also considerable 
variation in the proportion of patients that exhibit fMRI responses in the LPZ; estimates 
vary from zero to approximately 50% (Morland, 2015).  Given this variability, we sought to 
determine whether this property is unique to patients, or whether similar response 
variability can also be found in a sample of individual sighted participants using a 
simulated LPZ. 
A common approach to determining if reorganization occurs is to measure responses in 
the LPZ. In cases of congenital visual loss, e.g. rod achromats who have a small central 
scotoma from birth, there is evidence of remapping of visual inputs (Baseler et al., 2002).  





stimuli presented to intact peripheral visual field are frequently taken as a signature of 
reorganization of visual processing in MD (Baker et al., 2008, 2005).  However, the 
mechanism underlying LPZ responses remains unknown. Furthermore, some studies 
report an absence of any positive responses in the LPZ, suggesting cortical reorganization 
does not occur in MD (Baseler et al., 2011; Smirnakis et al., 2005; Sunness et al., 2004). 
One interpretation is that the LPZ starts to process information from the intact peripheral 
visual field not previously represented by this region of cortex (Baker et al., 2008, 2005; 
Dilks et al., 2009, 2014). An alternative view is that the signals observed in the LPZ reflect 
normal feedback to V1 from extrastriate areas, unmasked in partially blind individuals 
when engaged in a task (Masuda et al., 2008, 2010).  Further evidence for the role of 
feedback mechanisms is provided in sighted individuals; when naturalistic scenes are 
partially occluded, stimulus-related information can be decoded in the unstimulated visual 
cortex which represents the occluded visual field (Petro, Vizioli, & Muckli, 2014; Smith & 
Muckli, 2010; Williams et al., 2008).  It appears therefore that even in normally sighted 
participants, there is evidence of feedback in fMRI signals, although they are revealed in a 
consistent pattern of responses across voxels, rather than in a univariate increase in mean 
signal as found in patients. 
Given that evidence of feedback to V1 can be found in sighted participants we asked 
whether it could be unmasked in univariate responses in V1.  To answer this question, we 
used a more realistic simulation of a retinal lesion in normally sighted participants and 
measured their responses in V1’s representation of the simulated lesion, the ‘sLPZ’. 
Masuda and colleagues (2008) speculated that the sLPZ signals are not observed in 
sighted participants because retinal aftereffects signalled the presence of a uniform grey 
region, the ‘simulated lesion’. Therefore, we simulated the loss of central vision 
physiologically, not by manipulating the viewed images, but instead by temporarily (and 
reversibly) compromising photoreceptor function in the macula in normally sighted 
individuals. We had participants adapt to a bright white disk, saturating signals from the 
eye and ensuring the simulated ‘lesion’ was in retinal coordinates, irrespective of eye 
movements.  We reasoned that by making visual stimuli that were presented in the 
periphery also undetectable in the adapted region, we might unmask influences of cortical 
feedback on the mean signal measured in this simulated sLPZ.  We hypothesised that 
under conditions of bright light adaptation of the macular, we would detect signals in the 
sLPZ, which would be absent when normally sighted participants viewed stimuli without 





passive viewing conditions, predicting that signals would be more likely to emerge under 
the stimulus-related task condition as found previously in patients (Masuda et al., 2008).  
Finally, we asked whether responses in the sLPZ (sighted participants) and LPZ (patient) 
were consistent within individuals, or simply spurious or due to random chance. To do this 
we repeated our fMRI acquisitions for each condition, and for each participant assessed 
the average univariate response and its reliability across repeated acquisitions.   These 
data allowed us to gauge whether the responses we obtained from a patient with 
longstanding loss of macula vision were similar in scale and reliability to those we obtained 
from sighted participants. 
6.3 Methods 
6.3.1 Participants 
Eleven participants were recruited for the current study; 10 normally sighted participants (4 
males; ages 23 – 37, average age = 26.8 years) and one participant with Juvenile Macular 
Degeneration (Referred to as JMD throughout, male, aged 40 years). JMD was diagnosed 
with Stargardt’s disease, an inherited progressive disease, at 17 years old. JMD has 
bilateral absolute central scotomata (approximately 18 x 20 degrees of visual angle) and 
uses a preferred retinal locus (PRL) in the lower left visual field (fixating using an upper 
right retinal location at the edge of the scotoma). A visual representation of the scotoma, 
PRL and location of the stimulus is shown in Figure 6.1A. All participants participated in 
fMRI experiments, but JMD also completed an additional behavioural experiment and 
visual assessments at York Teaching Hospital. Written consent was obtained for all 
participants and the study was approved by the York Neuroimaging Centre ethics 
committee in accordance with the Declaration of Helsinki. 
6.3.2 Imaging Parameters 
Scanning was performed at the University of York Neuroimaging Centre using a GE 3 
Tesla HDx Excite MRI scanner.  
6.3.2.1 Structural MRI 
One high-resolution 3D T1-weighted, Fast Spoiled Gradient Echo pulse sequence 
(FSPGR) anatomical image was acquired (TR = 7.8ms, TE = 2.9ms, TI = 450ms, voxel 
size = 1.13 x 1.13 x 1mm3, flip angle = 20°, matrix size 256 x 256 x 176, FOV = 290mm) 
using the 8-channel whole head High Resolution Brain Array coil. Three T1-weighted 
anatomical images were acquired for each participant (TR = 7.8ms, TE = 3.0ms, TI = 





256mm) using a 16-channel Posterior Brain Array coil. One T2*-weighted fast gradient 
recalled echo scan was acquired (TR = 400ms, TE = 4.3ms, voxel size = 1 x 1 x 2mm3, flip 
angle = 25°, matrix size 128 x 128, FOV = 260mm) using the 16-channel coil. Finally, an 
axial proton density scan was also acquired during the functional MRI experimental 
session using the 16-channel coil and the same slice prescription to aid alignment 
between functional and high-resolution structural data (TR = 2700ms, TE = 34.84ms, voxel 
size = 1 x 1 x 2mm, flip angle = 90°, matrix size 192 x 192 x 39, FOV = 192mm). 
6.3.2.2 Functional MRI 
All functional data were acquired on the 16-channel coil to improve the signal-to-noise in 
the occipital lobe. TR = 3000ms, TE = 30ms, voxel size = 2 x 2 x 2mm3, flip angle = 90°, 
matrix size 96 x 96 x 39, FOV = 192mm. Data were acquired using a slice prescription with 
coverage including occipital and temporal lobes.  
6.3.3 Stimulus generation 
Stimuli were presented using a ProPixx LED projector (VPixx Technologies, Saint-Bruno, 
CA) and were rear-projected onto a textured screen in the bore of the MRI scanner, which 
could be viewed on the screen via a mirror attached to the head coil. To monitor 
participants’ fixation stability, we used an eye tracker to record a video of the eye, allowing 
us to monitor eye movements in real time throughout the experiment 
(https://www.crsltd.com/tools-for-functional-imaging/mr-safe-eye-tracking-for-fmri/livetrack-
fmri/).  
PNG images of faces were processed in MATLAB (Mathworks). First, all images were 
converted to greyscale with flattened histograms, to control greyscale ranges across 
images. Following this, the mean luminance value of each image was set to 705cdm-2 so 
that they would be undetectable in regions of the retina that were adapted to bright light of 
~15000cdm-2. All images were rescaled to take up 50% of a 400 x 400-pixel size stimulus. 
Finally, all images were placed on a dark grey background matching mean luminance of 
the images.  
To scramble the faces, each image was divided into a 20 x 20 square grid and each 
square was randomly shuffled through +/-90deg or 180deg. Finally, we applied a slight 
blurring to the intact and the scrambled images with a Gaussian filter (SD = 1px) to soften 





6.3.3.1 JMD behavioural test 
We devised a short behavioural experiment to confirm the location of JMD’s PRL. Stimuli 
(mean size was ~7 x 9° of visual angle) comprised greyscale faces, scrambled faces, 
objects, and control trials containing no stimuli. Stimuli were presented for 800ms, 
appearing in any quadrant of the visual field, or in the centre of the screen. JMD was given 
an auditory cue when a stimulus was presented and was asked the following: (1) Did you 
see anything? (2) If yes, where was the stimulus? (3) Can you describe what the stimulus 
was? There were 40 trials (10 for each stimulus condition). 
6.3.3.2 High light level adaptation experiment 
Red fixation lines were centred vertically and horizontally, occupying 20 degrees of visual 
angle, to aid central fixation in the absence of an explicit central fixation marker (Figure 
6.1B). During the ‘adaptation’ period, a white disk (12deg diameter, 15000cdm-2) was 
overlaid on the fixation lines. Previous work allowed us to estimate the level needed and to 
justify safe recovery after bleaching and 15000cdm-2 was the maximum we could achieve 
with the MRI projector and screen (Czeh, Casper, & Segraves, 1965; Stockman & Sharpe, 
2006). In control blocks, the circle changed to uniform dark grey (mean luminance: 
705cdm-2) to match the background. For all functional runs, the size of the adaptation 
circle, red fixation lines, and position of the stimulus remained the same. The size of 
individual face and scrambled stimuli varied slightly; the mean size was ~7 x 9° of visual 
angle. Images were positioned 10° of visual angle from the centre of the screen to the 
centre of the image. For sighted participants, stimuli were presented in the upper right 
quadrant of the visual field, abutting the edge of the adapted circle (Figure 6.1B). For JMD, 
they were presented in the lower left quadrant, corresponding with the PRL. Position 
differed due to JMD being recruited after the control participants.  
6.3.3.3 Retinotopic Mapping 
The travelling-wave method was used to acquire retinotopic maps to locate V1 in control 
participants (Engel, Glover, & Wandell, 1997). Stimuli were presented binocularly and 
consisted of high contrast (>98%, mean luminance = 400cdm-2) expanding checkerboard 
rings and 90° wedges rotating anti-clockwise. All checkerboards reversed at a rate of 6Hz. 
Stimuli were presented on a grey background (200cdm-2) with a red central fixation cross, 
traversing a circular region of radius 14.34deg.  Each cycle lasted 36 seconds, with 8 





6.3.3.4 LPZ and stimulus localiser 
For sighted participants, a central radial checkerboard (12deg diameter, reversal rate = 6 
Hz) was presented for 12 seconds, followed by a peripheral checkerboard annulus (radius 
extending from 6deg to 15deg radius) also presented for 12 seconds (Figure 6.1C, upper 
panel). This cycle was repeated 8 times to localise the representation of the simulated 
lesion.  Using a similar paradigm, we used checkerboard stimuli to localise the region 
representing the stimulus (Figure 6.1C, lower panel). We isolated the region where the 
stimuli were presented (upper right quadrant) and alternated between a flickering 
checkerboard occupying this region and the surrounding region. For JMD, the same 
paradigm was used, however instead of a central radial checkerboard, a full field 
checkerboard alternated with uniform grey (mean luminance = 200cdm-2). For all 
participants, stimuli were presented monocularly to the dominant eye only. Dominant eye 
was determined by having participants point to a corner of a room, then close each eye in 
turn and state during which interval their finger was closest to the corner.  
6.3.4 Experimental design 
Control participants completed three scanning sessions: one structural and two functional 
sessions, which included sLPZ/stimulus localiser scans and main functional scans (one 
with and one without the ‘adaptation’ disk). JMD completed two sessions: one structural 
and one functional session including LPZ localiser and main functional experiment without 
adaptation.  
6.3.4.1 MRI protocol for lesion simulations and control conditions 
All functional scans were completed under monocular viewing conditions, testing the 
dominant eye only. For each experiment (adaptation and no adaptation), all participants 
completed four functional runs; two passive viewing and two runs during which participants 
completed a one-back task. For the one-back tasks, participants were instructed to press a 
button when an image matched the previous one. For experiment 1, which included the 
‘adaptation’ disk, each of the 4 functional runs were preceded by a 180 second adaptation 
period, followed by 12 stimulus blocks (4 blocks of each stimulus category: faces, 
scrambled faces and uniform grey control blocks, block duration = 6 seconds) interleaved 
with 11 top up adaptation blocks (18 seconds). See Figure 6.1B for further details. 
Stimulus blocks were presented in a pseudorandom order whereby each functional run 
had blocks presented in a different order, but the same four order sequences were 
presented to each participant.  Six stimuli were presented per block (presented for 800ms, 





of the scan to allow us to capture the full hemodynamic response to the last stimulus. 
Participants were instructed to fixate centrally, where they perceived the red fixation lines 
to intersect. For experiment 2, the same procedures were used, but the initial adaptation 
period was reduced to 18 seconds and the white central disk was changed to uniform 
grey.  This experiment served as a control condition, replicating the conventional simulated 
lesions used in previous research (Baker et al., 2008, 2005; Baseler et al., 2011; Masuda 
et al., 2008) to contrast with our new approach that attempted to simulate a retinal lesion 
with adaptation.  Top-up adaptation intervals were replaced with a uniform grey disk to 
keep the timings of the functional runs consistent with experiment 1.  
JMD also completed 4 functional runs consistent with experiment 2, the ‘no adaptation’ 
paradigm. Given JMD has a PRL in the lower left visual field, the stimuli were positioned in 
the lower left quadrant. The red fixation lines were expanded to be the full width/height of 



















Figure 6.1. A: Schematic of JMD’s central scotoma in the right eye. Preferred retinal locus (PRL) located in the lower left visual field, so stimuli were 
positioned here. The patient’s scotoma was absolute, meaning no stimulus could be detected within the defined region. Only the right eye was tested in the 
functional MRI experiment. B: Schematic of main functional experiment (controls). Each run began with 180 second adaptation period; participants fixated 
centrally, using the red lines as a guide. 12 test blocks (6 seconds, comprising of either faces, scrambled faces or uniform grey) were presented, interleaved 
with top-up adaptation blocks (18seconds) to ensure adaptation was maintained. Each stimulus (faces or scrambled faces) were presented in the upper right 
quadrant of the visual field for 800ms, ISI of 200ms. For the first 2 runs, participants passively viewed the stimuli. For the last 2 runs, participants completed a 
one-back task. Participants were given a response box and were asked to indicate when an image was repeated by pressing a button. Each functional run 
lasted 7minutes 48seconds. For illustrative purposes, the RGB values are not the same as used in the experiment as images were too dark and very low 






6.3.5.1 Anatomical data 
Three high resolution T1 isotropic images were aligned and then averaged. This average 
was then divided by the T2* weighted data to correct for the gradient inhomogeneity 
caused by the 16-channel half head coil, and to improve the grey-white contrast. 
FreeSurfer software (http://surfer.nmr.mgh.harvard.edu/) was used to perform automatic 
segmentation of the averaged haem-corrected T1 scan. All automated segmentations 
were checked for quality and correctness and manual corrections were then performed 
where necessary to remove handles and bridges and fix poorly segmented white matter, 
using itkGrey software (https://web.stanford.edu/group/vista/cgi-
bin/wiki/index.php/ItkGrey). 
6.3.5.2 Retinotopic mapping: 
For our sighted participants, we used the standard travelling wave method to analyse data 
using mrVista (http://web.stanford.edu/group/vista/cgi-bin/wiki/index/php/MrVista, Engel et 
al., 1997; Wandell, Dumoulin, & Brewer, 2007). The first 3 volumes were removed to 
minimize the effects of magnetic saturation. Between- and within-scan motion correction 
was applied. Data were aligned to the high-resolution T1-weighted image, and to reduce 
noise we averaged across wedge scans and across ring scans (Vernon et al., 2016). An 8-
cycle sine wave was applied to each voxel in turn; the phase with the best fit was assigned 
to each voxel. Retinotopic maps were viewed on inflated cortical surfaces which were 
constrained to grey matter.  The region of interest (ROI) V1 was manually drawn on the 
partially inflated cortical surfaces derived from the grey/white brain segmentation created 
using ‘mrMesh’ (part of the mrVista software package). ROIs were drawn using mrVista, 
using phase reversals to identify boundaries. 
6.3.5.3 LPZ localiser Analysis 
Individual participant fMRI data were analysed using FEAT (FMRI Expert Analysis Tool 
v4.1; Worsley, 2001). The first 3 volumes were removed, the high-pass filter cut-off point 
was 100sec (correcting for low frequency drift), FILM prewhitening and spatial smoothing 
(Gaussian kernel with 5mm FWHM spatial smoothing) were used, and motion was 
corrected for (motion parameters were also entered as confound covariates). Stimuli were 
entered as an explanatory variable, convolved with a gamma hemodynamic response 
function (HRF), and contrasts were run to compare stimuli to baseline. This allowed us to 
isolate responses to the central 12degree stimulus, and the surrounding annulus. We also 





as they can be an additional source of noise (Gouws et al., 2014). Data were cluster 
corrected (Z>2.3, p<0.05) and were registered to the high-resolution structural space, 
using the axial proton density scan to aid alignments. 
6.3.5.4 High light level adaptation experiment analysis 
Upon initial analysis we identified artefacts in some participants (including JMD) around 
the sagittal sinus and took additional measures to remove them and applied these steps to 
all participants. Functional data were first motion corrected. We then took the cumulative 
sum of absolute differences (CSAD) across volumes within a functional run in each 
participant. We then converted these values to Z scores. We reasoned that as fluid flow 
within the sagittal sinus would elicit rapid changes across volumes leading to larger CSAD 
values, any voxels with a CSAD value greater than 3 standard deviations should be 
excluded (de Zwart et al., 2005; Olman, Inati, & Heeger, 2007).   
The remaining first level analyses were the same as for the LPZ localiser. The first 60 
volumes from the adaptation runs were removed as this constituted the initial adaptation 
period. For experiment 2 (no-adaptation condition), the first 6 volumes were removed. We 
used spatial smoothing (Gaussian kernel with 4mm FWHM spatial smoothing) for both 
experiments. All three stimulus conditions were entered as separate explanatory variables 
(EVs), convolved with a double-gamma HRF, and two contrasts were run: faces versus 
control blocks, scrambled faces versus control blocks. This allowed us to isolate any 
possible effects of stimuli. Individual participant data were entered into a higher-level group 
analysis. The two task runs were combined, as were two passive runs for each participant 
using fixed-effects analysis with cluster correction (Z>2.3, p<.050).  
6.3.5.5 ROI Analysis 
V1 ROIs for all control participants were restricted to central and peripheral 
representations, using LPZ localiser data. Each participant therefore had an sLPZ ROI and 
surround (not used in subsequent analyses) in the hemisphere contralateral to the visual 
field where stimuli were presented. We also had a stimulus representation ROI for each 
control participant, derived in a similar manner using the stimulus localiser (see Figure 6.1, 
lower panel in part C). Due to the poor quality LPZ localiser data, we drew anatomical 
ROIs for JMD on the surface - one for the LPZ, and the other the remaining V1 (including 
stimulated and unstimulated peripheral representations). All ROI analysis was performed 
at the individual level using FSL’s FEATquery. This was applied to the COPE (contrast of 





mean percent signal change. This gave us a measure of mean response to each stimulus 
type and task condition in each ROI.  
6.3.5.6 Data Visualisation 
For each participant, a partially inflated surface derived from the grey/white brain 
segmentation was created using ‘mrMesh’ (part of the mrVista software package), and 
functional data (thresholded zstat images from FSL) were imported as parameter maps 
into mrVista to view on the inflated surface with ROIs. 
6.3.5.7 Reliability Analysis 
To interrogate the reliability of responses across functional runs for each viewing condition, 
multivoxel pattern analysis was used to characterise the pattern of responses across 
voxels within the LPZ, which were then correlated across two runs using Pearson’s R.  
Values were subsequently converted into Fisher Z scores to ensure data were normally 
distributed. Each participant had four reliability scores: Faces with task, faces with passive 
viewing, scrambled faces with task, scrambled faces with passive viewing.  
6.3.5.8 Classifier Analysis 
We used the two measures from our fMRI data, response amplitude and the reliability of 
the response, to classify responses into two categories - those associated with the 
unstimulated LPZ or the stimulus representation. We applied linear discriminant analysis 
with leave one out cross-validation to train the classifier on adaptation and no-adaptation 
control data separately. Once the classifier had been trained on all of the control data, we 
applied it to JMD’s data to establish whether the responses from his LPZ were best 
categorized as those originating from the LPZ or stimulus representation; exploring 






6.4.1 Individual LPZ BOLD 
responses 
Given that stimuli were presented 
monocularly and appeared in one 
hemifield (right for sighted 
participants, left for JMD), we only 
report data from the left hemisphere 
in sighted participants, and the right 
hemisphere in JMD. This approach 
is consistent with that used by other 
researchers (Baker et al., 2005). In 
Figure 6.2 we provide thresholded 
statistical maps illustrating 
responses in the LPZ in JMD and 
three representative sighted 
participants, to highlight the 
variability in response patterns 
across individuals. When completing 
a task, JMD exhibited an increase in 
LPZ responses particularly when 
viewing faces (Figure 6.2). Whilst a 
slight increase is also observed 
when completing a task with 
scrambled faces, this effect was not 
as strong. JMD clearly shows a 
marked increase in BOLD in percent 
signal change within the LPZ in both 
experiments, typically taken as a 
signature of reorganisation of 
function. Sighted participant 1 
behaves in a similar manner to JMD, 
exhibiting a task-related response to 
faces (z>2.3, p<.05). Sighted 
Figure 6.2. Examples of univariate responses to face 
stimuli on the inflated cortical surface for JMD (A) and 3 
sighted participants (B) under two viewing conditions: 
task, no task. JMD data presented are from the right 
hemisphere and have been flipped for visualisation 
purposes. Data presented were obtained during 
adaptation (Sighted 2 and 3) and no adaptation (JMD and 
sighted 1).  Data presented were obtained when sighted 
participants adapted to a bright light over the macula.  Bar 
graphs illustrate thresholded z statistics to faces under 
task (black bars) and passive viewing (grey bars) 





participant 2 shows no marked increase or decrease in LPZ responses across all stimulus 
and task conditions. Finally, sighted participant 3 shows a large amount of negative BOLD 
for all stimulus and task conditions in terms of amplitude.  
As patient studies focus on individual data, we plotted the percent signal change for each 
individual participant (coloured dots in Figure 6.3) for both adaptation and no adaptation 
experiments. Data for the sighted participants show that all individuals exhibit positive 
univariate responses in the cortical representation of the stimulus (irrespective of whether 
the stimuli were intact or scrambled faces – Figure 6.3 A&D). There is also a hint that a 
stimulus-related task may enhance these stimulus-driven responses (shaded bars are 
greater than open bars in three of the four conditions). The individual sighted participant 
responses from the sLPZ are distributed around a mean that is close to zero in all 
conditions.  However, there are individuals that exhibited relatively large positive univariate 
responses in the sLPZ (Figure 6.3 B&E).  Indeed, some of the sighted participant 
responses are as large as or exceed those found in the LPZ of JMD, who had visual loss. 
The patient, JMD, exhibits consistent positive responses in the LPZ that also appear to be 
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Figure 6.3. Summary statistics for sighted participants (A,B,D,E) and JMD (C,F), for faces (A-C) and scrambled faces (D-F) under two viewing conditions: 
task (shaded bars), no task (open bars). Sighted group average for adaptation and no adaptation for each ROI are represented by the bars – stimulus 
representation (A and D, lower bank of the calcarine, anterior to the sLPZ) and the simulated LPZ (B and E). Each sighted individual is represented by a 





6.4.2 Group BOLD Responses 
6.4.2.1 LPZ 
We analysed the sighted group LPZ responses using a 2x2x2 (adaptation x task x 
stimulus) repeated measures ANOVA which confirmed there was no significant main effect 
of adaptation , F(1,9) = 0.003, p=.957, stimulus type, F(1,9) = 0.187, p=.676 or task 
condition, F(1,9) = 0.328, p=.581. Therefore, our hypothesis that a more realistic 
simulation of the retinal lesion would unmask feedback is not supported.  We were also 
unable to detect any effect of task on responses that has previously been observed in the 
LPZ responses from patients. It is possible that responses could emerge as a result of 
adapting and performing a task which would be highlighted by an adaptation by task 
interaction.  This two-way interaction was however not significant (F(1,9) = 3.67, p=.088). 
The results of this analysis are consistent with, but do not explicitly test for an absence of a 
positive mean univariate response in the sLPZ. To address this, we ran a series of one-
sample t-tests – one for each condition - to assess whether we observe positive responses 
significantly above zero. For the sLPZ, there were no significant positive responses for any 
combination of adaptation, stimulus, or task (t(9) ranged from -1.80 to 1.38, all p>.105). 
One result was significant (adaptation, scrambled faces, task), but this was a negative 
response in the sLPZ, indicative of an increase in negative BOLD (t(9) = -2.958, p=.016).  
6.4.2.2 Stimulus Representation 
The same ANOVA approach as described above was used to investigate the responses 
obtained from the stimulus representation in sighted participants.  In this case, there was a 
significant main effect of adaptation on responses, F(1,9) = 22.03, p=.001, but no main 
effect of stimulus type, F(1,9) = 3.38, p=.099 or task, F(1,9) = 2.947, p=.120. While not 
reaching significance with an ANOVA, the one-tailed trend for larger responses elicited 
during a stimulus related task (p=.060) and for scrambled images (p=.050) are consistent 
with previous research.  The plausible two-way interaction between adaptation and task 
was not significant (F(1,9) = 4.00, p=.076). To be consistent with the approach taken 
above, we also ran a series of one-sample t-tests to determine whether responses in the 
stimulus representation were significantly different from zero (in the positive direction). As 
expected, all combinations of adaptation, stimulus type and task emerged as significant in 
the positive direction (t(9) ranged from 10.14 to 19.30, all p<.001).  
6.4.3 Reliability analysis 
Thus far we have examined the mean of the sighted group responses, which shows no 





participants exhibit responses in the sLPZ that exceed those responses from the JMD 
patient. To interrogate the reliability of the individual responses from the LPZ, patterns of 
response across voxels within the LPZ were correlated across experimental runs within 
each condition, for example run 1 no task with run 2 no task for faces. The reliability 
measure (correlation converted to a Fisher Z score) was plotted against the percent signal 
change observed in the univariate analysis (Figure 6.4). Results for the sLPZ indicate 
patterns of responses within individuals were more reliable across runs than expected by 
chance as indicated by the generally positive Z scores (blue data points in Figure 6.4).  
This contrasts with the distribution of the univariate response across the group being 
centred on zero (on the vertical axis). The responses from the stimulus representation of 
sighted participants are both largely reliable and have a positive mean.   
Data for JMD lie on the fringe of the data ‘cloud’ consisting of all sighted participant data 
points for the sLPZ (JMD represented by black markers in Figure 6.4). Two data points 
represent task conditions for each stimulus type and two represent passive viewing of the 
same stimuli. The two most reliable responses are for the stimulus-related task, closely 
followed by the passive viewing of faces, with passive viewing of scrambled faces 
appearing least reliable.  It is also true that by lying on the fringe of the distribution of 
sighted participant data originating from LPZ responses, JMD’s data also lie near the 
fringe of the distribution of control data originating from the responses from stimulus 
representation.  In the case of the patient therefore it is a challenge to categorise the 
responses from the LPZ as being consistent with either responses from the sLPZ or the 







6.4.4 Classifier analysis 
We combined the measures of amplitude and reliability to categorise responses in sighted 
participants. Using the leave one out cross-validation method, the linear discriminant 
analysis classified responses in the adaptation experiment as coming from the 
unstimulated zone (LPZ) and stimulus representation with 93.75% accuracy. For the no-
adaptation condition, accuracy reached 98.75%. The LDA classifier trained on adaptation 
data for sighted participants, classified JMD responses as most comparable to the 
responses originating from the stimulus representation of sighted participants (3 of the 4 
data points classified as stimulus representation). However, an LDA trained on no-
adaptation data classified the same JMD responses as being most comparable to the 
unstimulated zone (LPZ) in sighted participants (all 4 data were classified as originating 
from the sLPZ). This supports data shown in Figure 6.4, illustrating that JMD responses 
fall largely within the 95% confidence intervals for the stimulus representation data in the 
adaptation condition, and all fall within 95% confidence intervals for the sLPZ for the no-
adaptation condition. 
Figure 6.4. Reliability analysis: Scatterplots showing all data for all stimuli and viewing conditions 
(faces, scrambled faces, task, no task). Data from the bleaching experiment (left) and no 
bleaching (right) are plotted for both the LPZ (blue) and stimulus representation (orange) ROIs.  
Reliability measure (transformed to a Fisher Z score, with positive numbers indicating more 
reliable responses) is plotted against the univariate response, measured in percent signal change. 
Ellipses represent 95% confidence intervals. Despite the difference in the polarity of the 
responses in the sLPZ, responses seem largely reliable. JMD results (black) lie on the fringe of 






Our overall aim was to determine whether an fMRI signature of reorganisation of visual 
processing is unique to patients with retinal lesions or whether they can be detected in 
normally sighted individuals. To explore this, we asked whether we could (a) create a more 
realistic simulation of a retinal lesion that might unmask responses in the simulated LPZ, 
and (b) assess signals in the sLPZ under different viewing conditions (task vs passive 
viewing). We predicted that signals would be more likely to emerge during stimulus-related 
task conditions. Our results suggest that our attempt to create a more realistic simulation 
of a retinal lesion did not alter responses in the sLPZ. Additionally, whilst at the group level 
sighted participants did not mimic the LPZ response of a patient with retinal lesions, an 
fMRI signature of reorganisation of visual processing can be observed in some, but not all, 
normally sighted individuals.  Given that only a minority of patients display responses in 
the LPZ too (Morland, 2015), careful consideration of evidence for reorganisation from LPZ 
signals is required.  
We examined the sighted participants on an individual basis to be consistent with case / 
case series studies reported in the literature. Some sighted participants responded in a 
similar manner to JMD showing task-related modulations of positive responses in the 
sLPZ. These results are consistent with those reported by Masuda and colleagues, who 
found some patients exhibited the same task-related modulations of signals from the LPZ 
for visual, tactile and auditory stimuli (Masuda et al., 2008, 2010, 2021). The JMD patient 
we tested, therefore, exhibited the hallmark of reorganisation of visual processing that has 
been detected in many studies, but not all patients (Baker et al., 2008, 2005; Dilks et al., 
2014).  At the same time, however, the same signature of reorganisation of visual 
processing could be detected in individual sighted participants. The number of these 
sighted participants (22%) falls within the number of patients also showing sLPZ 
responses in the literature - between 0% and 50% (Morland, 2015). Therefore, responses 
in the LPZ may not be unique to patients. Our reliability analysis revealed that signals from 
the sLPZ of sighted participants are not random, and that some sighted participants 
exhibited responses from the sLPZ that were as large and reliable as those found in the 
patient. 
Further to this, we analysed our sighted participants as a group which revealed a 
distribution of the univariate response that are centred around zero in the sLPZ for both 
adaptation and no-adaptation conditions, therefore suggesting that responses in the sLPZ 





regard to our aim to create a more realistic simulation of a retinal lesion, signals from the 
sLPZ were no greater when participants adapted to a bright light presented to the macula 
than when no adaptation occurred.  Our second prediction that a stimulus related task 
could plausibly enhance signals from the sLPZ, particularly during adaptation conditions 
was also not supported by our results from sighted participants. Given previous work has 
focused on case / case series, it is clear that if group averages were computed for the 
patients assessed by Baker et al., (2005, 2008), Dilks et al., (2009), Masuda et al., (2008), 
a better assessment of the effect could be achieved. This highlights the need to shift from 
case and case series approaches to group studies. In an earlier group study, we found no 
evidence of responses in the LPZ of patients (Baseler et al., 2011), but it is noted that the 
stimulus and task conditions did not reproduce those used in studies that have detected 
responses in the LPZ (Baker et al., 2008, 2005; Dilks et al., 2009, 2014). 
 
Our motivation to examine adaptation came from the framework put forward by Masuda et 
al. 2008 to explain signals in the LPZ of patients.  They proposed that feedback was the 
source of responses in V1 and that in the absence of incoming signals to V1 from the 
retina, the feedback registered a significant positive response in V1’s LPZ. Further, they 
reasoned that feedback to V1 would not register as a signal in the sLPZ of sighted 
participants because the retina would be signalling the presence of a zero contrast within 
the macula to V1, effectively cancelling out the feedback signals to V1. Our approach 
therefore was to assess the effect of dissociating macula signals to V1 from signals that 
would encode the stimulus.  We did this by adapting the macula to bright light such that no 
stimulus contrast, whether it was zero or greater could be relayed to V1. Potentially, this 
adaptation could unmask, in sighted participants, the feedback signals that V1 receives.  
Our results however did not highlight an average positive response in the sLPZ during 
adaptation or during no adaptation and no significant differences between the signals from 
each condition emerged.  The second aspect of Masuda et al’s framework is that signals in 
the LPZ emerge only during a stimulus-related task, again consistent with the feedback 
hypothesis. We tested therefore whether an interaction with task and adaptation might 
underpin our results but found it did not.   
The lack of a positive shift in the group mean of LPZ signals in the adaptation condition 
could indicate that the adaptation we used, while a better simulation of retinal lesions, did 
not match closely enough the total absence of retinal signalling found in patients. If that 





proposed by Masuda et al could still take place. Consistent with the presence of retinal 
signalling after adaptation was the report from participants of a strong visible afterimage 
with a sharp boundary.  Our adaptation approach therefore can be thought of as saturating 
retinal stimulation rather than removing it.  Our work contributes to the literature in so far 
as it shows that another manipulation to the experimental approach results in no 
detectable change in sLPZ responses at the group level.  It is now established therefore 
that the use of a black (Lerner et al., 2006), uniform grey (Baker et al., 2008, 2005; Baseler 
et al., 2011; Dilks et al., 2009, 2014; Schumacher et al., 2008; Sunness et al., 2004) or 
adapted stimulus design generates largely equivalent results.   
Finally, we have also shown that individual responses from the LPZ, despite varying in 
strength and polarity, are reliable. The reliability measure we computed provides some 
context. Overall, it seems responses were reliable for both adaptation and no-adaptation 
conditions, suggesting that perhaps the pattern of responses in the sLPZ, rather than the 
univariate response, contained some stimulus information. This is consistent with previous 
work reporting patterns of response in the representation of an unstimulated part of the 
visual field contained contextual information for the scenes presented to the surrounding 
regions (Smith & Muckli, 2010). It should be noted however that in such studies, there is 
an obvious missing component to the image that participants are presented, which is not 
the case in our study.  Our results are perhaps more like the work of Williams et al (2008), 
who presented stimuli in peripheral locations and found reliable signals in central 
representations. The origin of such responses could be larger draining veins that register 
BOLD responses - and reliable ones (Olman et al., 2007; Turner, Howseman, Rees, 
Josephs, & Friston, 1998).  However, these responses are not necessarily tied to the 
location of the neurons that may drive oxygen-level changes in these larger vessels.   
Using alternative imaging protocols that are less susceptible to large vessel artefacts, such 
as spin-echo sequences, would shed light on the origin of BOLD response patterns 
detected in the LPZ (Howseman & Bowtell, 1999; Yacoub et al., 2003).  
Our approach to use both the univariate response along with the reliability of responses 
also has the potential to help understand whether a reorganisation of visual processing 
genuinely occurs in patients.  As expected, responses from the stimulus representation in 
sighed participants are positive and reliable. Unequivocal evidence of reorganisation of 
visual processing following loss of visual input would register as similarly reliable and 
positive signals within the LPZ of patients (Morland, 2015). Whilst JMD does show reliable, 





found in the sLPZ in sighted participants. Indeed, the use of response amplitude and 
reliability in classifying the LPZ responses of the patient resulted in a greater number of 
classifications being associated with normal responses from the LPZ rather than the 
stimulus representation.   
Determining the source of LPZ responses is important; if there is evidence of 
reorganisation of visual processing, this will interfere with the success of visual restoration 
(Baseler et al., 2011; Morland, 2015). Even if the function of the eye were to be restored, it 
relies on the parts of the visual brain which previously processed input from the macula to 
remain capable of processing new incoming information. Effectively, cortex would have to 
reorganise again to resume its former role of processing information from central 
representation, to allow for some form of functionally useful vision. This clearly is not the 
desired outcome, and so the reliability of LPZ responses therefore needs to be considered 
in future work to determine if those responses represent genuine evidence of 






Chapter 7: General Discussion 
The aim of this thesis was to use different neuroimaging methods to address one 
overarching question: How does eye disease, namely macular disease (MD), impact the 
structure and function of the posterior visual pathway? The focus of research has largely 
been on the physiological changes in the eye; the posterior visual pathway has not been 
studied as extensively, and so it is not surprising there are some inconsistencies within the 
neuroimaging literature concerning how the posterior pathway is affected in eye disease. 
There is an assumption that following restoration of function in the eye, the brain will be 
capable of processing new information, as it did prior to acquired vision loss. It is evident 
from studies presented in Chapters 2, 3, 5 and 6 that there are alterations to both the 
structure and function of the visual pathway in different forms of partial blindness. 
Difficulties faced when conducting longitudinal patient work were examined in Chapter 4, 
addressing some of the issues we faced for the studies presented in Chapters 2 and 3. 
Despite the challenges, we followed the same group of MD patients and sighted controls, 
exploring different anatomical measures in the posterior visual pathway over a ~24-month 
period. We have contributed some new insights on how MD affects the brain at both the 
earliest and later stages of the disease, and how this compares to natural aging. Chapters 
5 and 6 explore more specific functional questions, examining how selective vision loss 
impacts on connectivity between early and higher-level visual areas with matching 
eccentricity biases, as well as trying to ascertain whether functional reorganisation in 
visual cortex can be observed in sighted individuals with simulated retinal lesions. 
Ultimately, we wanted to get a better understanding of how viable the brain may be in 
cases of MD. 
In Chapters 2 and 3, we assessed changes in cortical thickness, myelin density and the 
integrity of the optic radiations across the same group of MD patients and sighted controls. 
We also had the unique opportunity to follow two individuals for whom we had MRI data 
before and after a diagnosis of bilateral age-related MD. This rich data set allowed us to 
tackle some of the more challenging questions concerning if and when changes occur in 
the brain, at what rate changes may occur in two individuals in the early stages of the 
disease, and how this compares to a cohort who have had bilateral MD for a number of 
years. Additionally, having data for sighted controls over a similar time period allowed us to 
directly compare the effects of natural aging against changes that may be associated with 





matter tissues occur in individuals with some remaining vision, but two novel findings also 
emerged. The first was that changes in the posterior visual pathway may be occurring 
earlier in the disease progression than anticipated; for cortical thickness and myelin 
density measures, our cases showed a greater rate of decline for regions capturing the 
anatomical representation of the visual defect, but also regions capturing intact visual field 
representations. This suggests that broader changes occur within the first few years of 
AMD but following functional vision loss. For case MD13 - who had no loss of visual 
function despite a bilateral AMD diagnosis - there was evidence of a decline, but it was 
more akin to that observed in natural aging. For our white matter measurements in the two 
cases, there was evidence of a reduction in fractional anisotropy (FA) even in the time 
point prior to AMD diagnosis. Again, this was to a greater extent for MD7 we believe due to 
having loss of visual function. The second key finding was that there is evidence for a 
continued decline even in long-standing cases of bilateral vision loss. The majority of 
ophthalmic pathologies develop much later in life, and so plasticity is brought into question; 
will the mature brain be capable of responding appropriately if visual function were to be 
restored? This is especially important to consider, given the second finding of a continued 
decline in our MD cohort. 
The anatomical studies presented in Chapters 2 and 3 also establish a broader point, that 
in order to determine how natural aging differs from aging with disease, both cross-
sectional and longitudinal assessments should be adopted where possible. Longitudinal 
studies provide rich within subject data, and the measurements we have acquired for our 
two individual cases before and after an AMD diagnosis emphasise this point. We have 
shown how individuals with AMD can vary in terms of disease progression. Multiple 
assessments particularly in the earliest stages of AMD in a larger sample could point to 
possible biomarkers for the disease that precede functional vision loss. Assessing how 
these anatomical measures change within an individual therefore provide new insights that 
may be missed in group-based cross-sectional analyses (Schaie, 2005). For example, 
there are three instances in Chapters 2 and 3 where the cross-sectional and individual 
assessments over time were important. When examining myelin density in Chapter 2, 
cross-sectional data indicated that MD patients appeared to have a greater proportion of 
cortical myelin than our sighted control group. This could have been due to a number of 
factors as discussed in Section 2.5. What was interesting was that in spite of this, 
longitudinal assessments for both the MD group and our individual case MD7 suggest 





cross-sectional data may be misleading, as a reduction in cortical thickness may lead to 
higher myelin density values being reported and indeed, this is what we found when 
examining cortical thickness. Furthermore, the longitudinal data show that myelin density 
appears to decline as well - something that would have been missed from cross-sectional 
analyses alone. The second instance where multiple time points proved valuable was in 
Chapter 3; while no significant changes emerged in white matter volume over the time 
period of the study for either MD patient or sighted control groups, our individual 
assessment particularly for MD7 - for whom we have multiple post-diagnosis data sets - 
indicates how early in the disease this may not be the case. Finally, we found that in both 
cases before AMD diagnosis, there was a dip in the structural integrity of the optic 
radiations in a particular portion of the tract, in both our projections to the occipital pole and 
the calcarine sulcus. This demonstrates that perhaps changes to the posterior pathway 
precede functional vision loss. Assessing more individuals in this early time window would 
be highly valuable, acquiring measurements at the earliest point following diagnosis, and 
even before if possible. Given the prevalence of AMD and the fact we are an aging 
population (Office for National Statistics, 2018), we may see more of the older volunteers 
who routinely participate in neuroimaging research go on to develop AMD. Like MD7 and 
MD13, we could follow individuals over time to build up a model of how AMD might 
progress. Assessing a group of age-matched controls in the same manner will also provide 
the necessary context for understanding how the posterior visual pathway responds to 
aging naturally. 
As well as understanding why white matter shows signs of compromised structural 
integrity, as shown by the decline in FA, it is important to understand what is driving it. An 
increase in radial diffusivity (RD), as observed in Chapter 3, is thought to be indicative of 
myelin loss. Early mouse models have shown that white matter can be impaired through 
demyelination, axonal injury, or both. RD increases have repeatedly been reported in 
conjunction with demyelination, whilst only subtle changes emerged for axial diffusivity 
(Song et al., 2003; Song et al., 2002, 2005; Winklewski et al., 2018). Further support 
comes from the fact that during development, the inverse pattern emerges, whereby 
increases in FA are observed alongside increases in myelination (Natu et al., 2019; 
Rokem et al., 2017; Yeatman et al., 2012). Demyelination seems to fit with results reported 
in Chapter 2, where in the same patient group, there was evidence of cortical thinning and 
a reduction in myelin density over time in early visual cortex, in the same regions of 





As discussed in Chapter 2, we cannot say what this atrophy actually reflects, and with our 
diffusion measures we do not have a quantitative assessment of the number of axons for 
example, but we can make inferences based on the diffusion properties reported. This is 
where a combination of in vivo measurements would benefit us; assessing the 
neurochemistry with MR spectroscopy would help to identify whether cortical thinning is 
reflective of cell death, or whether tissue is shrinking in a manner that means, if signals 
from the eye were restored, atrophy could be reversed (Hanson et al., 2019). Post-mortem 
data has also provided support for in vivo results, also showing that retinal disease, 
affecting retinal ganglion cell layers, causes atrophy in early visual white and grey matter 
(Bartzokis et al., 2012; Ogawa et al., 2014). 
Determining which features of the eye disease progression drives atrophy in the posterior 
visual pathway is of primary concern. It is possible that anatomical changes in the layers of 
the retina are not necessarily coupled with the functional changes captured by standard 
clinical assessments of visual function, such as perimetry and visual acuity. It is also 
possible that atrophy in the posterior pathway results from the degeneration of retinal 
ganglion cell axons (the inner layers of the retina), as observed in glaucoma. The latter 
would indicate that it is the late stages of AMD driving cortical changes. If it is driven by 
photoreceptor changes (the outer layers of the retina), then it suggests atrophy begins 
earlier in the disease progression. However, disease type may influence the time course of 
changes in the eye and brain. As discussed in Chapter 3, Ogawa et al., (2014) have 
shown that the optic radiations are affected in similar manner even across different eye 
diseases that cause progressive central vision loss; leber hereditary optic neuropathy 
(LHON) and cone-rod dystrophy (CRD) impact the retinal ganglion cell layer and the 
photoreceptor cell layer respectively, and while the outcome measures are similar for both 
acuity and white matter changes, the rate of change is what differs between the groups. 
LHON patients had the disease for ~5 years whereas for the CRD patients it was closer to 
20 years. This suggests the progression is slower for the CRD patients and therefore 
managing the disease and determining the optimal time to implement treatment plans will 
vary for CRD and LHON patients. Most retinal pathologies develop later in life (Senthil, 
Khadka, Gilhotra, Simon, & Pesudovs, 2017), and given we are yet to fully understand the 
capacity of the posterior visual pathway to process newly restored retinal inputs, it is not 
clear how the brain will adapt, particularly in cases who are deprived of visual input for a 





further longitudinal studies may govern the success of restoration attempts, alongside 
understanding what is driving the observed cortical atrophy. 
In Chapters 3 and 5, we have explored structural and functional connectivity within the 
posterior visual pathway respectively; one of the current goals in neuroscience research is 
to tease apart the biological underpinnings of communication within the brain and 
understand the relationship between structure and function. Evaluating well established 
connections at the earliest points in the posterior pathway - namely the optic radiations - is 
not sufficient going forward. Reliably reconstructing white matter tracts between different 
visual maps will allow for more specific assessments of how vision is affected in health and 
disease. In Chapter 5, we explored functional connectivity between portions of V1 and 
ventral visual areas with known eccentricity biases - the parahippocampal place area 
(PPA) and the fusiform face complex (FFC). We found specific deficits in patients with 
central vision loss, whereby the central V1 and FFC connectivity was selectively reduced 
in the right hemisphere only, compared to connectivity between peripheral V1 and PPA - 
areas with a peripheral visual field bias. Complementary structural assessments would 
allow us to build a more complete picture of how other white matter tracts beyond the optic 
tracts and radiations are impacted by disease, but also to understand this structure and 
function coupling. Other white matter structures of interest could be those projecting from 
the occipital cortex, through temporal regions and as far as the frontal lobe. The inferior 
longitudinal fasciculus (ILF) and inferior fronto-occipital fasciculus (IFOF) have been 
investigated in very few studies of acquired vision loss, and evidence is mixed. In cases of 
retinitis pigmentosa (RP) reductions in FA have been observed for both the IFOF and ILF, 
while others report an increase in functional connectivity in a different group of RP patients 
(Hofstetter et al., 2019; Rokem et al., 2017). Yoshimine et al., (2018) found no significant 
changes in a small group of AMD patients (most with unilateral loss). Given we have 
observed reduced functional connectivity between regions with a foveal bias, exploring 
white matter tracts implicated in more complex processing such as face perception may be 
fruitful in a larger group of patients. As discussed in Chapter 1, there is growing 
behavioural evidence highlighting poorer performance in face discrimination tasks in MD, 
but there is also a decline in face discrimination ability with natural aging (Rokem et al., 
2017). Rokem and colleagues found that the size of a functionally defined fusiform face 
area (FFA) in the right hemisphere correlated with the volume of the right ILF, but also 
reported that performance on a face discrimination task correlated with FA and volume in 





age-related reductions in FA for the IFOF were more pronounced than ILF changes, which 
appeared to be more immune to age-related decline (Rokem et al., 2017). Cases of 
prosopagnosia - face blindness - also show compromised integrity of the right ILF (Grossi 
et al., 2014) and so it appears that ILF may be more vulnerable in clinical cases, whereas 
IFOF is more susceptible to age-related decline. Investigating how both structure and 
function changes in a group with an age-related visual pathology such as AMD would 
therefore be interesting. 
When establishing the effects of pathological versus natural aging, sensory deprivation is a 
key model to study, as shown by the early work of Hubel and Wiesel  (Hubel & Wiesel, 
1965; Wiesel & Hubel, 1963, 1965). Exploring changes in different pathologies e.g. 
congenital versus late acquired, or partial versus complete vision loss, helps us to piece 
together when critical developmental periods occur and how plastic the brain might be 
throughout the lifespan. It is important to acknowledge that functional changes may be 
observed in the absence of structural changes in the brain. An example of this comes from 
research with congenitally blind individuals, who despite showing a reduction in FA, also 
showed an increase in the functional connectivity between visual and language regions 
(Bridge et al., 2009; Reislev et al., 2016). However, the link between structure and function 
may be impacted differently, depending on the type of vision loss. A consensus for what 
may happen in congenital versus acquired vision loss has yet to be reached, but age at 
disease onset may dictate how the brain is affected. Evidence of a typically developed 
structure in the occipital lobe in congenital vision loss, despite serving a different function 
suggests this coupling will differ compared to acquired cases, for whom the role of the 
occipital lobe for visual function has already been established prior to disease onset. For 
our studies of acquired vision loss, we have shown reduced functional and structural 
connectivity within the visual pathway; it is worth noting that we had some individuals with 
juvenile MD, but given the small number, AMD versus JMD comparisons were not 
conducted. The literature largely suggests that within visual cortex the outcomes are 
similar, but differences emerge when looking elsewhere, for example frontal regions 
(Hernowo et al., 2014). Assessing this plasticity across the lifespan would also address an 
important issue of when interventions might be most effective. Generally, the extent of 
vision loss seems to correlate with the changes in structure, as well as functional 
connectivity, highlighting that they may indeed be clinically relevant measures (Frezzotti et 
al., 2014). To advance this further, collecting both resting state fMRI and diffusion data in 





connectivity within the posterior visual pathway. With advances in both structural and 
functional imaging sequences, acquiring more data without needing to increase the scan 
duration using multiband protocols for example, will help to reduce participant burden - 
something of particular importance for vulnerable and/or aging participants. 
The extent of changes observed in the brain, as shown in the literature, seems dependent 
on many factors including (but not limited to): pathology, age of disease onset, number of 
years since diagnosis, and severity of the vision loss. In terms of the research itself, 
variations in study design and analysis techniques may also contribute to the discrepancy 
in outcome measures. Establishing how these factors impact on findings requires a series 
of highly controlled studies, which presents challenges. In Chapter 4, the difficulties faced 
in our longitudinal neuroimaging and neurostimulation structural study reported in 
Chapters 2 and 3 were discussed. Using stringent inclusion criteria in order to control for 
variation within disease type can limit recruitment, making studies underpowered. 
However, without this, we face situations described previously whereby inconsistencies 
emerge within and between studies. For our research, we reasoned that disease aetiology 
was less relevant, but ensuring the patients had central-affecting bilateral vision loss was 
the most important factor when exploring changes in cortex. We did have to expand our 
criteria and recruit individuals with varying extents and types of central vision loss, for 
example allowing individuals with the wet form of AMD to enrol. This allowed us to recruit 
more individuals, primarily because these were the individuals routinely visiting the clinic 
for treatment, unlike patients with dry AMD who do not attend the clinic so frequently. 
Despite acquired vision loss such as AMD being common, it proved more difficult to recruit 
given the added contraindications associated with aging (e.g., more likely to have other 
ailments preventing them from participating in certain procedures). What we have learned 
in the process is that a delicate balance is required when considering longitudinal studies; 
balancing the participant burden - particularly if acquiring multiple measures on a smaller 
number of individuals - resources available and access to necessary equipment can be 
hard to achieve. Our studies suffered most with regard to ophthalmological assessments 
at the start and end of the study, due to lack of staff and equipment availability. Ensuring 
collaborations allow for sufficient and more reliable measures of visual function is 
important, especially when making inferences about the relationship between measures of 





The move towards more open science practises could be beneficial but is still more 
challenging in patient-based neuroimaging research; being more transparent about 
protocols, study design and analysis pipelines will allow for researchers to implement the 
same procedures in separate participant pools. With MRI studies, this can be more difficult 
given researchers will be limited by scanner type and so modifications to protocols may be 
required. Additionally, availability of software for analysis may also be a hindrance. Moving 
towards a more cohesive way of working, collaborating across research centres to build a 
larger database for patients may be the way forward. The human connectome project 
(HCP) protocols make consistency more achievable and were implemented in this thesis. 
They were adapted for our measures acquired in Chapter 2 as there was no guidance for 
setting it up on the GE scanner, but for Chapter 5 however, we could replicate the original 
HCP protocol for the Siemens scanner. Another issue identified in Chapters 2 and 3 which 
may explain part of the inconsistency in the literature, is the way in which cortex is 
parcellated and how ROIs are defined. Some researchers opt to explore V1 in its entirety, 
while others distinguish between central and peripheral representations using retinotopic 
mapping and anatomical or functional atlases. It is clear how different combinations of 
methods can lead to different results, especially when dealing with individuals with 
selective vision loss, but what was interesting for us is that we get very similar results in 
Chapter 2 when we used both the original anatomical parcellations for the occipital pole 
and calcarine sulcus, and those restricted to V1. An additional way to verify these results 
would be to use the Benson atlas, for example, where you can specify the degrees of 
visual angle you wish to restrict your ROI by. Having individuals with selective vision loss 
allows for participants to effectively act as their own control, by exploring representations 
of both lesioned and intact parts of the visual field; functionally defining which portions of 
early visual cortex are receiving visual input from the retina can therefore be highly 
valuable. Having said this, we have opted to use atlases for most of the work described in 
this thesis as it allowed for greater consistency across subjects (both patients and 
controls), as well as over time. Participant burden is also reduced this way as it means a 
shorter scanning session without a functional localiser. 
Functional reorganisation of visual function has been a topic of interest for a number of 
years, and there is still some disagreement. As discussed in Chapters 1 and 6, part of the 
debate concerns differing definitions for functional reorganisation. The broader definition is 
that if a patient exhibits a response that cannot be shown in normally sighted populations, 





refers to a change from what we know about the organisation of the visual system in 
normally sighted individuals but observing abnormal signals does not necessarily mean 
that any cortical reorganisation has occurred (Morland, 2015). While there is evidence 
suggesting the brain is capable of some form of reorganisation of function in response to 
changes e.g. the natural aging process, disease or injury, some additional modifications 
may serve a purpose. This allows for some form of compensation of function following a 
change, for example visual deprivation. Cross-modal plasticity, while useful in congenital 
blindness, may be more inconvenient in cases of acquired vision loss, particularly when 
visual restoration is the ultimate goal. The brain would effectively have to undergo 
reorganization for a second time, to revert to its former role of processing visual 
information from the central visual field (Baseler et al., 2011; Morland, 2015). In Chapter 6 
we wanted to investigate functional reorganisation further, by focusing more on whether 
we could observe responses in a simulated lesion projection zone (LPZ) in sighted 
participants when presenting images to the periphery, after inducing a transient retinal 
lesion - something that had not been done before. Previous work failed to report any 
responses in the simulated LPZ in sighted participants, for whom the central visual field 
was simply greyed out. Whilst at the group level we did not observe patient-like LPZ 
responses, and our more realistic simulation of a retinal lesion did not alter responses in 
the simulated LPZ, individual assessments were interesting. Given that in the literature, 
only a minority of patients display responses in the LPZ (Morland, 2015), it is important to 
determine whether the responses observed in this subset of individuals is genuine or not. 
In a small number of sighted participants, task-related responses in the simulated LPZ 
could be observed. An important addition to our study was an assessment of the reliability 
of these responses. Previous work has reported the presence or absence of response, but 
not the reliability within individuals. Our results suggest that despite individual responses in 
the simulated LPZ varying in strength and polarity, they are indeed reliable, and perhaps 
the pattern of responses within the simulated LPZ contained some stimulus information, as 
opposed to the univariate responses. Our work lends support to the idea that responses in 
the LPZ may not be unique to patients with retinal defects, and is likely that responses are 
a result of the unmasking of top-down feedback as proposed by Masuda and colleagues, 
described in more detail in Section 1.5.1 (Masuda et al., 2008, 2010, 2021). This additional 
information about the reliability of the responses observed gives the results some context 







Vision plays an important role in our overall health and well-being; it is essential for many 
everyday activities and so the consequences of vision loss, particularly if acquired later in 
life, can have a detrimental effect. Not being able to read, drive, accurately recognise 
familiar faces, or navigate round your home can make basic tasks much more challenging, 
in turn reducing independence. This is just one of the many justifications for investigating 
the full extent of MD and the consequences beyond the eye. To fully understand the 
disease progression in MD, a multi-pronged approach must be taken, to explore both 
ophthalmological and neural consequences of sensory deprivation. Combining ophthalmic 
measures with structural and functional MRI to further understand the relationship between 
the eye and brain could allow for reliable and earlier detection of biomarkers for disease, 
but also inform research focused on developing therapeutic and neuroprotective 
strategies. Glaucoma is a good example of how something originally thought to be a purely 
ophthalmological disease may indeed fall under neurodegenerative conditions. It has been 
reported that only 40% of individuals with wet AMD who are undergoing anti-VEGF 
treatment successfully regain some visual function (Gonzalez, 2011; Heier et al., 2012; 
Yoshimine et al., 2018), and so it is important to acknowledge that the viability of the visual 
brain may limit the success of current treatments as well as future attempts at visual 
restoration. Research focused on treating the eye is currently gaining pace, examining the 
effects of gene therapy, stem cell therapy, as well as retinal prostheses, in a bid to restore 
functionally useful vision in conditions such as MD. There is an assumption that visual 
areas will be able to process the restored retinal signals in an appropriate manner, but if 
the visual brain is no longer viable due to prolonged sensory deprivation, or if there is 
evidence of reorganisation of function, success will likely be limited. Previous work has 
demonstrated that following restoration of visual input using retinal implants, brain 
responses are not immediate, and it needs time to recalibrate and resume responding 
appropriately to the newly restored visual input (Castaldi et al., 2016). What has been 
highlighted in this thesis is that changes in the posterior visual pathway are broad. Using 
various MRI protocols as shown throughout this thesis, we can non-invasively tease apart 
the consequences of sight loss on both the structure and function of the entire visual 
pathway, from retina to cortex, in various stages of eye disease. It may also be a useful 
tool for identifying who may be better candidates for restoration based on the status of 
visual cortex. The fact we are an aging population further highlights the need to get a 





may be different to natural aging, as the prevalence of the age-related form of MD will 













A1. Results from one-way ANOVAs for the occipital pole and calcarine sulcus fiber 
bundles for fractional anisotropy for Chapter 3. Locations along the tract where 




Occipital Pole Calcarine Sulcus 
Location F (df) p Location F (df) p 
41 5.75 (1, 24.84) .024 42 5.35 (1,21.50) .031 
43 7.89 (1,26.90) .009 44 4.47 (1,24.04) .045 
44 4.87 (1,24.77) .037 45 6.28 (1,24.57) .019 
45 7.62 (1,23.50) .011 46 5.60 (1,24.84) .026 
46 5.77 (1,23.01) .025 47 7.50 (1,23.20) .012 
47 5.84 (1,21.21) .025 48 4.63 (1,21.99) .043 
48 5.65 (1,23.86) .026 49 8.35 (1,23.52) .008 
50 4.81 (1,21.66) .039 52 6.47 (1,22.77) .018 
52 5.21 (1,17.57) .035 53 5.15 (1,22.36) .033 
53 6.44 (1,16.17) .022 54 5.84 (1,21.23) .025 
54 13.25 (1,14.24) .003 55 4.61 (1,19.78) .044 
55 15.65 (1,16.58) .001 56 4.47 (1,17.22) .049 
56 12.91 (1,16.62) .002 57 6.36 (1,18.93) .021 
57 11.55 (1,17.24) .003 58 7.81 (1,18.47) .012 
58 9.13 (1,16.97) .008 59 10.04 (1,18.88) .005 
59 11.05 (1,15.18) .005 60 11.00 (1,22.62) .003 
60 11.31 (1,15.88) .004 61 10.51 (1,19.55) .004 
61 8.93 (1,17.09) .008 62 11.48 (1,21.14) .003 
62 8.41 (1,17.90) .010 63 11.70 (1,17.72) .003 
63 9.33 (1,17.45) .007 64 10.19 (1,17.28) .005 
64 8.88 (1,19.60) .008 65 7.02 (1,16.84) .017 
65 9.76 (1,19.17) .006 67 5.61 (1,16.80) .030 
66 9.88 (1,18.15) .006 68 5.11 (1,15.73) .038 
67 8.02 (1,18.83) .011 69 4.62 (15.79) .048 
68 16.43 (1,19.84) .001 70 5.33 (1,15.53) .035 
69 7.64 (1,16.60) .014 71 6.07 (1,14.98) .026 
70 10.16 (1,18.79) .005 72 5.89 (1,15.07) .028 
71 10.47 (1,17.42) .005 73 8.26 (1,16.53) .011 
72 7.53 (1,19.16) .013 74 9.08 (1,17.89) .007 
73 6.62 (1,18.33) .019 75 15.31 (1,19.25) .001 
74 4.94 (1,19.06) .039 76 9.03 (1,24.06) .006 
75 7.29 (1,17.95) .015 77 22.32 (1,21.64) .000 
79 5.09 (1,19.34) .036 78 22.88 (1,23.11) .000 
90 6.82 (1,20.82) .016 79 12.35 (1,23.58) .002 
      80 14.13 (1,21.70) .001 
      81 12.94 (1,26.17) .001 
      82 8.16 (1,22.91) .009 
      84 4.42 (1,24.95) .046 





A2. Results from one-way ANOVAs for the occipital pole and calcarine sulcus fiber 
bundles for axial diffusivity for Chapter 3. Locations along the tract where significant 




Occipital Pole Calcarine Sulcus 
Location F (df) p Location F (df) p 
25 5.75 (1,20.62) .026 27 4.60 (1,19.41) .045 
26 10.23 (1,26.00) .004 54 4.83 (1,24.07) .038 
73 5.29 (1,20.52) .032       
75 7.96 (1,18.41) .011       
76 8.35 (1,19.57) .009       
78 6.54 (1,13.45) .023       





A3. Results from one-way ANOVAs for the occipital pole and calcarine sulcus fiber 
bundles for radial diffusivity for Chapter 3. Locations along the tract where 





Occipital Pole Calcarine Sulcus 
Location F (df) p Location F (df) p 
53 4.74 (1,18.84) .042 47 4.46 (1,23.68) .045 
54 8.38 (1,15.52) .011 49 5.17 (1,23.43) .032 
55 8.53 (1,18.94) .009 52 8.18 (1,19.85) .010 
56 6.82 (1,19.28) .017 53 5.34 (1,21.77) .031 
57 6.27 (1,18.36) .022 54 7.11 (1,17.87) .016 
58 5.45 (1,17.61) .032 55 6.22 (1,15.14) .025 
59 6.31 (1,14.55) .024 56 4.57 (1,19.83) .045 
60 5.75 (1,16.95) .028 57 5.91 (1,16.72) .027 
61 5.66 (1,16.72) .030 58 6.17 (1,18.50) .023 
63 5.88 (1,17.46) .026 59 5.94 (1,17.77) .026 
64 4.97 (1,21.15) .037 60 7.18 (1,17.90) .015 
65 5.42 (1,19.74) .031 61 5.81 (1,19.75) .026 
66 6.31 (1,17.09) .022 62 5.85 (1,22.37) .024 
67 6.40 (1,18.33) .021 63 6.61 (1,17.16) .020 
68 11.90 (1,15.57) .003 64 5.43 (1,20.07) .030 
69 5.66 (1,17.70) .029 65 5.20 (1,18.53) .035 
70 9.19 (1,16.62) .008 67 4.64 (1,17.70) .045 
71 11.01 (1,15.20) .005 68 4.89 (1,14.71) .043 
72 9.99 (1,17.03) .006 73 5.28 (1,14.96) .036 
73 9.94 (1,16.18) .006 74 5.04 (1,16.98) .038 
74 5.54 (1,16.45) .031 75 6.60 (1,16.15) .021 
75 12.03 (1,16.56) .003 77 7.82 (1,18.02) .012 
76 7.92 (1,13.85) .014 78 6.35 (1,20.13) .020 
77 6.09 (1,15.52) .026 79 4.40 (1,21.60) .048 
78 9.49 (1,15.50) .007 80 5.79 (1,17.59) .027 
79 9.42 (1,14.29) .008 81 4.62 (1,19.73) .044 
80 7.10 (1,16.08) .017 85 5.56 (1,20.31) .029 
81 7.41 (1,17.07) .014 89 4.31 (1,26.93) .048 
82 5.40 (1,16.51) .033       
83 6.21 (1,16.50) .024       
85 5.48 (1,17.20) .032       
86 5.04 (1,20.01) .036       
88 4.47 (1,20.85) .047       





A4. Tract profiles for our individual AMD cases MD7 (A) and MD13 (B) for axial 
diffusivity for Chapter 3.  
 
  
Comparing AD along the tracts for individual cases before and after diagnosis against 
sighted control and MD patient groups. A: Individual time point AD data for MD7 
plotted against sighted control (black line) and MD group means (red for occipital pole 
projections, and blue for calcarine sulcus projections. Shaded regions represent 1 
standard deviation for each group (grey = controls, red/blue = MD patient group). MD7 
baseline data (before diagnosis) are shown in purple (left) and teal (right). Last time 
point (2.25 years after diagnosis) is shown in magenta (left) and cyan (right). B: Same 
as A, but for MD13 data. Second time point for MD13 (1.42 years post-diagnosis) is 





A5. Tract profiles for our individual AMD cases MD7 (upper) and MD13 (lower) for 
radial diffusivity for Chapter 3.  
  
Comparing RD along the tracts for individual cases before and after diagnosis against 
sighted control and MD patient groups. A: Individual time point RD data for MD7 plotted 
against sighted control (black line) and MD group means (red for occipital pole 
projections, and blue for calcarine sulcus projections. Shaded regions represent 1 
standard deviation for each group (grey = controls, red/blue = MD patient group). MD7 
baseline data (before diagnosis) are shown in purple (left) and teal (right). Last time 
point (2.25 years after diagnosis) is shown in magenta (left) and cyan (right). B: Same 
as A, but for MD13 data. Second time point for MD13 (1.42 years post-diagnosis) is 






B1. Full list of other eye affecting pathologies – Chapter 4 
Eye Disease / Injury Definition 
Retinal Pigment Epithelial Rip 
Rip in the RPE developed from an RPE detachment or 
caused by intravitreal injection. Associated with 
vascularised RPE detachment due to AMD.  
Retinal Detachment 
When retina pulls away from the blood vessels 
supplying it with oxygen 
Chronic branch retinal vein occlusion 
Second most common retinal vascular disorder (after 
diabetic retinopathy). Main symptom includes visual 
floaters from a vitreous haemorrhage (blood vessels 
leaking into the vitreous gel of the eye). Essentially a 
blockage of the small veins in the retina. 
Degeneration of Posterior Pole 
Degeneration of the retina between the macula and the 
optic disc. 
Central Serous Retinopathy /chorioretinopathy 
(CSR/CSCR) 
Fluid collects in the macula, causing it to swell, 
affecting central vision, usually temporary but can 
reoccur. Largely unknown cause, but could be Type A 
personality, steroid use, pregnancy, Cushing 
Syndrome.  
Pigment epithelial detachment 
Fluid beneath the RPE (layer of cells beneath the 
retina), usually caused by AMD and CSR 
Adult Vitelliform (Pattern Dystrophy) 
Genetic form of macular dystrophy with onset in mid-
adulthood. 
Choroidal Neovascularisation 
Growth of new blood vessels that originate from the 
choroid through a break in the Bruch membrane into 
the sub-retinal pigment epithelium or subretinal space. 
Pseudophakia Replacement lens following cataract removal surgery 
Corneal Surface Break 
Damage to the cornea resulting in blocking or distortion 
of light 
Fuch's Endothelial Dystrophy 
inherited eye condition causing the cornea to become 
cloudy 
Ocular Hypertension 
Increased intraocular pressure if left untreated can lead 
to glaucoma and permanent vision loss 
Amblyopia 
Lazy eye. Developmental eye disorder - eye fails to 
achieve normal visual acuity even with prescription 
glasses or contact lenses. Usually only one eye 
affected.  
Corneal epithelial membrane dystrophy 
Affects the anterior cornea, causing blurry vision, pain, 
sensitivity to light, excessive tearing, and a feeling of 
something being in the eye 
Polypoidal Choroidal Vasculopathy 
Loss of central vision caused by bleeding, leakage, and 
scar tissue formation.  
Band Keratopathy 
calcific degeneration of the superficial cornea that 
involves mainly the bowman layer.  Appearance of 
calcium in the central cornea.  
Glaucoma 
Caused by elevated intraocular pressure. Progressive 








Rare genetic disorders that cause a breakdown of cells 
in the retina. Peripheral vision loss and difficulty seeing 
at night. 
Optic Disc Pit 
Congenital anomaly of the optic disc complicated by 





B2. TDCS safety questionnaire 
 
York Neuroimaging Centre 
The Biocentre, York Science Park, Heslington, York, YO10 5DG 
Tel. 01904 435329, Fax 01904 435356 
Confidential 
SAFETY SCREENING FORM 
(version 1.1 – 9th February 2015) 
If you agree to take part in this study, please answer the following questions. It is 
essential that you answer truthfully. The information you provide is for safety 
screening purposes only and will be kept completely confidential. 
1. Have you ever suffered from any neurological or psychiatric 
conditions? 
If YES please give details (nature of condition, duration, 
current medication, etc). 
YES / NO 
2. Have you ever suffered from epilepsy, febrile convulsions in 
infancy, had a fit or seizure or recurrent fainting spells? 
YES / NO 
3. Does anyone in your immediate or distant family suffer from 
epilepsy? 
If YES please state your relationship to the affected family 
member. 
YES / NO 
4. Have you ever had an operation on your head or spine 
(including eye surgery)? 
If YES please give details. 
YES / NO 
5. Do you currently have any of the following fitted to your 
body? 
• Heart pacemaker   
• Cochlear (ear) implant 
• Medication pump 
• Surgical clips   
• Any other biomechanical implant 
 
YES / NO 
6. Have you ever had an injury to your eye involving metal 
fragments? 





7. Do you have any skin damage or disease affecting your 
scalp or face?  
YES / NO 
• 8. Do you suffer from recurrent headaches or 
migraines?  
YES / NO 
9. Are you currently taking any unprescribed or prescribed 
medication? 
If YES please give details. 
YES / NO 
10. Are you currently undergoing anti-malarial treatment? YES / NO 
11. Have you drunk more than 3 units of alcohol, or used 
recreational drugs in the last 24 hours? 
YES / NO 
12. Have you already drunk alcohol today? YES / NO 
13. Have you had more than one cup of coffee, or other 
sources of caffeine, in the last hour? 
YES / NO 
14. Did you have very little sleep last night? YES / NO 
15. Have you already participated in a TMS/tDCS experiment 
today? 
YES / NO 
16. Are you or could you be pregnant? YES / NO 
Participant details: 
16. Are you left or right handed?        
 Left / Right 
17. Date of birth            
__/__/__ 
I understand that the above questions check for serious risk factors. I CONFIRM 
THAT I HAVE READ, UNDERSTOOD AND CORRECTLY ANSWERED THE ABOVE 
QUESTIONS  




















B4. Notes on medications described in Figure 4.4. 
1 Anti-hypertensive medicines are defined as BNF codes 2.2, 2.4, 2.5 and 2.6.2. 
2 Lipid-lowering medicines are defined as BNF codes 2.12. 
3 Proton pump inhibitors are defined as BNF code 1.3.5. 
4 Analgesics and/or NSAIDs (non-steroidal anti-inflammatory drugs) are defined as BNF 
codes 4.7, 10.1.1 and 10.3.2 
5 Antidepressants medicines are defined as BNF code 4.3. 
6 Medicine for asthma or COPD are defined as BNF codes 3.1, 3.2, 3.3, and 3.6. 
7 Antiplatelet medicines are defined as BNF code 2.9. 







B5. Participant survey results – future research into the consequences of sight loss on the 
visual pathway – Chapter 4. 
Methods: 
Survey was sent out attached to an email to participants who had signed up to our Vision 
Research Mailing list. Participants had the option of filling out the survey themselves and 
returning electronically, by post or the survey could be completed over the phone with the 
researcher. Where electronic signatures were not possible, written consent was obtained 
from participants by posting out the study information. 12 participants responded to the 
survey (Age range 54 – 90 years, mean age = 66.75 years). 9 out of 12 participants 
reported having a visual impairment (3 sighted controls, 4 with retinitis pigmentosa, 4 with 
age-related macular degeneration, 1 with juvenile macular degeneration). 
The short study was devised to get some participant feedback on ideas for an upcoming 
grant application. This study followed the tenets of the Declaration of Helsinki with 
approval granted by YNiC Research, Ethics and Governance Committee.  
Summary of the survey:  
The Vision Research Group at York Neuroimaging Centre are hoping to secure funding to 
continue working on vision loss research, examining the consequences of vision loss on 
the entire visual pathway, from eye to brain. The aim for this survey is to engage with 
individuals with and without visual impairment and get some feedback on future research 
project ideas, as well as feedback on previous research experience.  
The relevant questions to the point made on page 13 are as follows: 
Did you find the multiple research visits problematic?  
5 out of 12 responded N/A due to the fact they have only participated in single session 
studies so far. The remaining 7 out of 12 had completed a multi-visit study, all of whom 
responded ’No’. 
For one of our future studies examining potential changes in the brain in sight loss, 
we anticipate having 8 visits for each participant over 4 years. This would include 1 
visit to the University for the MRI scans, and 1 visit to a clinic to acquire images of 
the eye each year. We would pay for all travel costs/expenses incurred. Does this 
seem reasonable?   
All 12 responded ‘Yes’.  
Typically, an MRI session itself would last no longer than 1 hour, plus 30 minutes of 





All 12 responded ‘Yes’.  
How much time would you be willing to give up for a research session (MRI or 
otherwise, EXCLUDING travel time)?  
1 – 1.5 hours 2 
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